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ABSTRACT
BATCH AND CONTINUOUS PRODUCTION OF STABLE DENSE
SUSPENSIONS OF DRUG NANOPARTICLES IN A WET STIRRED
MEDIA MILL
by
Afolawe mi Afolabi
One way to improve the bioavailability of poorly water-soluble drugs is to reduce particle
size of drug crystals down to nanoscale via wet stirred media milling. An increase in total
surface area per mass loading of the drug and specific surface area as well as reduced
external mass transfer resistance allow a faster dissolution of the poorly- water soluble
drug from nanocrystals. To prevent aggregation of nanoparticles, polymers and
surfactants are dissolved in water acting as stabilizers via adsorption onto the drug
crystals.
In the last two decades, ample experimental data were generated in the area of wet
stirred media milling for the production of drug nanoparticle suspensions. However, a
fundamental scientific/engineering understanding of various aspects of this process is still
lacking. These challenges include elucidation of the governing mechanism(s) during
nanoparticle formation and physical stabilization of the nanosuspension with the use of
polymers and surfactants (formulation parameters), understanding the impact of process
parameters in the context of first-principle-based models, and production of truly
nanosized drug particles (10–100 nm) with acceptable physical stability and minimal
contamination with the media. Recirculation mode of milling operation, where the drug
suspension in a holding tank continuously circulates through the stirred media mill, has
been commonly used in lab, pilot, and commercial scales. Although the recirculation is
continuous, the recirculation operation mode is overall a batch operation, requiring
significant number of batches for a large-volume pharmaceutical product. Hence,
development and investigation of a truly continuous process should offer significant
advantages. To explain the impact of some of the processing parameters, stress intensity
and stress number concepts were widely used in literature, which do not account for the
effect of suspension viscosity explicitly. The impact of the processing parameters has not
been explained in a predictive and reliable manner.

In this dissertation, a comprehensive investigation of the production of
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the
recirculation and continuous modes has been conducted to address the aforementioned
fundamental challenges. Griseofulvin has been selected as a model poorly water-soluble
BCS Class II drug. Impact of various formulation parameters such as stabilizer type and
loading as well as processing parameters such as rotor speed, bead loading, bead size,
suspension flow rate and drug loading was studied. A major novelty of the present
contribution is that the impact of processing and formulation parameters has been
analyzed

and

interpreted

using

a

combined

experimental–theoretical

(microhydrodynamic model) approach. Such a comprehensive approach allowed us to
intensify the process for the production of sub-100 nm drug particles, which could not be
produced with top-down approaches in the literature so far. In addition, a multi-pass
mode of continuous operation was developed and the so-called “Rehbinder effect”, which
has not been shown for the breakage of drug particles, was also elucidated. The
dissertation work (1) indicated the need for a minimum polymeric stabilizer-to-drug ratio
for proper stabilization of drug nanosuspensions as dictated by polymer adsorption and
synergistic interactions between a polymeric stabilizer and a surfactant, (2) demonstrated
the existence of an optimum polymer concentration from a breakage rate perspective in
the presence of a surfactant, which results from the competing effects of viscous
dampening and enhanced steric stabilization at higher polymer concentration, (3)
developed fundamental understanding of the breakage dynamics–processing–formulation
relationships and rationalized preparation of a single highly drug- loaded batch (20% or
higher) instead of multiple dilute batches, (4) designed an intensified process for faster
preparation of sub-100 nm particles with reduced specific energy consumption and media
wear (i.e. minimal drug contamination), and (5) provided first evidence for the proof of
Rehbinder effect during the milling of drugs. Not only do the polymers and surfactants
allow proper physical stabilization of the nanoparticles in the suspensions, but they also
do facilitate drug particle breakage. This dissertation also discusses applications of
nanosuspensions and practical issues encountered during wet media milling.
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CHAPTER 1
INTRODUCTION

1.1 Background and Motivation
Fast and efficient development of pharmaceutical formulations containing poorly watersoluble drug particles is of great interest to the pharmaceutical industry (Date and
Patravale, 2004). By some estimates, 60% of drug candidates currently under
investigation can be classified as Biopharmaceutical Classification System (BCS) Class
II, for which the bioavailability is limited by the dissolution rate. Recent advances in
combinatorial chemistry aided the discovery of new drug molecules with such low
solubility characteristics (Muller and Peters, 1998; Niwa et al., 2011). Few approaches
that have been employed to improve drug solubility are the use of co-solvents or salt/prodrug formation (Merisko-Liversidge and Liversidge, 2011), reduction of particle size of
the drugs (Merisko-Liversidge and Liversidge, 2011) and amorphous solid formation by
methods such as hot melt extrusion (Leuner and Dressman, 2000), super cooling of the
melt, rapid precipitation from solution (e.g., during freeze-drying or spray drying)
(Hancock and Zografi, 1997). While amorphous solids have higher solubility and
dissolution rates, they are generally less stable physically and chemically than their
corresponding crystal forms.
A popular approach for the bioavailability enhancement of poorly water-soluble
drugs is particle size reduction. Reduction in particle size leads to an increase in the
specific surface area of the drug particles which in turn improves the dissolution rate as
per the modified version of Noyes-Whitney equation (Noyes and Whitney, 1897).

1

dm
 k0 A(CS  C )
dt

(1.1)

Here, k 0 is the overall solute transfer coefficient defined by 1/k 0 = 1/k i + 1/k c, where k i and
k c are the interface rearrangement constant and the external mass transfer coefficient
respectively, Cs is the saturation solubility, C is the concentration in the bulk solution, A
is the total surface area, and m is the amount dissolved at time t. Upon a decrease in
particle size, the saturation solubility Cs increases according to the Ostwald-Freundlich
equation and results in an increased dissolution rate in the nanoparticle size domain
(Florence & Attwood, 1981). The increase in saturation solubility and surface area is
important for dissolution of the nanoparticles (typically particles smaller than 1 m,
prevalent within the pharmaceutical terminology); while the increase in surface area and
decrease in the thickness of diffusion layer around the microparticles (Bisrat & Nystorm,
1988) contribute to the higher dissolution rates of the microparticles (particles typically in
the size range 1–10 μm).
Ultrafine particles (or nanoparticles) can be produced either by the so-called topdown approach, which includes jet milling (Chan et al., 2002), high pressure
homogenization (Kamiya et al., 2009), and stirred media milling (Bilgili et al., 2004,
2006); or by the bottom- up approach (Anais et al., 2009; Chiou et al., 2008) which
involves building up particles by precipitation of dissolved molecules. Wet media milling
has been the most popular approach of producing nanocrystals with four products
Rapamune ® (Wyeth),

Emend ® (Merck), Tricor® (Abbott), and Megace® (Par

Pharmaceutical) currently on the market, which make use of Elan’s Nanocrystal
Technology® (Liversidge et al., 1992). During wet stirred media milling, an aqueous
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suspension containing drug particles and dissolved stabilizers (polymer and/or surfactant)
as well as hard beads (media) is stirred at high speed by a rotor. Repeated stressing of the
micron-sized drug particles that are captured between the co lliding beads causes breakage
and eventually production of nanoparticles provided that milling is continued for
sufficient time. The milled particles in nanosuspensions (suspensions with median size
typically less than a micron) interact significantly with the neighboring particles through
van der Waals (interparticle) forces, hydrophobic forces, etc. due to their large surface
area (Israelachvili, 1992). The attractive interparticle forces can ultimately result in
particle aggregation if the suspensions are not properly stabilized. Stabilization can be
achieved using polymers, surfactants or a combination of both; however, the particle
growth can also occur in the suspension by Ostwald ripening during storage (Wu et al.,
2011). Therefore, from a stability perspective as well as patient preference/compliance
perspective, the general practice in pharmaceutical industry is to dry these suspensions
into powders and incorporate them into solid dosage forms via standard pharmaceutical
unit operations such as blending, milling, capsule filling, and tabletting.

1.1.1 Physical Stability of Wet-Media Milled Suspensions
In general, physical stabilization of suspensions can be achieved either by electrostatic,
steric or electrosteric interactions (Kim, 2004; Napper, 1970). During electrostatic
stabilization, the surface of the particles is equally charged (e.g. by the formation or
adsorption of ions) so that repulsion forces emerge, which can overcome the attractive
van der Waals forces between the particles. Steric stab ilization results from the
adsorption of polymers or larger monomers onto the particles’ surface. If the adsorbed
polymer contains charged groups, steric and electrostatic components act simultaneously,
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which is typically described as electrosteric stabilization. To protect drug particles against
aggregation, formulators commonly use stabilizers like polymer(s) and/or surfactant(s).
A review by Van Eerdenbrugh et al. (2008) lists various polymers and surfactants
and their concentrations used for the stabilization of drug nanoparticle suspensions. Few
systematic studies on the stabilizing capability of adsorbed polymers suggest the
importance of hydrophobicity of the polymers (Lee et al., 2005, 2008) and surface energy
difference between drug particles and polymers (Choi et al., 2005; Lee et al., 2008).
Investigation of the polymer adsorption on drug nanoparticles in aqueous suspensions has
led to insight into the steric stabilization capability of the polymers and selection of
optimum polymer concentration (Choi et al., 2008; Lee, 2003; Panmai and Deshpande,
2003; Sepassi et al., 2007). Despite these advances, it is still not possible to predict, based
solely on first principles and mechanistic understanding, an optimal stabilizer
type/concentration for a given drug that ensures proper short- and long-term physical
stability of the drug nanoparticle suspensions. This task is usually carried out by stabilizer
screening studies at the bench-scale (Kesisoglou et al., 2007; Van Eerdenbrugh et al.,
2008), where milling dynamics, process cycle times, and scale-up effects are not of any
concern.

1.1.2 Breakage Dynamics and Microhydrodynamics
Milling in a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (e.g. Lee,
2003; Lee and Cheng, 2006; Liversidge and Cundy, 1995; Merisko-Liversidge et al.,
1996; Van Eerdenbrugh et al., 2007), both making use of vials containing drug
suspensions with various stabilizers, has previously been described for their capability in
obtaining nanoparticles. These mills are regarded as medium or low-energy mills; hence,
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suspension flow and microhydrodynamics are quite different in these mills than in the
wet stirred media mills. It is not surprising to see that the nanoparticles are produced after
several hours to a few days of milling even at the bench scale with suspension quantities
on the order of ~10 ml. In other screening studies, wet stirred media mills are used: e.g.
the Nanomill® System (e.g. Kesisoglou et al., 2007). However, the impact of stabilizers
on the microhydrodynamics has not been reported. More importantly, as pointed out by
Bhakay et al. (2011), most wet media milling work in pharmaceutical literature either
disregarded the breakage kinetics (rate) completely (as in Ain- Ai and Gupta, 2008;
Cerdeira et al., 2010; Choi et al., 2005; Liversidge and Cundy, 1995; Tanaka et al., 2009;
Van Eerdenbrugh et al., 2008, 2009) or did not characterize the breakage kinetics and its
relationship to the stabilizers quantitatively (as in Lee, 2003; Lee et al., 2005, 2008; Choi
et al., 2008; Deng et al., 2008).
While scant information is available regarding the impact of stabilizers on the
breakage rate during wet stirred media milling, the microhydrodynamics, which is the
study of the fluctuating motion of the beads in sheared suspensions, has not been
investigated at all. The milling process has been largely treated as a “black-box” in
pharmaceutical literature. The recent advances in wet media milling of nonpharmaceutical materials are summarized here. It is known that high solids loading
results in high suspension viscosity, which could dampen the collision speed of the
milling beads (viscous dampening) and reduce the breakage rate (Knieke et al., 2010;
Mende et al., 2003). Knieke et al. (2010) provided a semi-theoretical model based on the
kinematic equations describing the relative motion of undeformed spheres (beads).
However, their model does not allow calculation of the bead oscillation velocity and
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frequency (microhydrodynamic parameters), which fundamentally determine the
breakage rate along with the material properties in a wet stirred media mill (Eskin et al.,
2005a, 2005b). Using the well-known kinetic theory of granular flows and the
fundamental granular energy balance (Gidaspow et al., 1994), Eskin et al. (2005a, 2005b)
developed a microhydrodynamic model on the basis that the power spent on stirring the
mill rotor dissipates through bead–suspension viscous friction, lubrication, and partially
inelastic collisions of the beads. This model was used to study the effects of stirring
speed, beads loading, and bead size on the microhydrodynamic parameters in a mixing
tank with Rushton type paddles, which provided significant insight into the
experimentally observed impact of these process parameters on the bead collision
dynamics. However, this model has not been applied to the wet stirred media milling of
drug suspensions with the objective of elucidating the impact of stabilizers such as
viscous dampening of the polymers on the breakage rate.

1.1.3 Impact of Wet Milling Process Parameters
Although ample experimental data exists on pharmaceutical nanoparticles production and
their stabilization via wet media milling, the impact of process parameters on the
breakage kinetics and its relation to the microhydrodynamics has not been reported.
Considering that the breakage kinetics determines the process cycle times and production
rate for a desired fineness of the nanosuspension, it is fair to remark that a significant gap
exists in the pharmaceutical engineering literature regarding the dynamics of the wet
media milling process. As wet media milling process is time-consuming, costly, and
energy-intensive (Kawatra, 2006) and the breakage kinetics determines the cycle time
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and production rate for a desired fineness, milling process design and optimization entails
a good understanding of the breakage kinetics and its controlling process parameters.
Process parameters such as stirrer speed, bead loading, and drug loading can
significantly affect the breakage rate and milling time required in a wet stirred media
milling process. In a recent review paper, Peltonen and Hirvonen (2010) summarized
various process parameters and their ranges investigated in wet media milling processes.
While Peltonen and Hirvonen (2010) and the references cited therein provide great
understanding of the impact of stabilization and formulation, little fundamental
understanding of the impact of process parameters is available at the beads scale
(microhydrodynamics). In a more recent work, Ghosh et al. (2012) present the effects of
stirrer speed, bead size, and drug content on the final milled suspension; however, the
impact of these parameters on the breakage kinetics was not investigated. Singare et al.
(2010) and Singh et al. (2011) used a statistical design of experiments with a response
surface methodology (RSM) with the goal of optimizing the process parameters including
milling speed and time. However, no information regarding the breakage kinetics was
presented explicitly. In general, the statistically-based designs of experiments such as
those in Singare et al. (2010) and Singh et al. (2011) do not provide significant physical
insight at the beads scale as to how the process parameters affect the breakage kinetics.

1.1.4 Preparation of Sub-100 nm Drug Particles with Minimal Contamination
It is understood that faster particle breakage reduces the milling time required for desired
particle fineness and energy consumption, and can be achieved by the right selection of
mill process parameters such as bead size, bead load, stirrer speed, and suspension flow
rate. Influence of these operating parameters on the specific energy consumption and
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product fineness has been studied previously through experiments and empirical models
(Fadhel and Frances, 2001; Stehr, 1984; Tüzün et al., 1995). However, the combined
effect of these parameters on breakage kinetics leading to the preparation of fine drug
nanoparticles at a shorter time is not addressed. Therefore, a detailed strategy or
methodology for combining different mill process parameters has to be developed which
could lead to an intensified process for the faster production of fine drug nanoparticles
with reduced specific energy consumption.
In pharmaceutical applications, the demand for using fine drug nanoparticles with
size as low as possible is increasing steadily, as fine drug nanoparticles offers a much
faster dissolution rate, and also result in rapid onset of therapeutic action (Muller et al.,
2006). Most importantly, drug nanoparticles with size < 100 nm renders feasible and
efficient sterile filtration of aqueous drug nanosuspensions, and allows higher loading for
reduced injection volume in parenteral dosage forms (Baert et al., 2009; Xiong et al.,
2008). In addition to the nanosuspension dosage form, nanocomposite microparticles
made of very small size drug nanoparticles offer rapid redispersion of particles at an
increase drug loading in a given mass of dosage (Bhakay et al., 2013). Therefore, it is
important to prepare drug nanosuspensions with size as small as possible (< 100 nm) to
achieve enhanced efficacy in various pharmaceutical applications. By varying the process
parameters, several researchers have prepared inorganic nanoparticles in the size range of
10–100 nm using WSSM technique. For example, 20–50 nm Magenta pigment (Bilgili et
al., 2004, 2006), 50 nm Al2 O3 (Stenger et al., 2005), 50 nm BaSO 4 (Patel et al., 2012),
and 30–40 nm quartz, calcite and dolomite (Wang et al., 2006) have been prepared.
However, an investigation on the effect of process parameters for the preparation of drug
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nanoparticles having < 100 nm has not been attempted so far. From the current search in
literature, only using smaller initial drug particle size and at low batch volume, the drug
nanoparticles with a typical median size of 136 nm and above have been produced via
WSMM. It is to be noted that the preparation of drug particles with < 100 nm size is a
challenging task, especially if the mill is desired to operate with the large initial particle
size, high batch volume (> 200 ml at the bench scale), and high drug load > 10 % (w/w).
Despite the fact that drug nanoparticles with size as small as possible is of great
interest in pharmaceutical application, drug product contamination introduced by typical
bead wear (for example, e.g., yttrium stabilized zirconia) at intensified process conditions
is a major concern and is yet to be investigated. Due to the high turbulence during the wet
stirred media milling process, wear is generated, between grinding beads and grind ing
bead/milling chamber and transferred into the related drug products as undesirable
contamination (Juhnke et al., 2012; Peltonen and Hirvonen, 2010). In general, toxicity
data and contamination levels from ceramics is unknown and needs to be quantified
according to the current regulatory concepts and permitted daily exposures for oral,
parenteral, pulmonary and topical administration (Juhnke et al., 2012).
A literature review by Juhnke et al. (2012) lists several earlier publications that
explored the generation of wear from grinding beads. Few systematic studies on the
generation of grinding bead wear was investigated via the wet milling of alumina
particles with yttrium stabilized beads along with fused corundum beads (Mende and
Schwedes, 2006; Breitung-Faes and Kwade, 2008). The generation of wear was
characterized by a gravimetric method, including washing, drying and weighing of the
grinding media to determine the overall weight loss. Adam et al. (2008) investigated the
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wet media of zirconia with grinding beads made from zircon silicate as well as a grinding
chamber and a stirrer made from zirconia. The generation of wear from grinding beads
was characterized by determining elemental silicium using inductively coupled plasma
atomic emission spectrometry. Ohnishi et al. (2010) investigated the use of grinding
beads made from silica doped and undoped yttrium stabilized zirconia during wet milling
of barium titanate. The doped silica had a lower wear as compared to the un-doped
grinding media. Several material combinations of grinding beads and milling chamber
with respect to the overall generated wear during the production of fenofibrate
nanosuspensions by wet media milling has also been investigated (Stein et al., 2010).
Stein et al. (2010) investigated the use of various grinding beads made from glass,
polyamide, polycarbonate, polystyrene, stainless steel and zirconia as well as milling
chambers made from polyamide, polyurethane, stainless steel and zirconia. Wear
generated by the grinding beads was characterized by a gravimetric method. Despite
these advances, for a given drug, it is still not possible to predict drug contaminations
levels, based solely on the mill process parameters such as bead size, bead load, stirrer
speed, and suspension flow rate.

1.1.5 Continuous Production of Drug Nanoparticles and Rehbinder Effect
In all major chemical industries, continuous processing is widely used for large-scale
production. There is a growing interest in moving all pharmaceutical unit operations in
drug product manufacture from batch processes to continuous processes. Recent
publications on continuous mixing have made the case for the feasibility of continuous
drug product manufacture (see e.g. Berthiaux et al., 2008; Vanarase et al., 2010a, 2010b).
This manufacturing strategy could bring the pharmaceutical industry advantages such as
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consistent and improved product quality, reduced waste, lower inventory and equipment
costs, easy scale- up, flexibility, and short cycle times. Pharmaceutical unit operations
such as tabletting, roller compaction, and capsule filling are already performed semicontinuously; whereas mixing; wet milling, most granulations, drying, and tablet coating
are usually performed in the batch/recirculation mode. Although ample experimental
studies of batch and recirculation mode of wet media milling exist in literature, little
effort has been devoted to the cascade or multi-pass continuous modes. In the area of
continuous wet stirred media milling of drugs, there are only a couple of patents available
(Holland et al., 2006; Verhoff et al., 2003). Feasibility of nanomilling Fenofibrate using a
wet stirred media mill operating in single-pass mode was presented (Verhoff et al., 2003);
however, the figures and examples provided only described recirculation milling.
Another patent (Holland et al., 2006) presents what is believed to be the first
documentation of cascade continuous mode of wet media milling of drugs, where
Nabumetone nanoparticles were produced using five media mills in series. In both cases,
only the final median particle size was provided; procedural details were missing, and the
breakage dynamics was not studied.
During wet media milling of materials, stabilizers such as polymer(s) and/or
surfactant(s), also known as grinding aids, can affect or play a major role in three
phenomena: stabilization of the suspension and proper dispersion of the product particles,
microhydrodynamics during media milling as affected by suspension rheology, and
particle strength. However, it is interesting to note that most pharmaceuticals literature on
wet media milling focused on the first phenomena, i.e., stabilization and proper
dispersion of the particles, thus largely neglecting the impact of the stabilizers on the
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microhydrodynamics and the particle strength (associated with the Rehbinder effect).
Rehbinder effect is described as the facilitation of crystal cleavage and decrease in
hardness of crystals caused by surfactant solutions, and can be explained by the
weakening of bonds in the crystal surface layer due to adsorption and lowering of the
specific surface free energy (Rehbinder and Shchukin, 1972; Shchukin, 1999, 2006).
Rehbinder effect manifests itself as facilitated breakage of crystals and enhanced
breakage rate in the presence of surface-active agents (El-Shall and Somasundaran,
1984). There exists no prior work as to whether Rehbinder effect arises during the wet
media milling of drugs owing to the use of such agents as stabilizers.

1.2 Objectives and Major Research Tasks
Nanoparticle suspensions (nanosuspensions) of poorly water-soluble drugs are prepared
with the ultimate goal of increasing the dissolution rate and bioavailability of such drugs.
This dissertation work aims to achieve the following objectives: (1) develop a
fundamental understanding of the impact of various stabilizers, i.e., polymers and
surfactants,

on the breakage kinetics,

microhydrodynamics,

and suspension

rheology/stability; (2) investigate the impact of various milling parameters on the
breakage kinetics and explain the findings from a microhydrodynamic perspective; (3)
design an intensified process for faster preparation of sub-100 nm particles with reduced
specific energy consumption and media wear (i.e. minimal drug contamination); (4)
develop a continuous milling methodology that can mimick true cascade continuos
milling operation; and (5) explore if Rehbinder effect plays any role during the milling of
drugs.
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In this dissertation, a comprehensive investigation of the production of
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the
recirculation and continuous modes has been conducted to achieve the afore- mentioned
objectives. Griseofulvin was selected as a model poorly water-soluble BCS Class II drug.
Impact of various formulation parameters such as stabilizer type and loading as well as
processing parameters such as rotor speed, bead loading, bead size, suspension flow rate
and drug loading were studied. A major novelty of the present contribution is that the
impact of processing and formulation parameters has been analyzed and interpreted using
a combined experimental–theoretical (microhydrodynamic model) approach. Such a
comprehensive approach allowed us to intensify the process for the production of sub100 nm drug particles, which could not be produced with top-down approaches in the
literature so far. In addition, a multi-pass mode of continuous operation was developed
and the so-called “Rehbinder effect”, which has not been shown for the breakage of drug
particles, was also investigated. The five major objectives stated above have been divided
into four Chapters and are discussed in the dissertation outline.

1.3 Dissertation Outline
The dissertation work is presented in seven chapters. Chapter 1 begins with a review of
what has been done in literature followed by the objectives and outline of the dissertation.
Chapter 2 discusses the theoretical framework used in the current work. Chapter 3
explores the roles of various stabilizers such as polymers and surfactants during the wet
milling of drugs. Chapter 4 investigates the impact of processing parameters on the
breakage kinetics using a combined experimental–microhydrodynamic model approach.
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Chapter 5 presents an intensified process for the production of sub-100 nm particles and
how such a process is designed in view of the microhydrodynamic model. The
contamination of the drug product during milling was also investigated in Chapter 5. In
Chapter 6, the continuous production of drug nanoparticles suspension was investigated
with a fresh look at the Rehbinder effect. Chapter 7 gives an overall summary and
conclusion of the current work. Potential future work is discussed in Chapter 8.
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CHAPTER 2
THEORETICAL BACKGROUND

2.1 Fundamentals of Interparticle Interactions and
Stabilization of Drug Particles against Aggregation

2.1.1 Fundamentals of Interparticle Interactions
Several interparticle forces or interactions come into play when two colloidal particles
approach one another. The extent of interaction between two colloidal particles is
determined by how rapidly the approach occurs. The colloidal behavior which is
dependent on the surface properties of the particles affects both the state of aggregation
along with the suspension rheology.
2.1.1.1 van der Waals Interactions.

The most attractive van der Waals forces is

the interaction between induced dipoles, which arise due to orientation effects between
molecules with permanent dipoles or induction effects in neutral particles (Hunter, 1986).
Particle stressing and/or deformation as a result of two colliding beads can lead to
aggregation of particles during milling. The attractive van der Waals interaction energy,
Va is given by (Russel et al., 1987).
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where k B is Boltzmann’s constant, T is absolute temperature, Aeff is the effective Hamaker
constant, d1 and d2 are the core diameters of the two particles, which can be of different
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size, and r is the center to center distance between the particles. Whene ver an aggregate
of two or more particles is formed, the resultant aggregate is considered to be a spherical
particle of volume equal to the sum of the constituents (Kumar et al., 2010).
2.1.1.2 Electrostatic Interactions. Electrostatic repulsion energy ( Ve ) between two
particles is calculated using the expression below. (Hunter, 1987; Lee et al., 1998;
Ohshima, 1995)
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where subscript i indicates 1, 2; e is elementary charge,  is the dielectric constant of the
medium (water),   is the permittivity of free space,   is the surface potential and  is
Debye length. The surface potential   can be approximated by measuring values of the

 - potential.
In general, the repulsion potential during electrostatic interactions is generated
from electrical double layer (EDL) (see schematic in Appendix A (Figure A.1)). The
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EDL is sensitive to the ion concentration in the system (i.e. the ions move freely under
the influence of electrical and thermal forces in the so called diffuse layer). Upon an
increase in the ion strength, the thickness of the EDL decreases due to screening of the
surface charge (Kim, 2004). This effect leads to a decrease in the repulsion potential and
an increase in the attractive potential (van der Waals interaction) (i.e. the vulnerability of
dispersed particles to form aggregates). Zeta ( ) potential is the electric potential at the
shear plane and is the representative of the surface charge (see schematic in Appendix A
(Figure A.2)).
2.1.1.3 Steric Inte ractions. Attractive van der Waals and electrostatic interactions often
fail to describe the all interactions; steric repulsion energy between polymer coated
spherical nanoparticles is given by (Rosensweig, 1985)
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where g is the grafting density (i.e. the number of stabilizing groups bound to the particle
surface), s is the surface to surface separation distance,  is the thickness of the polymer
chain (shell) and d is the average core diameter of the two solid particles (see schematic
in Appendix A (Figure A.3). Steric interaction between two particles of diameters d 1 and

d 2 can be calculated using average core diameter d   d1  d2  / 2 (Castro et al., 2008).
In addition, l  2s / d and t  2 / d have been defined (see schematic in Appendix A
(Figure A.3)).
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The net interaction potential energy (Vtotal) can be calculated by summing all the
above individual interaction potentials. This is governed by van der Waals (Va ), steric
(Vs), and electrostatic (Ve) interactions and is discussed next further in the next section by
the DLVO theory.

2.1.2 Stabilization of Drug Particles against Aggregation
The physical stability of poorly water-soluble drug nanosuspensions produced by wet
media milling must be preserved against aggregation and ripening during the production
and storage. Milled drug particles with mean sizes below 1 m show a strong tendency to
aggregate due to a high number concentration (given solid loading), small interparticle
distances, enhanced Brownian motion, and relatively high surface energy (Bruno et al.,
1996; Knieke et al., 2009; Lee, 2003; Sommer et al., 2006). During milling, repeated
stressing of the micron-sized drug particles that are captured between the colliding beads
increases the turbulent shear, which can cause a high collision rate among the particles
and in turn high aggregation rate (Barthelmes et al., 2003; Peukert et al., 2005; Su et al.,
2004). The physical stability during the storage of the nanosuspensions is affected by the
sedimentation (gravity), Ostwald ripening, Brownian motion, along with van der Waals
interactions (see section 2.1.1.1). Based on the physical stability of the suspension, it is
known that drug particles below 1 m can be stabilized electrostatically due to unipolar
charging of particles; sterically by the adsorption of polymers on the particle surface; or
electrosterically by a combination of both electrostatic and steric mechanism (see
schematic of various forms of stabilization in Appendix A (Figure A.4)).
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2.1.2.1 Electrostatic Stabilization. The DLVO-Theory: The net interaction potential
(Vtotal) between particles is the result of repulsion forces (Vrepulsive) due to the electric
double layer (electrostatic interaction) and attraction due to the van der Waals interaction
(Vattractive). The superposition of the van der Waals interaction and electrostatic repulsion
can be traced back to the independent research of Derjaguin and Landau (1941) as well as
Verwey and Overbeek (1948) and is known as DLVO theory (see schematic in Appendix
A (Figure A.5)). Mostly the repulsive steric interaction is also included so that the net
interaction energy consists out of:

Vtotal  Vrepulsive  Vattractive  Vsteric

(2.6)

The probability of a particle to overcome the energy barrier leads to more aggregation
due to the attractive interaction (see schematic in appendx A (Figure A.5)). For this case,
attraction is very strong and redispersion of the particles is almost impossible (i.e. strong
aggregate formation). If repulsive forces are large enough, the suspension can remain
well dispersed.
2.1.2.2 Steric Stabilization. Unlike electrostatic stabilization, the influence of steric
stabilization on the energy barrier is complex to interpret. However, it can be understood
mainly through the adsorption or chemisorption of polymer chains on the surface of the
particles (Napper, 1977). If the concentration of the polymer is high (i.e. increase in the
polymer layer thickness), the attractive forces will be suppressed and the surface
coverage of the polymer on the particle will be high (Fleer et al., 1938). When two
particles coated with polymer approach each other, one can distinguish them by three
distance regimes (Davies and Binner, 2000). At large distances between the particles, no
overlap of the polymer is observed. For this case, no repulsive forces are acting. At a
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close distance, an overlap of the polymer chains is observed, for solvents, a densification
of the polymer chains is detected and solvent molecules are depleted out of the overlap
area into the solvent (Wu et al. 2011). In a good solvent, the entanglement of polymer
chains is unfavorable, strong enthalpic interaction (good solvation) between the solvent
and the stabilizing segment of the stabilizer is the key factor to achieve steric stabilization
and prevent particles from aggregation in the medium (Kim, 2004; Nutan and Reddy,
2009). The chemical potential of the solvent molecules is higher than in the bulk solvent,
resulting in an increase of the osmotic pressure and yielding a positive contribution to the
net interaction potential (Vtotal) (i.e. the reason for the repulsion). For the third case,
particles approach each other closer to the compressed polymer layer. The compression
forces in addition to the osmotic forces have to be considered.
2.1.2.3 Electrosteric Stabilization. Electrosteric stabilization occurs, if the adsorbed
polymer contains charged groups, steric and electrostatic components act simultaneously.
Basically, the development of a double layer is formed when the non-polar ends of the
polymers adsorb favorably on hydrophobic particles in polar surroundings, while the
polar ends reach into the polar solvent (Klimpel, 1999). Consequently, the concentration
of the ionic charge should be optimal to avoid suppression of the double layer. The
stabilization is strengthened by the polymer layer due to the steric effect suggesting t hat
the principle of the DLVO theory can be applied.

2.1.3 Comparison: Steric Stabilization vs. Electrostatic Stabilization
Steric stabilization offers several distinct advantages over electrostatic stabilization.


Steric stabilization is comparatively insensitive to the presence of electrolytes because
the dimensions of non- ionic chains vary relatively little with the electrolyte
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concentration. This contrasts sharply with the electrical double layers, which are
strongly dependent upon the ionic strength (Hunter, 1986). This accounts for the
coagulation of electrostatically stabilized dispersions on the addition of electrolyte.


Steric stabilization is equally effective in both aqueous and non-aqueous dispersion
media. This contrasts with electrostatic stabilization, which is relatively ineffective in
non-polar dispersion media.



Steric stabilization

is equally

effective at both

high and

low

volume

fractions/concentrations of the dispersed phase, the high volume fraction dispersions
displaying relatively low viscosities.


Sterically stabilized suspensions can be often be flocculated reversibly whereas this is
less common with electrostatically stabilized suspensions.



Sterically stabilized suspensions frequently display good freeze-thaw stability, which
can be a desirable attribute in some practical application (e.g. paint system).

Despite all these advantages, there exist several significant disadvantages for the
application in wet stirred media milling. High molecular weight polymers affect the
suspension rheology during the milling process which could dampen the collision speed
of the milling beads (viscous dampening), resulting in a reduced breakage rate.
Moreover, the adsorbed polymers can be desorbed from the particle surface by the high
shear forces during milling. However, the most critical issue and disadvantage is due to
the unknown adsorption kinetics for high molecular weight molecules.
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2.2 Impact of Apparent Shear Viscosity on
Suspension Rheology in Wet Stirred Media Mills
It is known that both a high solids loading and particle–particle interactions results in
high suspension viscosity. High solids loading could dampen the collision speed of the
milling beads (viscous dampening), resulting in a reduced breakage rate (Knieke et al.,
2010; Mende et al., 2003) while particle-particle interactions can increase the rate of
aggregation. Suspension viscosity affects the microhydrodynamics, which is the study of
the fluctuating motion of the beads during the media milling process. It is therefore
necessary to measure the rheological properties of the milled suspension.
The rheological behavior of suspensions is determined by the shear stress function
τ(γ*) or alternatively the shear viscosity function ηapp (*) which has to be measured in
stationary shear experiments. The two functions are connected by a constitutive equation
for the shear stress (Hunter, 1986). Here, * is the shear rate, which is applied by the
rheometer, and ηapp (*) a characteristic material function which describes the flow
behavior of the fluid. The typical flow characteristic of suspensions is further explained
in Appendix B.

2.3 Analysis of the Breakage Kinetics
When particle breakage governs the dynamics of a wet media milling process as opposed
to particle growth/aggregation in a properly stabilized suspension, the median particle
size d50 decreases in time t monotonically and approaches/attains a limiting value
provided milling is continued for a prolonged time. The evolution can be described by a
first-order exponential decay function as follows (Bilgili et al., 2008; Strazisar and
Runovc, 1996; Varinot et al., 1999):
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d50 (t )  d lim  d50 (0)  d lim exp( t /  p )

(2.7)

where dlim is the limiting median particle size, τp is a characteristic time constant of the
process, and d50 (0) is the initial median particle size. A lower τp corresponds to faster
breakage of the particles and a higher overall apparent breakage rate, which will be
shortly referred to as the breakage rate throughout the rest of this dissertation. To
estimate dlim and τp , Eq. (2.7) was fitted to the measured median size data via
minimization of the following sum of squared residuals (SSR):
2

exp
mod
SSR   log10 d 50
i   log10 d 50i 
n

(2.8)

i 1

where the superscripts ‘exp’ and ‘mod’ refer to experiment and model, respectively. The
median sizes at different time points were indexed by i (i = 1, 2, …, n). SigmaPlot’s
(Version 11) nonlinear regression wizard, which has a built- in Marquardt-Levenberg
algorithm, was used for the minimization. Preliminary analysis indicated that large
particles with as-received median particle size broke faster initially (within first minute)
than the particles produced after one minute or first turnover or pass. Therefore, Eq. (2.7)
with a single time constant τp was not able to fit the whole experimental data governed by
two or potentially more characteristic time constants (Cho et al., 1996). Hence, initial
median particle size at 0th min was discarded, thus making the 1 st min median size the
initial size for better fitting capability, which is in line with prior studies (Varinot et al.,
1999; Bilgili and Afolabi, 2012).
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2.4 Microhydrodynamic Analysis
Based on the kinetic theory of granular flows and the fundamental granular energy
balance (Gidaspow et al., 1994), Eskin et al. (2005a and 2005b) de veloped a model to
calculate the mean velocity of the milling bead oscillations (fluctuations) in a well- mixed
slurry. The salient features of this model are presented here and readers are referred to
Eskin et al. (2005a) for the full set of assumptions and the development of their model. It
is assumed that the power input by the mill rotor in a wet stirred media mill is uniformly
applied throughout the whole volume of the slurry and equals the total energy dissipation
rate. The power input dissipates through fluctuating motions of the beads and liquid–
beads viscous friction at the micro-scale; hence, the total energy dissipation rate (ε tot ) is
given by

 tot  Pw   visc   coll

(2.9)

where Pw is the power applied by the rotor per unit volume, ε visc is the energy dissipation
rate due to both the liquid–beads viscous friction and lubrication, and ε coll is the energy
dissipation rate due to partially inelastic bead–bead collisions. Numerical simulations
performed by Eskin et al. (2005a, 2005b) and Bilgili’s research group (not shown here for
brevity) indicate that ε visc is much greater than ε coll, making the viscous friction–
lubrication the main energy dissipation mechanism.
In its current form, Eq. (2.9) can be used for a suspension undergoing turbulent
motion, which is characterized by the stirrer Reynolds number (Re = ND2 L/L) greater
than 35000 (Kawatra, 2006). Re value between 120 and 35000 describes a laminar–
turbulent transition region and a Re value less than 120 describes a laminar region. In Re
definition, N is the rotor speed, D is the rotor’s tip diameter, L is the density of the
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equivalent liquid, and L is the apparent shear viscosity of the equivalent fluid. Eskin et
al. (2005a, 2005b) considered the equivalent liquid to be water (~1 cP); therefore, their
numerical simulations considered the turbulent motion. On the other hand, most drug
suspensions with polymeric stabilizers have orders of magnitude higher viscosity than
water and can exhibit a flow behavior in the transition region. As co mmonly assumed in
the wet stirred media milling literature (refer to Kawatra, 2006), the equivalent liquid was
taken as the milled suspension. The shear viscosity obtained at a shear rate of 1000 1/s
was taken as the L value. Although the shear rate in media mills could exceed this value,
earlier work (Bernhardt et al., 1999; Knieke et al., 2010) considered 1000 1/s to be a
representative value because the shear viscosity did not change drastically above 1000 1/s
and it can be reliably measured by most rheometers. Re values were calculated with the
equivalent liquid properties of the milled suspensions. In this dissertation, unless
otherwise indicated, Re typically ranged from 1000–35000; thus, the flow was in the
transition region in most runs.
Since Eq. (2.9) does not consider the energy dissipation due to friction between
“liquid layers”, which becomes more pertinent in the transition region, a new term should
be added to the right-hand-side. Eskin and Miller (2008) included such a term ε ht in the
granular energy balance for a slurry flow in fractures. ε ht is defined as the power spent on
shearing equivalent fluid of the slurry (beads–drug suspension here) at the same shear
rate but calculated or measured as if no particles (beads here) were present in the slurry.
Then, following Eskin et al. (2005a, 2008), Eq. (2.9) can be modified as

Pw   visc   coll   ht

(2.10)
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(2.11)

where c is the beads volumetric concentration, Rdiss is the dissipation or effective drag
coefficient, db is the average bead size (taken as the median size of the bead), b is the
density of the beads (measured to be ~6000 kg/m3 ), k is the restitution coefficient for the
bead–bead collisions (taken from Tatsumi et al., 2009), and  is the granular temperature
defined as the bead–liquid relative mean-square velocity. The dissipation coefficient Rdiss
is given by Wylie et al. (2003) as
Rdiss  Rdiss0 (c)  K (c) d b  L 1 2 L

(2.12)

L is the density of the equivalent liquid, K is a coefficient expressed as an empirical
correlation of bead concentration c expressed as
K (c)  0.096  0.142c 0.212  (1  c) 4.454

(2.13)

Rdiss0 is the dissipation coefficient taking into account squeezing in the equivalent liquid
film between two approaching beads and is expressed as follows:

Rdiss0 (c)  k1 (c)  k2 (c) ln  m

(2.14)

In Eq. (2.14), εm is the non-dimensional bead–bead gap thickness at which the lubrication
force stops increasing and becomes a constant. According to Sangani et al. (1996), εm can
be taken as 0.003. k 1 and k 2 in Eq. (2.14) are computed using

k1 (c)  1  3 c 2  135 64c ln c  11.26c(1  5.1c  16.57c 2  21.77c 3 )

(2.15)

k2 (c)  c 1  0.5c  (1  c) 3

(2.16)

Using the equivalent liquid properties (L and µL), power input values in the presence and
absence of the beads (Pw and εht ), and the aforementioned bead parameters, Eq. (2.11) is
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solved for the granular temperature () using MATLAB’s fsolve function. The average
bead oscillation velocity (ub) and the frequency of single-bead oscillation ( ) are
determined using the calculated  value from
ub 

8



and  

24c 1  0.5c  
d b  (1  c) 3  

(2.17)

The microhydrodynamic parameters (, ub, and  ) determine the intensity and frequency
of the bead–bead collisions, and thus the number of compression events and compression
forces to which the drug particles are subjected during the milling. At the micro-scale
(beads scale), these parameters are good predictors of the breakage rate for a given
material (Eskin et al. 2005b).
Eskin et al. (2005b) advanced the earlier microhydrodynamic model (Eskin et al.
2005a) by considering the elastic contact deformation of the beads along with the elastic–
perfectly plastic deformation of the particles caught between the beads. While the beads
frequently collide due to their fluctuating motions in a slurry, which are characterized by

, ub, and  , the beads capture and compress (deform) the particles to be milled. Based on
Hertzian theory of elastic impact, the average maximum normal force Fbn during collision
of two identical elastic beads, the radius of the contact circle formed at the contact of two
beads αb, and the maximum contact pressure at the center of the contact circle σbmax (see
schematic of bead–bead interaction in Appendix A (Figure A.6)) were calculated using
25
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max
b

3 Fbn

2  b2

(2.20)

where Yb, and b are the Young’s modulus and Poisson’s ratio of the bead material.
(yttrium stabilized zirconia here), and were taken from the literature as 200 GPa and 0.2,
respectively (Ashby, 1999; Srikar et al., 2004); Rb is the bead radius and was taken as half
of db. The probability p of a single particle with radius Rp being caught between beads
was estimated as the ratio of the volume containing the caught particles to the volume of
milled drug suspension falling on a pair of the milling beads and is expressed as
c   b 1   b2 
p  0.97

1  c 
Yb


2/5

 2/5

Rp

(2.21)

Rb

The average frequency of drug particle compressions a was estimated using Eq. (2.22)
below as the product of this probability p and the frequency of single-bead oscillations 

a  p

(2.22)

The energy dissipation rate resulting from the deformation of the drug particles per unit
volume Π characterizes the grinding intensity and is expressed as follows:
c 2 (2  c)
1
Π  2.23
3
5/ 2
1  c    y

18 / 15

 Yb 
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 1  b 



Y * 
R
   b 4 / 5 p  13/ 10
Y 
Rb2
 p

(2.23)

where ε, Y*, Yp , b, σy , Rp , and Rb respectively denote volumetric drug loading in the
milled suspension, reduced elastic modulus of the bead–drug particle contact, elastic
modulus of the drug particles, Poisson’s ratio of the beads, contact pressure in a drug
particle captured when the fully plastic condition is obtained, radius of the drug particle,
and radius of the bead.
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To calculate Π using the expressions derived by Eskin et al. (2005b) (Eq. (2.23)),
one must either find the mechanical properties of the drug particles ( Yp , p , σy ) from the
literature or measure them. First, it is difficult to find reliable mechanical properties of
the drug particles or to measure them. Second, the objective of this dissertation is to gain
fundamental insight into the impact of the process parameters on the breakage kinetics.
While the potential influence of different bead materials and drugs are of interest, it is not
considered here. Therefore, multiplicative decomposition or factorization of Π into a
material-dependent factor  and a process-dependent factor, F, which is referred to as the
milling intensity factor, yields: Π = F, where functional forms of and F will be
specifically introduced in Chapter 4 and Chapter 5.
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CHAPTER 3
A COMBINED MICROHYDRODYNAMICS–POLYMER ADSORPTION
ANALYSIS FOR ELUCIDATION OF THE ROLES OF STABILIZERS IN WET
STIRRED MEDIA MILLING

3.1 Introduction
About 40% of active substances identified through combinatorial screening programs in
pharmaceutical industry are poorly water-soluble (Lipinski, 2002). Size reduction of drug
crystals increases the specific surface area, which can improve the dissolution rate of
drugs according to the Noyes–Whitney equation (Noyes et al., 1897). Wet stirred media
milling has found common use as a robust process to reduce micron-sized drug particles
to nanoparticles, i.e., particles less than 1 μm (Bruno et al., 1996; Merisko-Liversidge et
al., 2003). In this process, an aqueous suspension containing drug particles and dissolved
stabilizers (polymer and/or surfactant) as well as hard beads is stirred at high speed by a
rotor. Stabilizers are added to prevent the aggregation of milled drug particles and to
inhibit particle growth (ripening) during milling/storage. An optimal stabilizer
type/concentration, which ensures proper short- and long-term physical stability of a drug
nanoparticle suspension, is usually obtained by stabilizer screening studies at the benchscale (Kesisoglou et al., 2007; Van Eerdenbrugh et al., 2008), where milling dynamics,
process cycle times, and scale-up effects are not of major concern. To this end, milling in
a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (e.g. Lee and Cheng,
2006; Van Eerdenbrugh et al., 2007), both making use of vials containing drug
suspensions with various stabilizers, has previously been described for their capability in
obtaining nanoparticles. These mills are regarded as medium or low-energy mills; hence,
suspension flow and microhydrodynamics are quite different in these mills than in the
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wet stirred media mills. It is not surprising to see that the nanoparticles are produced after
several hours to a few days of milling even at the bench scale with suspension quantities
on the order of ~10 ml. In other screening studies, wet stirred media mills have been
used: e.g. the Nanomill® System (e.g. Kesisoglou et al., 2007). However, the impact of
stabilizers on the microhydrodynamics has not been reported. More importantly, as
pointed out by Bhakay et al. (2011), most wet med ia milling work in pharmaceutical
literature disregarded the breakage kinetics completely (e.g. Ain-Ai and Gupta, 2008;
Tanaka et al., 2009). Other studies (Choi et al., 2008; Deng et al., 2008; Lee et al., 2008)
did not characterize the breakage kinetics and its relationship to the stabilizers
quantitatively.
While scant information is available regarding the impact of stabilizers on the
breakage rate during wet stirred media milling, the microhydrodynamics, which is the
study of the fluctuating motion of the beads in sheared suspensions, has not been
investigated at all. The wet media milling has been largely treated as a “black-box” in
pharmaceutical literature. It is known that high solids loading results in high suspension
viscosity, which could dampen the collision of the milling beads, resulting in a reduced
breakage rate (Knieke et al., 2010; Mende et al., 2003). Knieke et al. (2010) provided a
semi-theoretical model based on the kinematic equations describing the relative motion
of undeformed spheres (beads). However, their model does not allow calculation of the
bead oscillation velocity and frequency, which fundamentally determine the breakage
rate along with the material properties in a wet stirred media mill. Eskin et al. (2005a)
developed a microhydrodynamic model to study the effects of stirring speed and bead
size on the microhydrodynamics in a mixing tank with Rushton type paddles, which
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provided significant insight into the experimentally observed impact of these process
parameters on the breakage rate. However, this model has not been applied to the wet
milling of drug suspensions with the goal of elucidating the impact of stabilizers such as
viscous dampening of the polymers.
This chapter is a first attempt to develop a fundamental understanding of the roles
of a cellulosic polymer (hydroxypropyl cellulose, HPC) on the apparent breakage rate of
griseofulvin (GF), a model poorly water-soluble drug, in the presence–absence of an
anionic surfactant (sodium dodecyl sulfate, SDS) during wet stirred media milling. The
major novelty here is the use of a combined microhydrodynamics–polymer adsorption
analysis. To this end, temporal evolution of the particle size during milling was
investigated as a function of HPC concentration, in the presence and absence of SDS. The
particle size data were analyzed via an empirical rate model to quantify the overall
apparent breakage rate. Particle sizing via laser diffraction, scanning electron microscopy
(SEM), and rheometry were used to characterize the milled s uspensions. Another novelty
is that unlike most wet media milling studies that solely relied on particle sizing. This
chapter examined the aggregation state of the milled suspensions via both laser
diffraction and rheometry. HPC adsorption on GF particles was determined using a
thermo- gravimetric method. The viscosity of the milled suspensions was measured and
used in the microhydrodynamic model. In the absence of SDS, an increase in HPC
concentration reduced the extent/rate of particle aggregation leading to faster apparent
breakage. On the other hand, due to a synergistic stabilizing action of HPC with SDS,
lower HPC concentration was needed to stabilize the suspensions, and an optimum HPC
concentration for the fastest apparent breakage was found. The microhydrodynamic
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analysis quantified the viscous dampening effect of HPC, while only the combined
analysis could explain the experimentally observed optimum.

3.2 Experime ntal

3.2.1 Materials
Griseofulvin (GF, Cat# 606440, US Pharmacopeia, Letco Medical, Livonia, MI, USA)
was used as a model BCS Class II drug because of its low solubility in water: 7.7 µg/ml
(Merisko-Liversidge

and

Liversidge,

2011).

A

non- ionic cellulosic

polymer,

hydroxypropyl cellulose (HPC, Klucel® SL, Lot# NOH-4811, Nisso America Inc, New
York, NY, USA) and an anionic surfactant, sodium dodecyl sulfate (SDS, 99% ACS
reagent, Cas# 436143-100G, Sigma Aldrich, Bellefonte, PA, USA) were acquired due to
their common use in wet media milling (Kesisoglou et al., 2007). Wear-resistant yttrium
stabilized zirconia beads (Zirmil Y, Saint Gobain ZirPro, Mountainside, NJ, USA) with a
median size of 430 µm were used as the media in the milling.

3.2.2 Methods
3.2.2.1 Preparation of GF Suspensions.

Table

3.1

presents

the

suspension

formulations used in this chapter. Throughout the chapter, all percentages (%) refer to
w/w with respect to de- ionized (DI) water; suspension refers to drug particles with the
stabilizer solution; and slurry refers to a combination of the beads and the drug
suspension. The drug (GF) loading was 20 g GF per 200 g DI water (10%). Feed GF
suspensions were prepared using a shear mixer (Cat#. 14–503 Fisher Scientific
Pittsburgh, PA, USA) running at a fixed speed of 300 rpm. The required amount of
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stabilizer(s) was dissolved in DI water for 60 min followed by dispersion of the GF
powder in the stabilizer(s) solution for 30 min (except Run 1). The GF powder was
dispersed in DI water for 30 min in Run 1.
The wet stirred media mill used in this chapter was manufactured by Netzsch Fine
Particle Technology, LLC. (Model: Microcer) (Exton, PA, USA). The schematic of the
mill is shown in Figure 3.1. The milling chamber has a volume of 80 ml and is lined with
zirconia. During the milling, a peristaltic pump recirculated the suspension between the
holding tank and the milling chamber, while a 200 m screen kept the zirconia beads in
the milling chamber allowing the passage of the drug suspension. Process parameters
were selected based on previous work on the wet media milling of GF (Bhakay et a l.,
2012). The feed suspensions prepared using the shear mixer were poured into the holding
tank and milled under the same conditions: bead loading of 50 ml (bulk), suspension flow
rate of 126 ml/min, and stirrer (rotor) speed of 3200 rpm corresponding to a tip speed of
11.7 m/s. Both the milling chamber and the holding tank were equipped with a cooling
system (model number M1-.25A-11HFX, Advantage Engineering, Greenwood, IN, USA)
to keep the suspension in the holding tank below 35 o C. Due to the relatively high HPC
concentration, the heat dissipation rate in Runs 8, 9, 15, and 16 was high. To keep the
temperature below 35 o C, the rotor was stopped twice in Runs 8 and 15 and several times
in Runs 9 and 16 while the suspension continued to recirculate under cooling for few
minutes. The experiments were resumed once the temperature in the holding tank reached
~25 o C.
Samples at several milling times were taken at the outlet of the milling chamber
for particle sizing. The final suspensions (after 64 min milling) were tested for density
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and shear viscosity, and they were refrigerated at 8 o C for a period of 7 days. Particle
sizes right after milling and after 7 days of storage were compared to assess the physical
stability of the suspensions.
Table 3.1 Formulation used in the Wet Stirred Media Milling Experiments
Run
No.

Drug
HPC
SDS
Loading
Concentration
Concentration
(% w/w)a
(% w/w)a
(% w/w)a
1
10
—
—
2
10
—
0.5
3
10
0.1
—
4
10
0.5
—
5
10
1
—
6
10
2.5
—
7
10
5
—
8
10
10
—
9
10
15
—
10
10
0.1
0.5
11
10
0.5
0.5
12
10
1
0.5
13
10
2.5
0.5
14
10
5
0.5
15
10
7.5
0.5
16
10
10
0.5
b
17
10
3
—
b
18
10
3
0.5
a
% w/w with respect to de-ionized water.
b
Runs 17–18 were performed as part of the adsorption study.

3.2.2.2 Measure ment of Powe r Input for the Microhydrodynamic Analysis.

The

power input per unit volume of the slurry, i.e., Pw, was measured during a milling
experiment (Runs 5–9 and Runs 12–16), and an average value was reported. In the
absence of the milling beads, the power input per unit volume of the suspension, i.e., ε ht ,
was also measured while each stabilizer solution with 10% GF particles was stirred at
3200 rpm. In both cases, the no- load power value obtained from a dry run of the mill
rotor at 3200 rpm was subtracted from the power values in the calculation of P w and εht .
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Figure 3.1 Schematic of the Netzsch stirred media mill (Model: Microcer) operating in
the recirculation mode. P and T stand for pressure gauge and thermocouple, respectively.

3.2.2.3 Particle Sizing.

Particle size distributions were measured with the laser

diffraction device LS 13 320 (Coulter Beckman, Brea, CA). A polarized intensity
differential scattering (PIDS) obscuration water optical model was employed. The PIDS
was maintained between 40% and 50% while the obscuration was maintained below 8%
for all particle size measurements. Particle size distribution was computed by the
software using the Mie scattering theory. A refractive index (RI) value of 1.65 for the GF
particles (Watanabe, 2002) and 1.33 for the measurement medium (DI water) were used.
Prior to the size measurement, milled suspension samples (~2 ml) were diluted with 10
ml of DI water or solution of HPC, SDS, or HPC–SDS depending on the stabilizer(s)
used in the milling experiment. The refrigerated suspension samples after 7-day storage
were mixed with the shear mixer running at 300 rpm for 5 min. Then, ~2 ml samples
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were taken and diluted for particle size measurement using the pertinent stabilizer
solution.
3.2.2.4 Scanning Electron Microscopy (SEM).

SEM imaging was used to examine

the morphology of the as-received and milled particles and to determine the primary
particle sizes of the GF nanoparticles. Suspension samples were mounted on a silicon
chip (Ted Pella, Inc., Redding, CA, USA), placed on top of carbon specimen holders, and
dried in a desiccator. The samples were then sputter coated with carbon and observed
under a LEO 1530 SVMP (Carl Zeiss, Inc., Peabody, MA, USA).
3.2.2.5 Appare nt Shear Viscosity and Density of the Milled Suspensions.

The

apparent shear viscosity of the milled suspensions (Runs 5–9 and Runs 12–16) and the
stabilizer(s) solutions was measured using an R/S plus rheometer (Brookfield
Engineering, Middleboro, MA, USA) with a water jacket assembly Lauda Eco (LaudaBrinkmann LP, Delran, NJ, USA). A coaxial cylinder (CC40) was used to impart
controlled shear rate on the samples from 0 to 1000 1/s in 60 s. The temperature of the
jacket was kept constant at 25 ± 0.5 o C. The raw data were analyzed using the Rheo 3000
software (Brookfield Engineering, Middleboro, MA, USA) of the R/S plus rheometer to
obtain the apparent shear viscosity as a function of the shear rate. The suspensions with
very low HPC concentration (< 1%) (Runs 3–4; 10–11) could not be tested precisely by
this rheometer set-up since the viscosity was very low (< 4 cP). The density of the milled
suspensions (Runs 5–9; Runs 12–16) were experimentally determined using a 60 ml glass
cylinder (Cat#. 08-559D Fisher Scientific, Pittsburgh, PA, USA) for volume
measurements and a digital scale balance Adventurer-Pro (Ohaus Corporation,
Parsippany, NJ, USA) to obtain the weights. The weight was divided by the volume to
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obtain the density. Average value of three measurements on each suspension was
reported.
3.2.2.6 Differential Scanning Calorimetry (DSC). The melting point and heat of fusion
of the as-received GF powders and dried GF suspension (Run 1) were determined using a
Mettler-Toledo POLYDSC (Mettler Toledo Inc., Columbus, OH, USA). A sample of 9–
10 mg powder was placed in a sealed perforated aluminum pan. The samples were heated
under nitrogen flow from 25 °C to 300 °C with a rate of 10 °C/min.
3.2.2.7 Determination of the Polymer Adsorption on Milled GF Particles.

Fresh

GF suspensions with 0.1–10% HPC concentration in the absence and presence of 0.5%
SDS (Runs 3–8 and 10–16, respectively) were prepared by milling with similar
conditions to those described in Section 3.2.1. A 10 min milling yielded Sauter- mean
diameter values in the range of ~0.4–1.0 m, which allowed easier separation of these
particles from the suspensions during the centrifugation step. Two additional suspensions
with 3% HPC were produced similarly: one without SDS and the other one with 0.5%
SDS (Runs 17 and 18). The adsorption isotherms were determined using a thermogravimetric technique (Lee, 2003; Panmai and Deshpande, 2003). Each suspension was
centrifuged (Sorvall RS-28S, DuPont Company, Wilmington, Delaware, USA) at 20,000
rpm for about 6 h. The supernatant solution was assayed for stabilizer content using a
thermogravimetric analyzer (TGA): Mettler-Toledo TGA/DSC1/SF, Stare system
(Mettler Toledo Inc., Columbus, OH, USA). A sample (30–80 mg) taken from the
supernatant solution was heated to 200 °C under nitrogen environment with a heating rate
of 10 °C/min to remove the water and determine the residual weight. The stabilizer
concentration in the supernatant solution was determined using the initial weight and the
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residual weight. The amount of stabilizer adsorbed per mass of the GF particles was
back-calculated by subtracting the stabilizer concentration in the supernatant solution
from the total stabilizer concentration in the suspension sample. Assuming sphericity of
the GF particles, the external specific surface area (S) was calculated from S = 6/(p dsm),
where p is the true density of GF (1.45 g/cm3 ) and dsm is the Sauter- mean diameter of the
milled particles, which was obtained from the laser diffraction measurement. The S value
was used to express the amount of HPC adsorbed per GF surface area.

3.3 Results and Discussion

3.3.1 Main Role of Polyme rs and Surfactants: Stabilization/Dispersion
Polymers and surfactants play a major role in two phenomena that determine the apparent
breakage rate during wet media milling: stabilization/dispersion of the milled drug
particles (Kim, 2004; Kissa, 1999) and microhydrodynamics of the milling beads (Eskin
et al., 2005a) as affected by the suspension rheology. To elucidate the main role of the
stabilizers, milling was performed in the absence (Run 1)/presence (Runs 2, 6, and 13) of
stabilizers. Figure 3.2a shows the evolution of the GF particle size distribution (PSD)
during milling as measured by the laser diffraction method when stabilizers were not
used. The GF particles exhibited a bimodal PSD after milling; the shoulder in the 100–
400 nm region suggests the existence of primary nanoparticles and some small aggregates
of few primary particles. Although the fraction of particles in this region increased
slightly upon prolonged milling, overall the PSD did not seem to change after 4 min
milling.
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Figure 3.2 (a) Evolution of the cumulative particle size distribution of GF suspension
milled in the absence of stabilizers (Run 1), (b) cumulative particle size distribution o f
the unmilled GF suspension without stabilizers and various 64 min milled
suspensions: without HPC or SDS (Run 1), with 2.5% HPC (Run 6), with 0.5% SDS
(Run 2), and with 2.5% HPC and 0.5% SDS (Run 13).

SEM images of the unmilled and milled GF particles in Figure 3.3a–c confirm the
breakage of the GF particles and formation of 50–250 nm primary particles. A

40

comparison of LD results and SEM images suggests that GF nanoparticles were formed
by breakage; however, they aggregated fast via attractive interparticle forces (van der
Waals) in the absence of stabilizers. Hence, it can be noted that GF nanoparticles can
form even in the absence of stabilizers; however, the so-produced nanoparticles cannot be
preserved against aggregation.

Figure 3.3 SEM image of (a) the as-received GF particles (marker size: 20 m,1 kX
magnification), (b) the GF particles milled for 64 min without stabilizers (Run 1, marker
size: 1 m, 46 kX magnification), (c) the GF particles milled for 64 min without
stabilizers at a higher magnification (Run 1, marker size: 200 nm, 131 kX magnification)
, (d) the GF particles milled for 64 min with 2.5% HPC and 0.5% SDS (Run 13, marker
size: 200 nm, 131 kX magnification).
In general, polymers and surfactants adsorb on particle surfaces, providing a steric
or electrostatic barrier (Merisko-Liversidge et al., 2003; Ploehn and Russel, 1990). In
addition, they allow proper wetting of the hydrophobic drug surfaces, which can help to
disperse aggregates formed during the milling process (Kissa, 1999). Various
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concentrations of stabilizers (0.5% SDS (Run 2), 2.5% HPC (Run 6), and 2.5%
HPC/0.5% SDS (Run 13)) were used to elucidate their stabilizing roles. Figure 3.2b
illustrates that finer GF particles were obtained after 64 min milling when the stabilizers
were used. In view of the median size of Run 1 suspension (4.725 m), the addition of
2.5% HPC alone (Run 6) improved the dispersion of the nanoparticles, leading to a
smaller median size (1.599 m). HPC, an electrically neutral polymer, stabilizes particles
by steric forces that are created by the long-tail interference of adsorbed protruding large
chains onto the particle surfaces (Stuart, 1991). The median particle size of GF was
reduced to 0.273 m in the presence of SDS alone (Run 2). SDS (an anionic surfactant)
appears to disperse the nanoparticles more effectively than HPC (a non- ionic cellulosic
polymer). SDS has a smaller molecular weight than HPC and thus diffuses and adsorbs to
the drug particle surfaces faster. In addition, being an anionic surfactant, SDS can make
the GF particles negatively charged after adsorption and increase the electrostatic
repulsion among the GF particles, thereby preventing the aggregation.
Figure 3.2b also shows that a combination of HPC–SDS (2.5% HPC and 0.5%
SDS, Run 13) led to the narrowest PSD and smallest d50 and d90 values (0.163 and 0.211
m). HPC–SDS mixtures are known to have synergistic effects in the stabilization of
drug suspensions (Basa et al., 2008; Lee et al., 2008; Ryde and Ruddy, 2002). HPC and
SDS interact, forming aggregates or micelle-like SDS clusters bound to HPC (Winnik
and Winnik, 1990). These clusters can co-adsorb on surfaces (Berglund et al., 2003a,
2003b; Evertsson and Nilsson, 1997), potentially facilitating adsorption of HPC (Cerdeira
et al., 2010) and enabling electrosteric stabilization. The SEM image (Figure 3.3d) shows
the primary GF nanoparticles in the size range of 50–250 nm. Along with the LD results,
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where the d50 and d90 sizes after 64 min milling were 0.163 and 0.211 m (Figure 3.2b,
Run 13), the SEM image suggests that the HPC–SDS stabilized suspension had relatively
small extent of aggregation. GF primary particle sizes in the absence or presence of
stabilizers was in the range of 50–250 nm, as seen in the SEM images (Figures 3.3c and
3.3d, respectively), which suggest that stabilizer(s) are needed to disperse the
nanoparticle aggregates. A combination of stabilizers (HPC–SDS) can help to disperse
the aggregated nanoparticles effectively. On the other hand, a slight reduction in the
fraction of GF nanoparticles in the <100 nm size range when SDS was used at 0.5%,
above the critical micelle concentration (CMC) of 0.23%, either alone or along with HPC
is observed. The aqueous solubility of GF increases above the CMC of SDS (Rao et al.,
1997), which may cause preferential loss of <100 nm particles due to enhanced
dissolution or aggregation.
The reproducibility of the wet media milling process was checked by repeat
experiments of Run 2 (0.5% SDS), Run 6 (2.5% HPC), and Run 13 (0.5% SDS/2.5%
HPC). The d50 and d90 values of the repeat experiments were 0.289 and 0.532 m, 1.765
and 3.182 m, and 0.163 and 0.207 m, respectively. The (absolute) percent deviations
from the d50 and d90 values were all less than 10%: 5.86 and 5.51%, 10.4 and 6.89%, and
0.0 and 1.90%, respectively. Hence, the particle size statistics were fa irly reproducible. In
general, the reproducibility was better for the suspensions with a smaller extent of
aggregation (Runs 2 and 13 vs. Run 6). Excellent reproducibility observed for the
suspension with HPC–SDS combination and higher variability observed for the
suspension with HPC alone agree with the recent work on the wet media milling of
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griseofulvin, naproxen, and azodicarbonamide suspensions containing HPC or HPMC in
the presence/absence of SDS (Bhakay et al., 2011, 2013; Monteiro et al., 2013).
The DSC thermograms of the as-received GF particles and milled GF particles
exhibited a sharp endothermic peak associated with the melting of the crystalline GF
(Figure 3.4). The peak melting temperature decreased slightly from 219.3 o C (as-received
GF powder) to 217.5 o C after milling (Run 1), while the heat of fusion did not change
much: 115 J/g to 113 J/g. These results indicate that a significant change to the
crystallinity of GF did not occur during the wet milling. Readers are referred to Monteiro
et al. (2013) for a more detailed characterization using powder-XRD and Raman
spectroscopy on milled GF particles, which supported the above finding.
1
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Figure 3.4 DSC thermograms of the as-received GF particles and 64 min milled GF
particles in the absence of stabilizers (Run 1).

3.3.2 Analysis of the Apparent Breakage Kinetics
To investigate the role of HPC in the apparent breakage rate, a wide range of HPC
concentrations was considered in the absence/presence of SDS. Figures 3.5a and 3.5b
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illustrate the evolution of the median particle size (d50 ) and the 90% passing size (d90 ) as
a function of HPC concentration: 0.1–2.5% (Runs 3–6) and 2.5–15% (Runs 6–9),
respectively, in the absence of SDS. Figures 3.6a and 3.6b present the same information
as a function of HPC concentration: 0.1–2.5% (Runs 10–13) and 2.5–10% (Runs 13–16),
respectively, in the presence of 0.5% SDS. Table 3.2 presents the particle size statistics
for the suspensions that were milled for 16 min and 64 min.
3.3.2.1 Effects of HPC in the Absence of SDS.

Both d50 and d90 decreased fast

within the first 4 min as the large micron-sized GF particles were easier to break (Figure
3.5). As milling continued, the apparent breakage rate decreased, and the particle size
exhibited either a clear minimum followed by an increase or varied about a plateau size.
This non-monotonic evolution of the particle size cannot be explained by pure breakage
of the particles. The GF suspensions with HPC as the sole stabilizer, even after prolonged
milling (64 min), did not have d90 less than 1 µm. Moreover, the suspensions with 0.1–
2.5% HPC had median sizes greater than 1 µm. Both d50 and d90 after 16 min and 64 min
milling were smaller at higher HPC concentration (Table 3.2, Runs 3–9), which suggests
that the overall apparent breakage rate increased with an increase in the HPC
concentration. Considering that 50–250 nm primary GF nanoparticles were produced
even in the absence of stabilizers (Figure 3.3c), the findings here imply the significant
impact of the particle aggregation in the apparent breakage rate and the particle size of
the final milled suspension.
During wet stirred media milling, two particle change mechanisms act
simultaneously: breakage of as-received particles, fragments of already broken particles
as well as aggregates (also known as deaggregation) and aggregation of the particles
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(Bilgili et al., 2004; Sommer et al., 2006). The particle size distribution at a given time
reflects the net effect of the competing breakage and aggregation mechanisms (Monteiro
et al., 2013). During the course of milling (Runs 3–9), the particle size decreased initially
within the first 4 min and increased/decreased instantaneously thereafter and seemed to
approach or varied around a large plateau size because the aggregation rate of the
produced fine particles equaled or exceeded the rate at which the particles and aggregates
broke upon prolonged milling. Initially, the breakage was faster than the aggregation due
to the presence of relatively large (micron-sized), weaker GF particles.
As milling progressed, the aggregation rate increased upon production of finer
(colloidal) drug particles because steric stabilization imparted by HPC alone was not
sufficient to keep the freshly formed nanoparticles discrete. Moreover, as the drug
particle size decreased, particle number concentration in the suspension increased and the
interparticle distance decreased, leading to more frequent collisions and potentially
higher aggregation rate (Sommer et al., 2006). An increase in HPC concentration reduced
the extent and rate of the aggregation, which resulted in finer particles and a higher
apparent breakage rate.
3.3.2.2 Effects of HPC in the Presence of SDS.

Unlike the evolution of d50 and d90 in

the absence of SDS (Figure 3.5), the evolution of both d50 and d90 exhibited a monotonic
decrease in the presence of SDS (Figure 3.6). For the formulations with SDS (Runs 10–
16), Table 3.2 shows that the suspensions with an HPC concentration greater than 0.5%
reached identical particle size after 64 min (within experimental accuracy), and all
suspensions reached ~160 nm median size after 64 min milling (except Run 10, with the
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lowest HPC concentration). All of the suspensions had d50 and d90 values less than 1 m
after 64 min.
Table 3.2 Effects of the HPC Concentration on the Median Size (d50 ) and 90% Passing
Size (d90 ) of the GF Suspensions for Runs 1–9 (without SDS) and Runs 10–16 (with
0.5% SDS) After 16 and 64 min Milling and After 7 Day Storage
Run
HPC
Milled (16 min)
Milled (64 min)
7 day storage
No. Concentration d50 (µm), d90 (µm)
d50 (µm), d90 (µm)
d50 (µm), d90 (µm)
(% w/w)
1
—
4.586, 7.995
4.725, 9.023
4.416, 7.568
2a
—
0.648, 1.723
0.273, 0.563
0.279, 0.543
3
0.1
2.976, 5.295
2.895, 5.173
2.318, 4.265
4
0.5
2.334, 4.855
2.189, 4.362
2.173, 4.127
5
1
2.001, 3.932
2.030, 3.721
NMb
6
2.5
1.588, 2.894
1.599, 2.977
1.684, 3.709
7
5
1.117, 2.176
0.473, 1.762
1.178, 2.327
8
10
0.559, 2.022
0.358, 1.425
0.390, 1.725
9
15
0.426, 1.460
0.300, 1.125
0.332, 1.176
10
0.1
0.419, 1.442
0.274, 0.469
0.257, 0.510
11
0.5
0.450, 1.470
0.165, 0.394
0.197, 0.442
12
1
0.441, 1.483
0.154, 0.238
0.158, 0.258
13
2.5
0.256, 0.476
0.163, 0.211
0.164, 0.214
14
5
0.315, 0.577
0.162, 0.221
0.161, 0.228
15
7.5
0.367, 0.670
0.165, 0.235
0.173, 0.250
16
10
0.399, 1.170
0.161, 0.237
0.190, 0.314
a
This run has 0.5% SDS and included here for comparative purpose.
b
NM: not measured.

In view of the 50–250 nm primary particles produced in Run 13 (Figure 3.3d) and the
above information, the extent of aggregation in the 64 min milled suspensions was low,
and the breakage mechanism dominated over the aggregation mechanism when SDS was
used in combination with HPC. Moreover, the presence of SDS allowed a much lower
concentration of HPC (as low as 1%) that can ensure the formation of a stable GF
nanosuspension. This finding can be explained by the aforementioned synergistic
stabilizing action of the HPC–SDS combination (Section 3.4.1).
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Figure 3.5 Effects of the HPC concentration on the evolution of d50 and d90 during the milling of the GF particles in the absence of
SDS: (a) 0.1–2.5% HPC (Runs 3–6), (b) 2.5–15% HPC (Runs 6–9).
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The particle size decreased fast within the first 8 min (Figure 3.6). The apparent
breakage rate decreased with further milling and the particle size approached or reached a
plateau size: d50 value of ~160 nm and d90 value of ~220 nm for HPC concentration
greater than 0.5%. The monotonic decrease of the particle size and tendency toward a
plateau size signify the dominance or higher extent of particle breakage over particle
aggregation for these relatively stable suspensions. For prolonged milling, a plateau size
is theoretically expected for two reasons: a dynamic equilibrium between the particle
breakage and aggregation can be established (Bhakay et al., 2011) and the true breakage
rate decreases upon generation of finer particles, especially nanoparticles, which are more
difficult to break stemming from their high strength (Lee, 2003; Bilgili et al., 2006).
Since a plateau size was approached after 64 min milling, the apparent breakage rate may
be conveniently assessed considering the particle size at an earlier time point, e.g., 16 min
of milling in Table 3.2 and Figure 3.6. Within the HPC range studied, an optimum HPC
concentration of 2.5% was identified, which yielded the smallest d50 and d90 at 16 min.
The larger values of d50 and d90 for the other HPC concentration values can be explained
as follows: below 2.5% HPC, the particle aggregation might have occurred to a larger
extent leading to slower apparent breakage, whereas the viscous dampening effect might
have reduced the true breakage rate and led to the formation of coarser particles for the
relatively more stable suspensions with an HPC concentration above 2.5%. These aspects
will be elucidated in Section 3.4.7 using the combined microhydrodynamics–polymer
adsorption analysis. The result suggests that 2.5% is the optimal HPC concentration in
view of the HPC concentrations studied. Finding a more accurate and precise value of the
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optimum polymer concentration entails additional milling experiments with many more
HPC concentrations within the 1–5% range. However, since an emphasis is on the
qualitative nature of this optimum, this aspect will not be studied.
To confirm the optimality of 2.5% HPC in the presence of SDS, a quantitative
analysis of the breakage rate, which considers all milling time points including 16 min,
was performed using the two-parameter empirical model (Section 3.1). The evolution of
the median size in Runs 12–16 (1–10% HPC), excluding runs with 0.1 and 0.5% HPC,
was fitted to minimize the confounding effect of the particle aggregation and to improve
the goodness-of- fit and statistical significance of the parameters. Table 3.3 presents the
values of the parameters dlim and τp (see Chapter 2.3) and the coefficient of determination
(R2 ). For all fits, R2 value was greater than 0.90 and the empirical model was statistically
significant (p-value < 0.05). In addition, all p-values for the parameters estimated were
found to be less than 0.005, proving the statistical significance of the parameter estimates.
The process time constant τp correlates negatively with the overall apparent breakage
rate: a larger τp indicates a slower apparent breakage during the milling.
Table 3.3 confirms the aforementioned result obtained from the analysis of 16
min milling data: 2.5% HPC concentration led to the fastest apparent breakage. The
monotonic increase of τp with an increase in HPC concentration from 2.5% to 10% could
be attributed to greater viscous dampening of the beads and resultant slower particle
breakage. The estimated dlim values were about 200 nm (Table 3.3) and slightly greater
than the experimental d50 values obtained after 64 min milling (Table 3.2), suggesting a
limitation of the simple empirical model expressed by Eq. (2.7).
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Figure 3.6 Effects of the HPC concentration on the evolution of d50 and d90 of the GF particles in the presence of 0.5% SDS: (a) 0.1–
2.5% HPC (Runs 10–13), (b) 2.5–10% HPC (Runs 13–16).
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This deviation is the largest for Run 12 (1% HPC) among Runs 12–16, which may
suggest that the deviation can be partly explained by the presence of particle aggregation.
Experimental errors may also partly explain the deviation: experimental d50 values (64
min) were still within 2 standard deviations of the estimated dlim, which were quantified
by the coefficient of variation (COV) values.
Table 3.3 Fit of the Empirical Model (Eq. (2.7)) to the Evolution of the Median Particle
Size in Runs 12–16 (with 0.5% SDS)
Run
HPC
dlim , COV%
τp , COV%
R2
No.
Concentration
(µm), (–)
(min), (–)
(–)
(% w/w)
12
1
0.239 (20.7)
4.33 (23.6)
0.919
13
2.5
0.194 (14.4)
2.22 (15.7)
0.960
14
5
0.202 (20.0)
2.45 (18.4)
0.940
15
7.5
0.218 (14.5)
3.90 (15.9)
0.962
16
10
0.209 (16.4)
5.40 (16.6)
0.961

3.3.3 Physical Stability of the Milled Suspensions
Milled GF suspensions were refrigerated at 8 o C for a period of 7 days to examine the
aging effects. In the absence of SDS, the size-dependence of the aged particles on the
HPC concentration followed the same trend as that for 64 min milled suspensions:
smaller particle size at higher HPC concentration (Table 3.2). Interestingly, upon storage,
the particle size increased for the milled suspensions with an HPC concentration greater
than 1% (Runs 6–9), while it decreased for the milled suspensions with 0%, 0.1%, and
0.5% HPC (Runs 1, 3, and 4). It must be noted that the latter group of suspensions had
such a low viscosity (less than 4 cP) that could not be measured reliably with the current
rheometer set-up. After refrigerated storage for 7 days, the suspensions were mixed using
a shear mixer for 5 min at 300 rpm to obtain a homogeneous sample for particle sizing.
Due to the very low viscosity and presence of a appreciable fraction of large and weak
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aggregates (>3–4 m after milling and storage), Runs 1, 3, and 4 suspensions were
subjected to higher shear, leading to the breakage of the large aggregates and reduction in
d50 and d90 . On the other hand, Runs 6–9 suspensions were more viscous and subjected to
lower shear rate at the same rotation rate (300 rpm). Since they had a much smaller
fraction of large aggregates after milling, the low shear did not lead to significa nt
breakage; hence, an increase in d50 and d90 was observed possibly due to Brownian
aggregation during the storage. It should be noted that this shear rate dependence of the
particle size of 7-day stored GF suspensions was mainly a consequence of the high extent
of aggregation in these relatively less stable suspensions with HPC as the sole stabilizer
and the relatively high speed of the mixer.
In the presence of SDS, the particle size of the milled suspensions increased
slightly after 7-day storage (Table 3.2) because of the synergistic stabilizing action of the
HPC–SDS combination, except at the very low HPC concentrations (0.1% and 0.5%).
The particle sizes (d50 and d90 ) measured by the laser diffraction were similar to the
primary nanoparticle size range of 50–250 nm observed in Figure 3.3d, suggesting
minimal or limited extent of aggregation in these suspensions. It appears that Ostwald
ripening was not a serious issue during the 7-day refrigerated storage of these
suspensions. Long-term stability of these suspensions was not investigated here as they
were intended to be dried shortly after the milling (Bhakay et al., 2013; Sievens-Figueroa
et al., 2012).
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3.3.4 Polyme r Adsorption on Milled GF Particles
To gain a deeper understanding of the steric stabilization imparted by HPC, HPC
adsorption on the milled GF particles was studied in the absence/presence of SDS. HPC
concentration in the GF suspension determines the maximum amount of HPC that can
possibly adsorb on the GF particles and the thickness of the HPC layer. A thicker layer of
the adsorbed polymer and strong adsorption are desirable for good steric stability (Lee,
2003). In the absence of SDS, the amount of HPC adsorbed per surface area of the GF
particles increased with an increase in the total HPC concentration from 0.1% to 0.5%
(Figure 3.7). It continued to increase and appeared to reach a plateau at about 2.5–3%
HPC. Beyond 3%, the adsorption resumed to increase. One explanation may be that
mono- layer adsorption occurred up to 3% HPC (mono- layer saturation) followed by
multilayer adsorption. Similar observations were made about the HPC adsorption onto
ibuprofen particles (Law and Kayes, 1983). The monotonic increase in the amount of
HPC adsorbed with an increase in HPC concentration means a monotonic increase in the
adsorbed HPC layer thickness and thus better steric stability. This enhanced steric
stability at higher HPC concentration reduced the aggregation probability of the colliding
GF particles, leading to the monotonic decrease in d50 and d90 (Table 3.2). In addition, an
increase in HPC concentration led to a higher suspension viscosity (Section 3.4.5), which
can reduce the collision rate among the GF particles and thus the aggregation rate
(Sommer et al., 2006). In spite of all the positive effects associated with the use of a
higher HPC concentration, the particle aggregation was not completely suppressed with
the use of HPC even at the highest concentration (15%). An insufficient layer thickness
on the GF particle surfaces, slow adsorption of large HPC molecules during milling, and
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small repulsive forces stemming from the non- ionic nature of HPC and small surface
charge of GF particles in aqueous cellulosic suspensions (Meng et al., 2011) could
explain the inadequacy of HPC.
Adsorption of HPC on GF particles in the presence of 0.5% SDS was also studied
to explain the synergistic effects observed during the milling (Figure 3.7). The amount of
stabilizers (mostly HPC) adsorbed on the hydrophobic surfaces of the GF particles
monotonically increased with an increase in the HPC concentration. The amount
adsorbed was much higher in the presence of SDS potentially due to the co-adsorption of
SDS with HPC and the facilitation of HPC adsorption by SDS, which was suggested
earlier by Cerdeira et al. (2010) for HPC adsorption on miconazole particles in the
presence of SDS. The co-adsorbed layers can impart electrosteric stabilization to the GF
particles. Strictly speaking, the amount of stabilizers adsorbed reflects the contributions
from both HPC and SDS. On the other hand, since SDS concentration was kept constant
at 0.5%, the dramatic increase of the amount adsorbed above 0.5% HPC can only be
explained by the enhanced adsorption of HPC and the amount adsorbed is mainly
contributed by HPC. Regardless of the underlying mechanisms for the observed
enhancement in the adsorption, the presence of SDS could allow formation of a thicker
HPC–SDS layer at higher HPC concentration, leading to enhanced electrosteric
stabilization.
The adsorption isotherms presented in Figure 3.7 explain the synergistic effects of
the HPC–SDS combination, the larger d50 and d90 values of the milled suspensions with
HPC concentration less than 1% and the large τp value of Run 12 as well as the relatively
good physical stability of the suspensions with >1% HPC. At higher HPC concentrations,
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the shear viscosity of the suspensions were higher (see below), which could reduce the
collision rate of the GF particles, leading to a reduced aggregation rate besides the lower
aggregation probability (thicker HPC–SDS layer). Interestingly, since the adsorption
isotherm is a monotonically increasing function of the HPC concentration when 0.5%
SDS is present, the optimal HPC concentration (2.5%) cannot be explained by the
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2
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Figure 3.7 Adsorption of HPC on milled GF particles in the absence (Runs 3–8 and 17)
and presence (Runs 10–16 and 18) of 0.5% SDS.

3.3.5 Suspension Rheology and Assessment of the Aggregation State
The apparent shear viscosities of aqueous HPC solutions (without GF) and 64 min milled
GF suspensions (Runs 5–9) without SDS were measured as a function of shear rate at
various HPC concentrations and presented in Figures 3.8a and 3.8b, respectively. An
increase in HPC concentration significantly increased the viscosity in the absence or
presence of the milled GF particles. In general, as the shear rate was increased, the
viscosity of the HPC solutions decreased significantly (shear-thinning behavior) and
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tended to an asymptotic value (Newtonian fluid behavior) above a shear rate of 500 1/s
(Figure 3.8a). A slight increase in the viscosity was observed for the 1% HPC solution
above 400 1/s shear rate. The milled suspensions had higher viscosity and exhibited
stronger shear-thinning behavior that was prevalent up to 1000 1/s as compared with the
HPC solutions. The approach to an asymptotic viscosity was delayed, and the decrease of
viscosity above 500 1/s was still notable. These findings accord well with other studies in
literature and could be attributed to the higher extent of aggregate breakage
(deaggregation) at higher shear rates (Barthelmes et al., 2003; Bernhardt et al., 1999).
Presence of aggregates, which can occlude liquid in their void space, increases the
effective volume fraction of the solid in a suspension with fixed solids loading. Hence, in
general, an aggregated suspension has a higher shear viscosity than a fully-dispersed
suspension consisting of discrete primary particles. Since the GF aggregates broke more
extensively at higher shear rates, the apparent shear viscosity decreased with an increase
in the shear rate. As a crude measure of shear-thinning, the ratio of shear viscosity at a
low shear rate (s) to that at a high shear rate (1000 1/s), i.e., L0 /L, was calculated.
The ratio decreased from 8.2 (1% HPC) to 1.6 (15% HPC) monotonically, which
suggests a less pronounced shear-thinning behavior, thus signifying a less aggregated
state of the GF suspensions at higher HPC concentrations. The same behavior can be seen
from the absolute value of the slope of the viscosity curve on semi- log axes (Figure 3.8b):
as the HPC concentration was increased, the absolute value of the slope decreased at a
given shear rate (e.g. 250 1/s). The viscosity measurements independently confirmed the
aggregation state of the milled suspensions, agreeing well with the laser diffraction data
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(Table 3.2). Both methods suggest that the extent of aggregation decreased monoto nically
when the milled suspension had a higher HPC concentration.
In order to investigate the impact of HPC–SDS combination on the suspension
rheology, the apparent shear viscosity was obtained as a function of shear rate in the
absence (solution) and presence of GF (milled suspension) (see Figures 3.8c and 3.8d,
respectively). An increase in HPC concentration increased the viscosity significantly in
the absence or presence of the milled GF particles. A comparison of Figures 3.8a and
3.8c shows that addition of SDS to an HPC solution increased the viscosity significantly,
which can be attributed to the formation of HPC–SDS aggregates or micelle- like SDS
clusters bound to the polymer (Berglund et al., 2003a; Evertsson and Nilsson, 1997;
Winnik and Winnik, 1990).
Unlike the viscosity profiles presented in Figures 3.8a and 3.8b (no SDS), the
viscosity of a milled suspension was lower than that of the HPC–SDS solution (Figures
3.8c and 3.8d). This finding can be explained by the relatively well-dispersed nature of
the GF suspensions with HPC–SDS (less number of smaller aggregates) and the reduced
concentration of HPC–SDS in the bulk solution of the GF suspensions due to enhanced
HPC adsorption, as mentioned above. Moreover, a comparison of the absolute value of
the slope of the viscosity curves in Figures 3.8b and 3.8d suggests that at the same HPC
concentration, the shear thinning behavior was weaker (flatter curves) in the presence of
SDS. Figure 3.8d also illustrates that the apparent viscosity of the milled s uspensions
tends to plateau at low shear rates, exhibiting a near-Newtonian behavior. Similarly, the
shear viscosity ratioL0 /L) was lower (0.9–1.8) in the presence of SDS than in its
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absence (1.6–8.2). These results agree with the laser diffraction results in that the milled
suspensions with HPC–SDS were better dispersed and more stable.
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Figure 3.8 Effects of the HPC concentration on the apparent shear viscosity as a function
of the shear rate for (a) the HPC solutions without SDS, (b) 64 min milled GF
suspensions without SDS (Runs 5–9), (c) the HPC solutions with 0.5% SDS, (d) 64 min
milled GF suspensions with 0.5% SDS (Runs 12–16).

3.3.6 Microhydrodynamic Analysis of the Wet Stirred Media Milling Process
A microhydrodynamic analysis was performed to further elucidate the impact of the HPC
concentration and absence (Runs 5–9)/presence (Runs 12–16) of SDS. Table 3.4 presents
the power input (P w and εht ), density and shear viscosity of the milled suspensions (L and
µL), and the microhydrodynamic parameters ( ,  , and ub) (see Chapter 2.4). The power
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applied by the rotor in the presence of the beads (P w) and in the absence of the beads (εht )
monotonically increased with an increase in the HPC concentration, which can be
explained by a corresponding increase in the suspension viscosity. On the other hand, for
the same reason, the granular temperature ( ), average bead oscillation velocity (ub), and
the single bead frequency ( ) monotonically decreased. Hence, the microhydrodynamic
analysis has enabled the quantification of the viscous dampening effect of HPC during
the wet media milling of drugs for the first time. The decrease in the values of  ,  , and
ub at higher HPC concentration correlates to a reduction in the number and intensity of
the bead–bead collisions, which implies a smaller number of less intense compression
events during which the GF particles are deformed and/or broken by the colliding beads
during milling. The general trends for the effects of HPC concentration on the power
input and the microhydrodynamic parameters were similar regardless of the
absence/presence of 0.5% SDS. However, the use of SDS in addition to HPC has a
negative effect on the microhydrodynamic parameters, as suggested by the lower  ,  ,
and ub values (except at 1% HPC). The higher viscosity of the milled suspensions with
HPC–SDS can explain this negative effect even though Pw values were also higher in the
presence of SDS.
Although the decrease in  ,  , and u b values at higher HPC concentration
(viscous dampening) suggests a decrease in the breakage rate of the GF particles, the
overall apparent breakage rate presented in Table 3.2 and Figure 3.5 suggests otherwise
(Section 3.3.2.1). Hence, in the absence of SDS, the apparent breaka ge kinetics and final
particle size distribution of the milled GF suspensions, with HPC as the steric stabilizer,
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are affected more by the rate–extent of the particle aggregation than the viscous
dampening observed at the higher HPC concentration.

3.3.7 Combined Microhydrodynamics–Polyme r Adsorption Analysis
Figure 3.9 summarizes the effects of HPC concentration, in the presence of SDS, on the
median size after 16 min milling, the characteristic process time constant estimated by the
empirical model, the adsorption isotherm, and the granular temperature. Both the median
size and the process time constant showed a minimum at 2.5% HPC (most favorable
condition from a processing and physical stability perspective). The same optimum, even
more pronounced, could be identified if the 90% passing size instead of the median size
was plotted in Figure 3.9. The granular temperature was a monotonically decreasing
function of the HPC concentration (viscous dampening), whereas the adsorption isotherm
was a monotonically increasing function. Therefore, neither the granular temperature nor
the adsorption isotherm alone can explain the observed optimum at 2.5% HPC: both of
these values should be sufficiently high to ensure the highest apparent breakage rate.
Below 2.5% HPC, the particle aggregation was more pronounced due to the relatively
small thickness of the adsorbed HPC layer and higher GF particle collision frequency at
the low viscosity of the milled suspensions. Above 2.5%, the viscous dampening effect
becomes pronounced for the stable suspensions with the lower extent of aggregation.

3.3.8 Correlating the Microhydrodynamics with Equipment-Scale Hydrodynamic
Behavior
The stirrer (rotor) Reynolds number (Re) and the stirrer (rotor) Euler number (Eu), also
known as the power number, are widely used to assess the overall flow behavior of the
suspensions and to relate the power consumption to the operating parameters, equipment
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parameters, and the fluid properties (Kawatra, 2006; Mannheim, 2011). In the absence or
presence of SDS, Re decreased and Eu increased with an increase in the HPC
concentration (Figure 3.10). For scale-up purposes, one can relate Eu to Re (Manneheim,
2011), which is beyond the scope of this work.
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Figure 3.9 Effects of the HPC concentration, in the presence of 0.5% SDS, on (a) the
median size of the GF particles after 16 min milling and the characteristic time constant
(Runs 12–16) , (b) the granular temperature (Runs 12–16) and the amount of HPC
adsorbed on the GF particles (Runs 10–16).

Eu exhibited a continuous increase with HPC concentration in the presence of SDS
(Figure 3.10b), whereas it had a smaller slope and tend to plateau at higher HPC
concentration in the absence of SDS (Figure 3.10a). In both cases, the granular
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temperature ( ) monotonically decreased and exhibited a profile similar to that of Re,
suggesting a correlation.
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Figure 3.10 Effects of the HPC concentration on the stirrer Reynolds number, the stirrer
Euler number, and the granular temperature: (a) in the absence of SDS (Runs 5–9), (b) in
the presence of 0.5% SDS (Runs 12–16).

Figure 3.11 presents a statistically significant correlation between the fundamental
microhydrodynamic parameter  and macro-scale (equipment/stirrer scale) flow
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parameter Re in the form of a simple logarithmic function, which was built on both HPC
formulations and HPC–SDS formulations.
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Figure 3.11 A correlation between the granular temperature and the stirrer Reynolds
number for the formulations without SDS (Runs 5–9) and with 0.5% SDS (Runs 12–16).

3.4 Summary and Conclusions
Impact of polymers and surfactants on the wet stirred media milling of poorly watersoluble drugs is commonly examined within the context of their stabilizing action. Hence,
a significant gap exists in terms of a fundamental engineering understanding of their roles
in breakage kinetics, which determine the cycle times and production rate–volume for a
desired fineness of the drug suspension. With the goal of developing such an
understanding, for the first time, used a combined microhydrodynamics–adsorption
analysis and elucidated the impact of a non- ionic cellulosic polymer (HPC), in the
absence/presence of an anionic surfactant (SDS), on the apparent breakage kinetics of
griseofulvin (GF) during wet stirred media milling. The aggregation state of the milled
suspensions was examined by both particle sizing and rheometry.
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Table 3.4 Effects of the HPC Concentration on the Parameters Measured (P w, εht, L, and µL) and the
Microhydrodynamic Parameters ( ,  , and ub) for Runs 5–9 (without SDS) and Runs 12–16 (with 0.5% SDS)
Run
HPC
Pw
εht
µL
ρL
ub
ν

No. Concentration
(W/m3 )
(W/m3 )
(cP) (kg/m3 )
(m/s)
(1/s)
(m2 /s2 )
(% w/w)
5
1
0a
11
1084
6.88105
2.2510–2
2.3910–1
6.42103
6
2.5
0a
17
1161
8.13105
2.1210–2
2.3210–1
6.24103
a
7
5
0
40
1178
1.00106
1.5610–2
2.0010–1
5.35103
6
4
–3
–1
8
10
135
1266
1.2810
5.7410
7.1010
1.3510
3.61103
9
15
1366
1.31106
2.11105 346
2.6010–3
8.1810–2
2.20103
a
5
–2
–1
12
1
0
5
1024
7.5010
2.9310
2.7310
7.33103
13
2.5
25
1037
9.69105
5.74104
1.9810–2
2.2410–1
6.02103
14
5
93
1067
1.41106
7.66104
1.0810–2
1.6610–1
4.45103
15
7.5
1077
1.53106
1.15105 180
6.3010–3
1.2710–1
3.41103
6
5
–3
–1
16
10
270
1100
1.9710
1.9110
5.4010
1.1710
3.14103
a
Too small to be measured accurately.
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Due to the non- ionic nature of the HPC and low inherent charge of GF in aqueous
suspensions, HPC, even at high concentrations, was not able to fully stabilize the milled
suspensions: the milled GF particles were highly aggregated in the absence of SDS,
which was confirmed by laser diffraction and rheometry. The suspensions exhibited
strong shear-thinning behavior that spanned the whole shear rate range investigated in
this chapter. Although an increase in HPC concentration caused a reduction in the
granular temperature (viscous dampening), the particle size decreased monotonically due
to a decrease in the extent of particle aggregation, which was facilitated by the lower
collision frequency (higher suspension viscosity) and lower aggregation probability
(greater thickness of the adsorbed HPC layer). The inclusion of SDS during milling
enhanced the HPC adsorption (thicker adsorption layer), allowing a synergistic
electrosteric stabilizing action. Less HPC was needed to reduce the aggregation tendency
in the presence of SDS. Similarly, these milled suspensions showed a weaker shearthinning behavior and exhibited a lower extent of particle aggregation. Since they were
physically more stable, the viscous dampening effect associated with high HPC
concentration (above 1% HPC) was dominant in determining the apparent breakage
kinetics. The combined microhydrodynamics–adsorption analysis aided the explaination
of not only the viscous dampening effect of HPC, but also the optimum HPC
concentration (2.5%) in the presence of SDS. The apparent breakage rate was the fastest
at 2.5% HPC because both the granular temperature and the HPC adsorbed per unit
surface area of the GF particles were relatively high. A simple logarithmic correlation
between the granular temperature and the stirrer Reynolds number connected the
intensity of the bead–bead collisions at the microscopic (bead) scale to the flow behavior
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of the suspensions at the macroscopic (stirrer) scale. This correlation expresses the
impact of suspension formulation parameters on the granular temperature for a given
scale and operating conditions of the mill. The combined microhydrodynamics–polymer
adsorption analysis has opened a new path to the work of the wet media milling process
in terms of microhydrodynamic parameters as they are affected by formulation–design–
operating parameters. It will potentially help formulators and engineers to design the
nanosuspension formulations, to select the operating mill parameters, and to scale-up
milling processes. Future work will involve the analysis of the impact of other commonly
used polymers such as HPMC and PVP with/without SDS on the apparent breakage rate.
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CHAPTER 4
IMPACT OF PROCESS PARAMETERS ON THE BREAKAGE KINETICS OF
POORLY WATER-SOLUBLE DRUGS DURING WET STIRRED MEDIA
MILLING: A MICROHYDRODYNAMIC VIEW

4.1 Introduction
Size reduction of drug crystals is known to be a feasible approach for improving the
dissolution rate and bioavailability of poorly water-soluble drugs (Muller and Peters,
1998). Among all size reduction techniques, wet stirred media milling has proved to be a
robust top-down process for producing drug nanoparticles (Bhakay et al., 2011; Bruno et
al., 1996; Merisko-Liversidge et al., 2003). In this technique, micron-sized drug particles
and media (beads) in an aqueous solution of stabilizers, usually polymers and/or
surfactants are mixed by a stirrer at very high speeds. Repeated stressing of the micronsized drug particles that are captured between the colliding beads causes size reduction
down to the nanometer size range provided milling is continued for a sufficient time.
Stabilizers are usually added to prevent the aggregation of the milled drug particles, while
some polymeric stabilizers can also inhibit particle growth (ripening) during
milling/storage (Ghosh et al., 2011; Kesisoglou et al., 2007).
Finding an optimal stabilizer type/concentration is an important aspect of drug
nanoparticle formulation development because short or long-term physical stability of a
drug nanoparticle suspension must be ensured for the intended end use of the suspension
in a desired dosage form. Therefore, a great majority of the wet media milling studies
have focused on the physical stability of the milled drug suspensions that are formulated
with various stabilizers (Kesisoglou et al., 2007; Van Eerdenbrugh et al., 2008). For
example, milling in a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (Lee
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and Cheng, 2006; Van Eerdenbrugh et al., 2007), both making use of vials containing
drug suspensions with various stabilizers, has previously bee n described for their
capability in obtaining nanoparticles. These mills are regarded as medium or low-energy
mills. Hence, the suspension flow and microhydrodynamics, which is the fluctuating
motion of the beads in suspensions, are quite different in thes e mills than in the wet
stirred media mills. It is not surprising to see that nanoparticles are produced after several
hours to a few days of milling, even at the bench scale, for suspension quantities on the
order of ~10 g. In other studies (e.g. Cerdeira et al., 2010; Merisko-Liversidge et al.,
2003), wet stirred media mills have been used; however, the impact of process
parameters on the breakage kinetics and microhydrodynamics has not been reported. It is
clear that milling dynamics, breakage kinetics, process cycle times, and scale-up effects
have not been of major concern in these formulation studies. Bhakay et al. (2011) points
out that most wet media milling studies in pharmaceutical literature (e.g. Ain- Ai and
Gupta, 2008; Tanaka et al., 2009) did not consider the breakage kinetics explicitly and
focused mainly on the physical stability of the final milled suspensions, which were
produced upon prolonged milling. Other studies (Choi et al., 2008; Deng et al., 2008; Lee
et al., 2008) reported limited analysis of the effects of milling time, with little to no
quantification of the breakage kinetics and its relation to the microhydrodynamics.
As wet media milling process is time-consuming, costly, and energy- intensive
(Kawatra, 2006) and the breakage kinetics determines the cycle time and production rate
for a desired fineness, milling process design and optimization entails a good
understanding of the breakage kinetics and its controlling process parameters. Process
parameters such as stirrer speed, bead loading, and drug loading can significantly affect
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the breakage rate and milling time required in a wet stirred media milling process. In a
recent review paper, Peltonen and Hirvonen (2010) summarized various process
parameters and their ranges investigated in wet media milling processes. While Peltonen
and Hirvonen (2010) and the references cited therein provide great understanding of the
impact of stabilization and formulation, little fundamental understanding of the impact of
process parameters is available at the beads scale (microhydrodynamics). In a more
recent work, Ghosh et al. (2012) present the effects of stirrer speed, bead size, and drug
content on the final milled suspension; however, the impact of these parameters on the
breakage kinetics was not investigated. Singare et al. (2010) and Singh et al. (2011) used
a statistical design of experiments with a response surface methodology (RSM) with the
goal of optimizing the process parameters including milling speed and time. However, no
information regarding the breakage kinetics was presented explicitly. In general, the
statistically-based designs of experiments such as those in Singare et al. (2010) and Singh
et al. (2011) may not provide significant physical insight at the beads scale as to how t he
process parameters affect the breakage kinetics.
While valuable and sizeable body of work exists in pharmaceutical literature
regarding the impact of processing parameters on the particle size of milled suspensions,
as mentioned above, the breakage kinetics and its relation to the microhydrodynamics has
not been investigated. To a certain extent, wet media milling has been treated as a “blackbox”. In a separate field, Eskin et al. (2005a, 2005b) developed a model to study the
microhydrodynamics in a mixing tank filled with beads that are stirred with a pair of
Rushton type paddles. The impact of bead size, stirrer speed, and bead concentration was
simulated for a mixing tank with water as the medium. Bilgili and Afolabi (2012) have
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applied this model (see Chapter 3) to the wet media milling of drug suspensions with
polymer–surfactant and elucidated/quantified the viscous dampening effect of the
stabilizers. While the excellent work by Eskin et al. (2005a, 2005b) built the theoretical
foundation for analysis of the microhydrodynamics, developing a fundamental
understanding of the impact of milling process parameters on the breakage rate of drug
nanoparticle suspensions entails a combined analysis of the microhydrodynamics and
breakage kinetics.
The preceding chapter investigates the impact of formulation parameters; the key
results suggest a minimum stabilizer-to-drug ratio, synergistic stabilizing effect of a
hydrophilic polymer and surfactant, and a dampening effect of the polymer on the
breakage kinetics above an optimum loading level. The major objective of this chapter is
to elucidate the impact of stirrer speed, bead concentration, and drug loading on the
breakage kinetics during the wet stirred media milling of griseofulvin (GF), a model
poorly water-soluble drug, via a microhydrodynamic model of the milling process. GF
particles were wet-milled in the presence of two stabilizers, hydroxypropyl cellulose
(HPC) and sodium dodecyl sulfate (SDS), to prepare stable GF suspensions under various
processing conditions. Laser diffraction, scanning electron microscopy, and rheometry
were used to characterize the suspensions. The evolution of the median particle size was
measured and fitted by a well-established empirical model (Strazisar and Runovc, 1996),
yielding a characteristic time constant of the process as a measure of the breakage
kinetics. The impact of the process parameters on the breakage kinetics was explained in
terms of various microhydrodynamic parameters, including the newly defined milling
intensity factor. Besides providing physical insight and guiding process optimization, the
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theoretical analysis also rationalizes preparation of a single highly drug- loaded batch
(20% or higher) instead of multiple dilute batches.

4.2 Experime ntal

4.2.1 Materials
Griseofulvin (GF, Cat# 606440, BP/EP micronized grade of GF was purchased from
Letco Medical, Decatur, AL, USA) was used as a model BCS Class II drug.
Hydroxypropyl cellulose (HPC) and sodium dodecyl sulfate (SDS) were used as
stabilizers as reported in Chapter 3.

4.2.2 Methods
4.2.2.1 Preparation of GF Suspensions.

Feed suspensions to be milled were prepared

in a shear mixer (Cat#. 14–503 Fisher Scientific Pittsburgh, PA, USA). Based on a
previous formulation study (see Chapter 3) with GF (Bilgili and Afolabi, 2012), a 2.5%
HPC–0.5% SDS aqueous solution was prepared with 200 g deionized water so as to
properly stabilize GF suspensions during milling and after storage. Note that all
percentages (%) refer to w/w with respect to deionized water unless otherwise specified.
SDS was added to deionized water in a beaker gradually for 15 min while the mixer ran
at a fixed speed of 300 rpm. Then, HPC was added to the SDS solution gradually for 30
min. The final HPC–SDS solution was further mixed for 15 min to ensure proper
dissolution of HPC and SDS particles. Desired amount of GF powder was weighed and
added to this solution gradually for 30 min while mixing continued.
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The feed suspensions were milled in a Microcer wet stirred media mill (Netzsch
Fine Particle Technology, LLC. Exton, PA, USA), whose schematic is shown in Figure
3.1. Table 4.1 presents the process parameters examined in this chapter, while other
parameters were kept constant. Run 1 was regarded as the base-case as its process
parameters were selected based on prior formulation study (see Chapter 3) (Bilgili and
Afolabi, 2012).
Table 4.1 Processing Parameters used in the Wet Milling Experiments
Run
Drug
Stirrer Speed
Bead Load,
No.
Loading
(rpm, m/s)
Concentration
(% w/w)a
(ml), (c)
1
10
3200, 11.7
50, 0.388
2
10
1600, 5.86
50, 0.388
3
10
2400, 8.80
50, 0.388
4
10
4000, 14.7
50, 0.388
5
10
3200, 11.7
14, 0.107
6
10
3200, 11.7
32, 0.244
7
10
3200, 11.7
75, 0.572
8
5
3200, 11.7
50, 0.388
9
20
3200, 11.7
50, 0.388
10
a

30

3200, 11.7

50, 0.388

% w/w with respect to de-ionized water.

In Runs 2–10, stirrer speed, bead concentration, and drug loading were
systematically studied by varying only one variable at a time and keeping the other
variables constant. The suspensions were milled for 96 min, which allowed sufficient
time for preparation of GF nanoparticles (d90 < 1000 nm) under all processing conditions.
The maximum stirrer speed allowed per mill design is 4200 rpm; hence, 4000 rpm was
studied as the highest value (Run 4). The milling chamber is lined with zirconia and has a
volume Vm of 80 ml. To minimize potential pressure build-up and fast temperature rise,
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the mill was loaded with a maximum of 75 ml of zirconia beads (bulk volume) in Run 7.
Also, a maximum of 30% drug loading was used to conserve the drug (Run 10).
The milling procedure was followed as in section 3.2.2.1 at a constant volumetric
flow rate Q of about 126 ml/min by a peristaltic pump (Figure 3.1). In Runs 4 and 7, the
stirrer was stopped occasionally when the temperature reached 35 o C due to high heat
generation rate. Samples were taken from the outlet of the milling chamber at several
intervals of milling and the particle size distribution was measured. The final milled
suspensions were stored in a refrigerator at 8 o C after density and shear viscosity
measurements.
4.2.2.2 Measure ment of Powe r Consumption for the Microhydrodynamic Analysis.
The power applied by the mill motor P was measured during 96 min milling. The stirrer
power per unit volume of the slurry in the milling chamber (shortly will be referred to as
the stirrer power), i.e., Pw = P/Vm was calculated and an average value was reported. The
power input per unit volume of the milled suspension in the absence of the beads i.e., Pht ,
was also measured. Its value was multiplied by the equivalent liquid (drug suspension)
volume fraction to obtain ε ht , which will be used in the microhydrodynamic analysis
along with P w (Section 2.4). The no-load power values obtained from dry runs of the mill
stirrer running at 1600, 2400, 3200, and 4000 rpm were subtracted from the measured
power values in the calculation of P w and Pht .
4.2.2.3 Particle Sizing and Scanning Electron Microscopy (SEM).

Particle

size

analysis was followed as in section 3.2.2.3. Prior to the size measurement, milled
suspension samples (~2 ml) were diluted in a vial with 10 ml of HPC–SDS solution by
using a vortex mixer (Fisher Scientific Digital vortex mixer, Model No: 945415, NH,
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USA), which rotated at 1500 rpm for 1 min. The PSD of the milled suspe nsion samples
was also measured after 7 day storage at 8 o C to assess the physical stability. SEM
imaging was carried out as in section 3.2.2.3 to examine the morphology of the milled
particles and to determine the primary particle size of the GF.
4.2.2.4 Appare nt Shear Viscosity and Density of the Milled Suspensions.

The

apparent shear viscosity of the milled suspensions (Runs 1–10) was measured using an
R/S plus rheometer (Brookfield Engineering, Middleboro, MA, USA) as reported in
section 3.2.2.5. The suspension densities were determined by weighing the suspension
filled in a 60 ml glass cylinder. The weight of the suspension was divided by the volume
to obtain the density. Average value of three measurements on each suspension was
reported in Table 4.4.
4.2.2.5 Milling Intensity Factor.

Recall the energy dissipation rate Π can be

decomposed into a material-dependent factor  and a process-dependent factor, F, which
is referred to as the milling intensity factor, as follows:
 Y
  2.23 5 / 2  b 2
  y 1 b
1

F

c 2 (2  c) 1

1  c  
3






18 / 15



Y* 
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  b4/ 5 p
Y 
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 13 / 10

(4.1)

(4.2)

Where F represents the milling intensity factor with the use of the same drug, same bead
material, and the same bead size. Upon a change in each process parameter, a possible
increase/decrease in F corresponds to a proportional increase/decrease in Π in some timeand space-averaged sense because well- mixedness and average power consumption
during the milling are considered, and  is taken as a constant for a given pair of drug–
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bead materials. One can then refer to either F or Π while reporting the impact of the
process parameters. All microhydrodynamic parameters calculated are presented in Table
4.4.

4.3 Results and Discussion

4.3.1 Preparation of Stable GF Suspensions
As the major objective of this chapter is to elucidate the impact of processing parameters
on the breakage kinetics, potential confounding effects that may arise from particle
aggregation should be minimized via proper stabilization of the GF nanoparticle
suspensions. Based on a previous formulation study (Bilgili and Afolabi, 2012), a 2.5%
HPC–0.5% SDS stabilizer combination was selected here for proper stabilization. Figure
4.1a shows the evolution of the GF particle size distribution (PSD) during milling (Run 1,
base-case) as measured by the laser diffraction method. Upon further milling, the PSD
shifted toward finer particles monotonically. At 96 min, GF particles had d50 and d90
values of 0.149 and 0.180 m, respectively. The SEM image (Figure 4.1b) shows the
primary GF nanoparticles in the size range of 50–200 nm, similar to the range observed
in Figure 4.1a. Hence, both the laser diffraction and the SEM imaging suggest that the
HPC–SDS stabilized suspension had relatively small extent of aggregation and the
dominant mechanism during the milling was breakage and not aggregation. The
combination of HPC and SDS is known to have a synergistic effect in the stabilization of
drug suspensions (Basa et al., 2008; Lee et al., 2008). HPC and SDS interact, forming
aggregates or micelle- like SDS clusters bound to HPC (Winnik and Winnik, 1990). These
clusters can co-adsorb on surfaces (Berglund et al., 2003; Evertsson and Nilsson, 1997),
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facilitating adsorption of HPC on drug particles (Cerdeira et al., 2010) and enabling
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Figure 4.1 Wet media milling of GF particles in the presence of stabilizers (Run 1): (a)
evolution of the cumulative particle size distribution, (b) SEM image of the GF particles
milled for 96 min (marker size: 200 nm, 27 kX magnification).

To establish the reproducibility of the milling process, the milling experiment
(Run 1) was repeated. The d50 and d90 values of the repeat experiment were 0.151 and
0.186 m. The (absolute) percent deviations from the d50 and d90 values were negligibly
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small: 1.34% and 3.33%, respectively. Hence, both the process and the particle size
measurements were fairly reproducible. Good reproducibility has also been established in
recent work on the wet stirred media milling of several poorly water-soluble drugs such
as azodicarbonamide, fenofibrate, griseofulvin, and naproxen with HPC or HPMC
(hydroxypropyl methyl cellulose) in the presence of SDS (Bhakay et al., 2013; Bilgili and
Afolabi, 2012; Knieke et al., 2013; Monteiro et al., 2013).
Table 4.2 The Median Size d50 and 90% Passing Size d90 of the GF Suspensions
After 96 min Milling and After 7 Day Storage
Run
Milled (96 min)
7 day storage
No.
d50 (µm), d90 (µm)
d50 (µm), d90 (µm)
1
2
3
4
5
6
7
8
9
10

0.149, 0.180
0.228, 0.393
0.167, 0.212
0.148, 0.178
0.292, 0.497
0.167, 0.218
0.132, 0.160
0.139, 0.170
0.161, 0.208
0.156, 0.220

0.152, 0.185
0.230, 0.401
0.164, 0.218
0.152, 0.187
0.311, 0.516
0.165, 0.221
0.140, 0.171
0.139, 0.169
0.161, 0.209
0.158, 0.220

Short-term physical stability of the milled suspensions prepared in Runs 1–10
were assessed by comparing the particle size after milling and after 7 day storage (see
Table 4.2). Long-term stability of these suspensions was not investigated here as they
were intended to be dried shortly after the milling via various drying methods (as in
Bhakay et al., 2013; Sievens-Figueroa et al., 2012). After 7 day storage, d50 and d90 of the
milled suspensions did not change significantly; the suspensions were physically stable
and remained colloidal mainly due to the synergistic stabilizing action of the HPC–SDS
combination. In view of the effectiveness of the 2.5% HPC–0.5% SDS stabilizer
combination and reproducibility of the milling process, the differences in d50 and d90
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values during 96 min milling can be mainly attributed to the changes in the process
parameters.

4.3.2 Impact of Process Parameters on the Breakage Kinetics and
Microhydrodynamics
The impact of stirrer tip speed, beads loading, and drug loading on the breakage kinetics
was investigated and the effects were elucidated via the microhydrodynamic model in the
present chapter. The overall apparent breakage rate or shortly the breakage rate was
quantitatively assessed by two separate measures: the median size at 4 min and the
characteristic time constant p of the process, which was obtained by fitting Eq. (2.7) to
the evolution of the median size. The breakage rate can be described mathema tically by
1/p . Albeit chosen somewhat arbitrarily, 4 min was long enough for the effects of
different process parameters to develop, yet was still shorter than what a dynamic
equilibrium would entail. Table 4.3 presents the values of the parameters dlim and p
estimated (see Chapter 2.3), their coefficient of variation COV, and the coefficient of
determination R2 . Considering the simplicity of the model, the fits were fairly good: R2
values were greater than 0.90, COV values were less than about 20%, and the parameters
were all statistically significant (p-value < 0.05). The estimated dlim values were slightly
greater than the experimental median particle sizes obtained after 96 min milling (Table
4.2), except for Runs 2 and 5, which entail further milling to approach a dynamic
equilibrium. The differences are mostly small and within 1–2 standard deviation of the
dlim estimated and can be explained by experimental variability in d50 measured,
insufficient number of time samples in the fitting, presence of low extent of aggregation
that was not considered by the simple two-parameter model. Overall, the fit statistics
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suggest that the use of p to assess the impact of process parameters on the breakage
kinetics.
Table 4.3 Parameters and Their Statistics Estimated From the Empirical Model
(Eq. (2.7)) Fit to the Evolution of the Median Particle Size
Run
dlim , COV%
τp , COV%
R2
No.
(µm), (–)
(min), (–)
(–)
1
2
3
4
5
6
7
8
9
10

0.160 (3.78)
0.269 (8.94)
0.184 (8.18)
0.165 (8.62)
0.404 (13.6)
0.190 (7.97)
0.144 (2.60)
0.163 (7.56)
0.171 (7.10)
0.173 (8.17)

2.56 (7.07)
9.77 (8.95)
3.57 (12.7)
1.97 (20.8)
7.06 (12.5)
3.78 (13.0)
1.91 (11.6)
1.50 (17.2)
3.14 (13.0)
4.46 (1.31)

4.3.2.1 Impact of Stirrer (Rotor) Tip Speed.

0.99
0.98
0.97
0.91
0.95
0.97
0.97
0.94
0.97
0.96

Figure 4.2a shows the temporal

evolution of d50 and d90 for angular speeds of 1600–4000 rpm or equivalent tip speeds of
5.86–14.7 m/s (Runs 1–4). For proper scaling and good discrimination of the impact of
various tip speeds, the median size was plotted in log-scale and the initial size was not
shown (d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m at t = 0 min). Both d50 and d90
decreased monotonically upon an increase in milling time, and no size increase was
observed. This finding suggests that breakage was the dominant mechanism and
aggregation of the particles probably occurred at a much smaller rate than the breakage in
the presence of HPC–SDS. In general, the rate of decrease in d50 and d90 decreased with
time, suggesting a slowing-down of the breakage. Hence, a dynamic equilibrium
(plateau) in d50 was approached or practically attained, except at the tip speed of 5.86
m/s, for which the overall breakage rate appeared to be the lowest and d50 continued to
decrease for the whole 96 min. In general, the dynamic equilibrium was approached or
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attained earlier with an increase in the tip speed. Since d90 heavily weighs the
contribution from the coarser particles, whose breakage into smaller particles of desired
fineness will take more time, d90 continued to decrease up to 96 min. The slowing-down
of the breakage and approach to a dynamic equilibrium can be explained as follows:
while milling progressed, finer particles were produced, which are more difficult to
capture between the beads and are harder to break. Finer particles, especially
nanoparticles, are mechanically stronger and have a much smaller breakage probability
than coarser particles (Bilgili et al., 2006). Theoretical work from Bilgili’s research group
using population balance models, even without any aggregation terms, were able to
capture the sharp decrease in the breakage rate (Bilgili et al., 2006; Bilgili and Capece,
2011).
The particle breakage appears to get faster with an increase in the stirrer speed, as
shown by the smaller median size at any given time point (Figure 4.2a). At the lowest
speed of 5.86 m/s (Run 2), the breakage rate was so low that d50 and d90 continued to
decrease significantly up to and including 96 min; much more time would be needed to
reach a dynamic equilibrium. The breakage rate increased monotonically with an increase
in the stirrer speed as indicated by the monotonic decrease in both d50 at 4 min and τp
(Figure 4.2b), while dlim decreased with an increase in the tip speed (Table 4.3). These
effects got weaker at higher speeds (especially >11.7 m/s).
To explain the aforementioned effects of the stirrer speed at the beads scale, the
microhydrodynamic parameters (see Chapter 2.4) granular temperature , the average
bead oscillation velocity ub, the frequency of single-bead oscillations  , the maximum
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contact pressure compressions bmax , the milling intensity factor F, and the average
frequency of drug particle a were calculated (Figures 4.3a and 4.3b).
Experimentally, upon an increase in the tip speed, the stirrer power increased and
the viscosity of the milled suspension decreased due to the presence of finer particles
(both reported in Table 4.4). Since more mechanical energy was imparted on the slurry
and the beads, all microhydrodynamic parameters increased monotonically, as one would
expect intuitively. Upon an increase in the stirrer speed, the fluctuating motion of the
beads became more vigorous (higher   There were more frequent bead oscillations
(higher  ), which led to a more frequent compression of the drug particles (higher a), i.e.,
a greater number of stressing events.
The beads had higher fluctuating velocity (higher ub ) and fluctuating momentum,
which led to more impactful bead collisions and development of higher compressive
stresses (higher bmax ), i.e., a greater stress intensity. For the griseofulvin (drug)–zirconia
beads (milling media) pair, the energy dissipation rate attributed to the deformation of the
drug particles per unit volume can be expressed in terms of a milling intensity factor F,
which captures all of the above effects of the stirrer speed on the number/intensity of the
stressing events through a lumped microhydrodynamic parameter. The increase in the
overall breakage rate upon an increase in the stirrer speed (Figure 4.2b) can be simply
explained by more bead collisions with greater stressing intensity (Figures 4.3a and 4.3b).
In summary, a decrease in τp resulted from an increase in the stirrer speed through an
increase in F. Despite the rapid rise of F especially above 11.7 m/s, τp decreased more
gradually, implying that the impact of the milling intensity factor on the breakage rate
begins to saturate above a certain value.
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Figure 4.2 Effects of the stirrer speed on (a) the time-wise variation of the characteristic
sizes of GF particles, (b) the median size of GF particles after milling for 4 min and the
characteristic time constant (Runs 1–4). At t = 0 min, the GF particles have d50 = 19.65 ±
1.17 m and d90 = 50.88 ± 6.33 m.
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Figure 4.3 Effects of the stirrer speed on (a) the granular temperature, the average bead
oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum
contact pressure, the milling intensity factor, and the average frequency of drug particle
compressions (Runs 1–4).

4.3.2.2 Impact of Bead Concentration.

The temporal evolution of d50 and d90 is

illustrated in Figure 4.4a for bead concentrations of 0.107–0.572, which were described
in terms of volume fraction c (Runs 5–7 and 1). In general, the evolution of d50 and d90
followed similar patterns as discussed in Section 4.2.1: both d50 and d90 decreased
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monotonically with milling time. The absolute value of the slope of the d50 and d90
profiles decreased with time, suggesting a decrease in the breakage rate as milling
progressed. Although d90 was evolving very slowly even up to 96 min of milling; a
dynamic equilibrium (plateau) in d50 was approached or attained, except at a bead volume
fraction of 0.107, for which the overall breakage rate was the lowest. The dynamic
equilibrium was approached or attained earlier with an increase in the beads loading. The
breakage rate appears to increase with an increase in the bead concentration, as shown by
the smaller median particle size at a given time (Figure 4.4a). This finding was further
reflected by the monotonic decrease in p (Figure 4.4b) and decrease in dlim (Table 4.3)
upon an increase in the bead concentration. Interestingly, Figures 4.5a and 4.5b exhibit
two counteracting effects of an increase in the bead concentration: , ub, and bmax
decreased while  , a, and F increased. In other words, the number of stressing events
dramatically increased, but their intensity decreased (less impactful collisions and particle
compressions). The increase in  , a, and F seems to be more drastic than the decrease in

ub, and bmax in relative terms. Upon an increase in the bead concentration, the number
of the beads increased and the clearance between the beads decreased, leading to a
dramatic increase in the bead–bead collisions and the average number of drug particle
compressions per unit time ( and a).
On the other hand, despite the increase in the stirrer power and the decrease in the
suspension viscosity at the higher bead loading (Table 4.4), higher number of inelastic
bead–bead collisions and liquid- film squeezing events coupled with an increase in the
effective drag coefficient Rdiss led to greater energy dissipation.
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Figure 4.4 Effects of the bead concentration on (a) the time-wise variation of the
characteristic sizes of GF particles, (b) the median size of GF particles after milling for 4
min and the characteristic time constant (Runs 5 –7 and Run 1). At t = 0 min, the GF
particles have d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m.
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Table 4.4 Power Values (Pw and εht ) and Properties of the Milled Drug Suspensions (µL and L) Measured as Well
as the Microhydrodynamic Parameters ( , ub,  , bmax , a, and F) Calculated
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Run

Pw

εht

µL

ρL



ub

ν

bmax

a

F

No.

(W/m3 )

(W/m3 )

(cP)

(kg/m3 )

(m2 /s2 )

(m/s)

(KHz)

(GPa)

(mHz)

(m2.6 /s2.6 )

1
2
3
4
5
6
7
8
9
10

5.23105
1.70105
2.95105
9.55105
2.50105
3.64105
1.32106
5.00105
6.02105
6.20105

0
7.66104
0
0
2.03104
0
0
0
0
0

17
31
24
10
37
22
6
13
26
34

1029
1024
1022
1023
1021
1024
1028
1006
1039
1070

1.5310–2
2.2010–3
7.7010–3
2.9910–2
5.3310–2
2.8410–2
1.1110–2
1.6710–2
1.3610–2
1.1710–2

1.9710–1
7.5010–2
1.4010–1
2.7610–1
3.6810–1
2.6910–1
1.6810–1
2.0610–1
1.8610–1
1.7310–1

5.29
2.01
3.76
7.40
1.03
2.63
17.3
5.53
5.00
4.63

2.03
1.38
1.77
2.32
2.60
2.30
1.90
2.06
1.98
1.92

2.0410–1
5.4610–2
1.2310–1
3.7010–1
2.4210–2
7.4110–2
1.09
2.0610–1
1.9810–1
1.6810–1

6.6710–2
5.3610–3
2.7310–2
1.5910–1
9.7110–3
3.4210–2
2.4810–1
1.5010–1
2.8610–2
1.5710–2
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Consequently, the fluctuating motion of the beads was less vigorous (smaller  and ub),
which in turn led to smaller bead compression stresses (smaller bmax ). It is worthmentioning that even a decrease in  could not prevent the drastic increase in  and a
because the impact of more beads and reduced clearance between them upon an increase
in the bead loading was stronger.
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Figure 4.5 Effects of the bead concentration on (a) the granular temperature, the average
bead oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum
contact pressure, the milling intensity factor, and the average frequency of drug particle
compressions (Runs 5–7 and Run 1).
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It is of fundamental importance to determine which of the aforementioned two effects
will be dominant in explaining the observed increase in the breakage rate upon an
increase in the bead concentration. A comparison of the trends in Figure 4.4b and Figures
4.5a and 4.5b suggests that upon an increase in the bead loading, the dramatic rise in a
was more prevalent than the decrease in bmax , leading to an increase in the milling
intensity factor F, which explains the decrease in τp . Despite the rapid rise of F especially
above a bead concentration of 0.388 in Figure 4.5b, the breakage rate did not change
significantly (Figure 4.4b), implying that the impact of the milling intensity factor on the
breakage rate begins to saturate above a certain value (similar to the impact of the tip
speed).
4.3.2.3 Impact of Drug Loading.

The temporal evolution of d50 and d90 is illustrated

in Figure 4.6a for 5%, 10%, 20%, and 30% drug loadings (Runs 8–10, and Run 1). The
evolution of d50 and d90 followed similar patterns as discussed in the previous sections;
hence, this aspect will not be elaborated. In comparison with the impact of the stirrer
speed and the beads loading, the impact of the drug loading appears to be weaker, within
the parameter space investigated. A slight difference worth mentioning is the attainment
of similar median size values after 96 min for all drug loadings. Figure 4.6 suggests that
the overall breakage rate slightly decreased with an increase in the drug loading. Table
4.3 presents dlim values that are slightly greater than the median size values at 96 min
(Table 4.2).
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Figure 4.6 Effects of the drug loading on a) the time-wise variation of the characteristic
sizes of GF particles and b) the median size of GF particles after milling for 4 min and
the characteristic time constant (Runs 8–10 and Run 1). At t = 0 min, the GF particles
have d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m.
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Figure 4.7 Effects of the drug loading on (a) the granular temperature, the average bead
oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum
contact pressure, the milling intensity factor, and the average frequency of drug particle
compressions (Runs 8–10 and Run 1).
An increase in the drug loading from 5% to 30% led to a slight, almost linear
decrease in all microhydrodynamic parameters except the milling intensity factor F (see
Figure 4.7), which exhibited a sharper decrease. While bmax did not decrease
significantly upon an increase in drug loading, the increase in the number of drug
particles that are captured by the colliding beads caused a decrease in the compressive
force applied on each drug particle, which in turn led to a stronger decrease in F. It is
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worth noting that both the stirrer power and the suspension viscosity increased (Table
4.4), due to the presence of larger number of drug particles in the milled suspension.
However, these changes counteracted each other and led only to a slight reduction in
most hydrodynamic parameters except the milling intensity factor.

4.3.3 A Unified Correlation for the Breakage Kinetics–Microhydrodynamics
It is important to determine if a single microhydrodynamic parameter can explain the
impact of all process parameters on the overall breakage rate, which is quantified by the
characteristic time constant τp . The specific energy Ps is defined as the mechanical energy
spent per unit mass of the drug particles and used in the milling literature for process
design and scale-up purposes (Kawatra, 2006):
Ps  PwVm Q p

(4.3)

As a fundamental microhydrodynamic parameter, the milling intensity factor F appears to
explain the impact of individual process parameters on the breakage rate directly. In
addition, P w was considered to determine if the stirrer power plays a direct role in the
breakage kinetics.
Figure 4.8 exhibits considerable scatter when τp is plotted against Ps and
especially Pw. As a result, it was not possible to correlate τp to Ps or Pw using any of the
linear or nonlinear regression models in SigmaPlot’s (Version 11) comprehensive library
of models. To be precise, a statistically significant model with statistically significant
parameters could not be generated; R2 was less than 0.80 and p- values were greater than
0.05 in all cases. On the other hand, the plot of τp vs. F showed relatively small scatter
and the three-parameter exponential decay model

 p  A1  A2 exp  A3 F 

(4.4)
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fitted the data very well, as indicated by R2 = 0.96, SSR = 2.387 min2 , and a standard
error of the estimate of 0.584 min.
2.6
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Figure 4.8 Scatter plots for the characteristic time constant versus the specific energy, the
milling intensity factor, and the stirrer power per unit volume. Fit: an exponential decay
correlation.
Both the model and its parameters were statistically significant with p-values < 0.05; the
model parameters exhibited acceptably low COV values: 13.2%, 12.2%, and 18.1% for
A1 , A2 , and A3 , respectively. The empirical model approaches a plateau above an F value
of about 0.07 m2.6 /s2.6 , confirming that above a certain milling intensity, the breakage rate
will not be affected significantly by F, which has already been elaborated in Sections
4.3.2.1 and 4.3.2.2. A caveat to the correlation in Figure 4.8 is strictly valid for
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griseofulvin particles milled with 430 m zirconia beads, signifying its descriptive
nature.
Nonetheless, to the best knowledge of the author, no such simple three-parameter
correlation, which connects breakage kinetics to a single microhydrodynamic parameter
(F here) lumping three different process parameters, exists in the literature. It is expected
that use of different drugs and beads could lead to a similar type of correlation with
different A1 , A2 , and A3 . To develop relationships between the breakage kinetics of
different drugs and their mechanical properties, it would be best to work with  instead
of F in Eq. (4.4). These aspects will be considered in a future study.

4.3.4 Implications for Process Design and Optimization
The effects of the process parameters on the specific energy Ps, the milling intensity
factor F, and the stirrer power per unit volume Pw were illustrated in Figure 4.9. An
increase in either the stirrer tip speed or the bead concentration led to an increase in Ps, F,
and P w, whereas an increase in the drug loading led to a decrease in Ps and F but an
increase in Pw. The analysis of the data illustrated in Figures 4.9 and 4.10 suggests that a
wet media milling process should operate at the highest F, which will increase the
breakage rate and minimize the milling time required for desired prod uct fineness (d50 or
d90 ). For the range of processing parameters considered, the mill should be operated at the
highest possible stirrer tip speed (14.7 m/s) and the highest beads loading (0.572 or 93.8
vol.% of the milling chamber) provided that the prod uct contamination due to bead wear
is acceptably low (not studied here) and the heat dissipation can be controlled via
effective cooling. Owing to the plateau observed for the region F ≥ 0.07 in Figure 4.8, the
mill could be operated at a lower tip speed (11.7 m/s) and bead loading (0.388) than the
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above- mentioned values to minimize potential media contamination and to control the
temperature rise reliably, while still ensuring fast particle breakage.
For a given batch size and desired end point particle size, selecting a drug loading
level that minimizes the overall process cycle time seems to be a complex task. On one
hand, Figure 4.6b suggests that the mill should be loaded with 5% drug to ensure the
highest breakage rate (lowest τp ) and shortest milling time as compared with 10%, 20%,
and 30% drug loading cases. On the other hand, engineers/formulators must consider the
fact that the negative effect of an increase in τp can be compensated by the positive
impact of having more drug processed per batch at higher drug loadings: e.g. twice at
10% as compared with 5%. Note that τp increased with an in drug loading: 1.50 min, 2.56
min, 3.14 min, and 4.46 min for the 5%, 10%, 20%, and 30% drug loadings, respectively.
Similarly, the times to produce suspensions with a median size of 400 nm and 300 nm,
which are some potential end points in industrial scale milling operations, were
calculated by Hermite interpolation of the data in Figure 4.6a. They were 3.19 min and
7.74 min, 5.98 min and 8.41 min, 7.70 min and 13.7 min, and 10.6 min and 18.7 min for
the 5%, 10%, 20%, and 30% drug loadings, respectively.
A conjecture from these three different measures can be made that although the
breakage kinetics slowed down or τp increased upon an increase in the drug loading, the
time it takes to mill per mass of the drug for a desired median size decreased even more
significantly, signifying enhanced operational efficiency and a decrease in the overall
process cycle time. Hence, for a given mass of drug particles to be milled, engineers
should prefer a single milling batch with 20% or 30% drug loading as opposed to two or
three batches at 10% drug loading.
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Figure 4.9 The specific energy, the milling intensity factor, and the stirrer power per unit
volume at various (a) stirrer speeds (Runs 1–4), (b) bead concentrations (Runs 5–7 and
Run 1), (c) drug loadings (Runs 8–10 and Run 1).
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Considering the suspension preparation/unloading/cleaning times in-between the multiple
batches with 10% drug loading along with the above breakage kinetics arguments,
milling at a higher drug loading appears to be operationally more efficient, with
appreciable reduction in the overall process cycle time. Depending on the final
application of the milled suspension and its properties (viscosity, physical stability, etc.),
the high drug- loaded suspensions may either be diluted or used as- is.
It is important to investigate if the milling intensity factor can be correlated to the
energy consumption. Figure 4.10 presents scatter plots for the milling intensity factor
versus the specific energy, and the stirrer power per unit volume. A statistically
significant correlation between the milling intensity factor F and specific energy Ps in the
form of a linear function is found. Considerable scatter is also seen when F is plotted
against P w. Therefore, it was not possible to correlate F to Pw using any of the linear or
nonlinear regression models in SigmaPlot’s (Version 11) comprehensive library of
models. Despite the correlation between F and P w, Ps was not able to predict the breakage
rate (Figure 4.8) due to scatter in both the time constant and spec ific energy
measurements. Moreover, F is a fundamental microhydrodynamic parameter which
accounts for the physics of bead-bead collisions, whereas Ps cannot yield such
fundamental information.
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Figure 4.10 Scatter plots for the milling intensity factor versus the specific energy, and
the stirrer power per unit volume. Fit: a linear correlation.

4.4 Summary and Conclusions
Significant advances have been made, for about two decades, in preparation and
stabilization of drug nanoparticle suspensions via wet stirred media milling. Nevertheless,
a fundamental understanding of the impact of process parameters on the breakage
kinetics in terms of the underlying microhydrodynamics in the mills has not been
developed. Considering the importance of nanoparticle production for the enhancement
of dissolution rate/bioavailability and the relatively expensive and energy- intensive
nature of the wet stirred media milling, it is of utmost importance to study the breakage
kinetics, which determines the process cycle time and production rates for a desired
fineness of the drug product. With the goal of developing a fundamental understanding
and gaining physical insight, in this chapter, an elucidation of the impact of the stirrer
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speed, the bead concentration, and the drug loading on the breakage rate of griseofulvin
(GF) via a combined microhydrodynamics–breakage kinetics analysis was performed.
The experiments have shown that an increase in either the stirrer speed or the
bead concentration led to an increase in the specific energy and the milling intensity
factor, consequently faster breakage; whereas an increase in the drug loading led to a
decrease in these parameters and consequently slower breakage. All microhydrodynamic
parameters provided significant physical insight while only the milling intensity factor
was capable of explaining the influence of all parameters uniquely through its strong
correlation with the process time constant. Besides guiding process optimization and
providing fundamental physical insight, the theoretical analysis has also rationalized the
use of a single highly drug-loaded batch (20% or higher) over multiple dilute batches.
This study has opened a new path to the investigation/design/optimization of the wet
media milling process in terms of microhydrodynamic parameters as they are affected by
the formulation–design–operating parameters. It will help formulators/engineers to
streamline the development of nanosuspension formulations and to select the operating
mill parameters in the context of a theoretical framework. Future studies will focus on the
influence of bead size/type, suspension flow rate, batch size, and mechanical properties
of different drugs and beads on the breakage kinetics and microhydrodynamics.
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CHAPTER 5
FAST PRODUCTION OF DENSE, STABLE DRUG SUSPENSIONS WITH SUB 100 NM PARTICLES AND MININMAL MEDIA CONTAMINATION VIA
INTENSIFIED WET STIRRED MEDIA MILLING

5.1 Introduction
In recent years, wet stirred media milling (WSMM) technique has received much
attention in producing fine drug particles in suspension form, because of its capability in
producing a narrow particle size distribution, high drug loading, organic solvent- free
processing, batch and continuous operation capability, and ease of scale up (Bilgili and
Afolabi, 2012; Bruno et al., 1996; Merisko-Liversidge et al., 2003). In this method of
preparing the drug nanoparticles, micron-sized drug particles and media (beads) in an
aqueous solution of stabilizers is fed into the mill at a control flow rate, mixed by a rotor
(mill stirrer) at very high speeds. Repeated stressing of the micron-sized drug particles
that are captured between the colliding beads causes size reduction down to the
nanometer size range provided milling is continued for a sufficient time (Ghosh et al.,
2011; Verma et al., 2009).
Although several commercial nanoparticulate oral and parenteral drug products
are being produced via WSSM, the technique is generally considered as time-consuming,
costly, and energy-intensive (Kawatra, 2006). Even at the bench scale milling operations,
drug nanoparticle suspension quantities in the order of ~10 g are produced after several
hours to a few days of milling, leading to increased energy consumption. Perhaps the lack
of fundamental understanding of the impact of process parameters and/or heavy reliance
on purely empirical approaches make the process energy intensive and time consuming
(Afolabi et al., 2013). In fact, the majority of the wet media milling studies have focused
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mainly on optimization of various stabilizers, and physical stability of the milled drug
suspensions (Kesisoglou et al., 2007; Lee et al., 2008; Peltonen and Hirvonen, 2008; Van
Eerdenbrugh, 2008), and no explicit information on reducing the mill time, energy
consumption, and bead wear is given. It is known that faster particle breakage rate leads
to reduction in both milling time and energy consumption, and can be achieved by right
selection of mill operating parameters such as bead size, bead load, rotor speed, and
suspension flow rate. Influence of these parameters on final drug particle size has been
studied previously through experiments (Cerdeira et al., 2011a; Ghosh et al., 2011, 2013)
and statistical based approach (Singare et al., 2010; Singh et al., 2011). However, the
influence of these parameters at intense conditions on breakage kinetics leading to the
faster preparation of fine drug nanoparticles is not addressed. Therefore, a detailed
strategy or methodology for combining different mill process parameters has to be
developed which could lead to an intensified process for the faster production of fine
drug nanoparticles with reduced specific energy consumption and bead wear.
In pharmaceutical applications, the demand for using drug nanoparticles with size
as low as possible is increasing steadily, as fine drug nanoparticles offers a much faster
dissolution rate due to their high surface area to volume ratio, and also result in rapid
onset of therapeutic action (Merisko- Liversidge et al., 2011; Müller and Peters, 1998;
Shegokar and Müller, 2008). Most importantly, drug nanoparticles with size < 100 nm
renders feasible and efficient sterile filtration of aqueous drug nanosuspensions, and
allows higher loading for reduced injection volume in parenteral dosage forms (Baert et
al., 2009; Xiong et al., 2008). In addition to the nanosuspension dosage form,
nanocomposite microparticles made of very small size drug nanoparticles offer rapid
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redispersion of particles at an increase drug loading in a given mass of dosage (Bhakay et
al., 2013). Therefore, it is important to prepare drug nanosuspensions with size as small
as possible (< 100 nm) to achieve enhanced efficacy in various pharmaceutical
applications. By varying the process parameters, several researchers have prepared
inorganic nanoparticles in the size range of 10–100 nm using WSSM technique (Patel et
al., 2012; Stenger et al., 2005; Wang and Forssberg et al., 2006). However, an
investigation on the effect of process parameters for the preparation of drug nanopart icles
having sub-100 nm has not been attempted so far. Table 1 shows the list of drugs milled
in WSMM with their initial drug load, initial particle size, batch volume and the final
particle size. To the best of our knowledge, only using smaller initial dr ug particle size
and at low batch volume, the drug nanoparticles with a typical median size of 136 nm and
above have been produced via WSMM. It is to be noted that the preparation of drug
particles with < 100 nm size is a challenging task, especially if the mill is desired to
operate with the large initial drug particle size, high batch volume (> 200 ml at the bench
scale), and high drug load > 10 % (w/w).
Although the preparation sub-100 nm drug particle at a shorter milling time with
reduced energy consumption is of great interest, the drug product contamination
introduced by bead wear at intense process conditions is also not known. All of these
aspects can be understood by investigating the impact of mill operating parameters on
particle breakage rate and the energy dissipation rate during the deformation of the
particles. This can be elucidated by studying the fluctuating motion of beads in sheared
suspensions i.e., microhydrodynamics. Eskin et al., (2005a,b) developed a comprehensive
microhydrodynamic model describing the dynamics of the milling beads and their
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interactions with the particles in a dense slurry flow. Recently, Bilgili and Afolabi (2012)
modified this model to understand the viscous dampening effect caused by the use of
polymeric stabilizers in WSMM. The model consists of several intrinsic bead parameters
and the magnitude of change in parameter values at different mill operating conditions
enable us to select right process parameters.
The preceding Chapters 3 and 4 sheds more light on the impact of formulation
and processing parameters on drug nanoparticle suspension produced via WSMM. A
minimum stabilizer-to-drug ratio was attained and individual process parameter was
optimized. The major objective of this chapter is to elucidate a combined experimental
and theoretical approach to achieve faster production of sub-100 nm BCS class II drugs
having reduced specific energy consumption with minimal bead wear contamination. In
the experiments, the effects of media (bead) size on the energy consumption, bear wear
and breakage kinetics of two model poorly water-soluble drugs, griseofulvin (GF) and
naproxen (NAP) were studied. Then, this baseline process conditions with the optimal
bead size was intensified by increasing the rotor tip speed, bead load, and suspension
flow rate systematically, as guided by a microhydrodynamic model of the process. The
intensified process led to the production of sub-100 nm particles within 30 min of milling
with significant reduction in bead wear. Similarly, milling of NAP also led to sub-100 nm
particles within 30 min. The use of small beads has enabled us to intensify the process,
increase the particle breakage rate (shorter cycle time), and reduce the energy
consumption with minimal bead wear contamination.
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5.2 Experime ntal

5.2.1 Materials
GF, (EP/BP grade) was purchased from Letco Medical (Decatur, AL, USA). Naproxen,
NAP, (USP grade, solubility in water: 15.9 mg/l) was purchased from Medisca
(Plattsburgh, NY, USA). The d10 (10% passing size), d50 (median or 50% passing size)
and d90 (90% passing size ) values of as-received GF and NAP particles measured by
laser diffraction device (LS 13-320, Coulter Beckman, Brea, CA) were 5.0 µm, 21.85
µm, 57.77 µm, and 6.93 µm, 16.60 µm, 77.12 µm respectively. Hydroxypropyl methyl
cellulose (HPMC, Methocel- E3), a neutral polymeric stabilizer, was purchased from
Dow Chemical (Midland, MI, USA). Sodium dodecyl sulfate (SDS), an anionic
stabilizer, and nitric acid was purchased from Sigma Aldrich (Bellefonte, PA, USA).
Wear resistant yttrium- stabilized zirconia milling media (YSZ) with a nominal size of
100, 200, 400 and 800 µm was purchased from Saint Gobain ZirPro (Zirmil Y,
Mountainside, NJ, USA), were used as milling media. The reported density of milling
media was 6000 kg/m3 , consists of 93 % ZrO 2 and 5 % Y2 O3 . De-ionized water was used
in all experiments.
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Table 5.1 Literature Summary of Drug Particles Prepared via Wet Stirred Media Milling with Median Particle Size < 200 nm
Drug
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Initial median
particle size
(m)

Drug
loading
(% w/w)

Batch
volume
(ml)

Process
time

Final median
drug particle
size (nm)

Etravirine

11

20

300

60 min

140

Cerdeira et al., 2011

Fenofibrate

16

10

200

120 min

150

Knieke et al., 2013

Griseofulvin

22

10

200

64 min

161

Bhakay et. al. 2013

Itraconazole

20

20

300

60 min

136

Cerdeira et al., 2013

Miconazole

20

20

300

60 min

140

Cerdeira et al., 2013

Naproxen

13

10

490

64 min

143

Monteiro et al., 2013

15-20

5

NM

6h

200

Bose et al., 2012

Undisclosed
NM: not mentioned
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Reference

5.2.2 Methods
5.2.2.1 Wet Stirred Media Milling. The milling procedure followed in the present work
is the same as reported in Chapter 3 and Chapter 4. The schematic of the mill can be seen
in Figure 3.1. The mill chamber has a volume (Vm) of 80 ml lined with zirconia,
connected to a rotating shaft (diameter, D = 7 cm). A stainless steel screen (Netzsch,
Exton, PA, USA) was used to restrict the flow of milling media (beads) out of the
chamber. Screens having different opening (pore) size was used for varying bead size,
and a ratio of 1:2 screen opening size to bead size was maintained in all experiments. 200
ml of aqueous suspension containing 10 % w/w (with respect to water) drug along with
stabilizers was initially added to the holding tank (500 ml) of mill, and the recirculation
of suspension between holding tank and milling chamber was achieved at a controlled
flow rate with use of peristaltic pump. A paddle mixer connected to the holding tank was
operated continuously at 800 RPM to ensure the suspension homogeneity in the holding
tank. The suspensions at several milling time points (4, 8, 16, 32, 64, 120, 180, 240, 300
and 360 min) were collected from the outlet of milling chamber, and used for particle size
and morphology analysis. The final milled suspensions were stored in a refrigerator at 8
o

C. Table 5.2 shows different milling conditions (Runs 1–9) followed in the present work,

with respect to change in mill operating parameters such as bead size d b, mill tip speed u,
bead volumetric concentration c, and suspension flow rate Q.
Prior to milling, the as received drugs were prepared in the form of suspensions
along with stabilizers with use of low shear laboratory stirrer [Fisher Scientific (Catalog
no. 14–503), Pittsburgh, PA, USA]. The procedure was followed as reported in Chapter 3
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and Chapter 4. Stabilizer solution was prepared by initially adding 0.4 g of SDS to 200
ml de- ionized water, followed by gradual addition of 5 g of HPMC-E3 within 30 min
under stirring (300 rpm).
Table 5.2 Processing Conditions used in the Wet Milling Experiments (Runs 1–9)
at Drug Load: 10%a, Batch Size: 200 Mlb and HPMC/SDS Concentration: 2.5%/0.2%

a

Run
No.

Drug

Bead Size
(µm)

Stirrer Speed
(rpm, m/s)

Bead Load,
Concentration
(gm), (c)

Suspension
Flow rate
(mL/min)

1
2
3
4
5
6
7
8
9

GF
GF
GF
GF
GF
GF
GF
NAP
NAP

800
400
200
100
100
100
100
100
100

3200, 11.7
3200, 11.7
3200, 11.7
3200, 11.7
4000, 14.7
4000, 14.7
4000, 14.7
3200, 11.7
4000, 14.7

195.7, 0.408
195.7, 0.408
195.7, 0.408
195.7, 0.408
195.7, 0.408
260.7, 0.543
260.7, 0.543
195.7, 0.408
260.7, 0.543

126
126
126
126
126
126
343
126
343

% w/w with respect to de-ionized water.
de-ionized water.

b

The resultant solution was further stirred for 10 min and left at rest until a clear
solution was obtained. To this stabilizer solution, 20 g of as received drug particles was
added gradually within 30 min of stirring, and kept in refrigerator (8 o C) for 90 min. The
prepared final suspension has 10 % w/w drug, 2.5% w/w HPMC, and 0.2% w/w SDS (all
with respect to water). The particle size of drug in pre-suspension form was measured,
and referred as 0th minute particle size. At the end of milling process, the cumulative
energy consumption (E) of the slurry (beads, drug, stabilizer and solvent) was directly
recorded from the mill control panel. From this, the average stirrer power applied per unit
volume of slurry Pw was calculated as
Pw=E/ΔtVm

(5.1)
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where, Δt is the cumulative milling time i.e., final time point of milling process. The
specific energy consumption, E*, which is the energy spent per unit mass of drug in mill
chamber was also calculated from E, and is given as
E*  E ms

(5.2)

where ms is the mass of the drug in the mill chamber.
Recall the energy dissipation rate Π (see Chapter 2.4) can be decompose into a
material-dependent factor  and a process-dependent factor, F, which is referred to as the
milling intensity factor, defined as follows:

 b 4 / 5 Rp
  2.23 5 / 2
 y
F

18 / 15

 Yb 


2 
1


b 


Y * 
 
Y 
 p



(5.3)

c 2 (2  c) 1
 13/ 10
1  c 3 Rb 2

(5.4)

Where F represent the milling intensity factor with the use of the same drug, same bead
material, but different bead sizes. Upon a change in each process parameter, a possible
increase/decrease in F corresponds to a proportional increase/decrease in Π in some timeand space-averaged sense because well- mixedness and average power consumption
during the milling are considered, and  is taken as a constant for a given pair of drug–
bead materials. One can then refer to either F or Π while reporting the impact of the
process parameters. All microhydrodynamic parameters calculated are presented in Table
5.3.
5.2.2.2 Characterization Techniques.

Laser

diffraction

(LD)

was

used

to

determine the particle size of milled suspensions with median particle size d50 above 200
nm. The measurements were performed in LS 13-320 Beckman Coulter instrument (Brea,

108

CA) as reported in Chapter 3 and Chapter 4. A refractive index (RI) of 1.65, 1.41 and
1.33 were used for GF, NAP and water (measurement medium) respectively. All the
measurements were performed at 25 °C, and the particle size was measured at least thrice
and the average values were reported. Milled suspensions with d50 less than 200 nm were
investigated by dynamic light scattering (DLS) using Delsa Nano C Particle analyzer
(Beckman coulter, Brea, CA). The milled suspension was diluted with de- ionized water,
and the median particle size, d50 based on intensity weighted distribution was recorded
along with polydispersity index (PI). All the measurements were performed at 25 °C, and
the particle size was measured at least thrice and the average values were reported. The
combined use of LD and DLS to analyze the particle size data have been previously
reported by Knieke et al. (2009) and Schubert et al. (2006) and similar procedure is
followed.
Particle size and morphology of the as-received and milled drug particles were
examined using LEO 1530 SVMP (Carl Zeiss, Inc., Peabody, MA, USA) scanning
electron microscopy (SEM). For this analysis, 0.5 ml of the milled suspensio n was
diluted with 30 ml de- ionized water, and a drop was placed on a silicon chip (Ted Pella,
Inc., Redding, CA, USA). The chip was mounted on a carbon specimen holder, followed
by drying in dessicator for 2 h. All the samples were then sputter coated wit h carbon and
observed in SEM. X-ray Powder Diffraction (P-XRD) technique was used to analyze the
crystallinity of the as-received and milled GF particles. The suspension sample was dried
at 40 ºC for overnight in a convective drier (Gallenkamp, Netherlands), and the particles
were finely grounded with the help of a mortar and pestle. As-received drug powder was
directly used for analysis. The dry powder was packed in an aluminum holder and
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mounted on a Empyrean series 2 X-ray diffractometer (PANalytical, Westborough, MA,
USA), provided with Cu K radiation ( = 1.5406 Å). The samples were scanned for 2θ
ranging from 5o to 40o at a scan rate of 0.165 s–1 .
The apparent shear viscosities L of the milled suspensions were measured at 25 ±
0.5 o C using R/S plus Brookfield rheometer (Brookfield Engineering, Middleboro, MA,
USA) as reported in Chapter 3 and Chapter 4. The density of the milled suspension was
performed as reported in Chapter 3 and Chapter 4. Bead wear contaminants (zirconium
and yttrium) levels in the final milled suspensions were analyzed by inductive coupled
plasma mass spectrometry (ICP-MS) according to European Pharmacopeia 6.0 §2.2.58
with a limit of quantification of 0.1 µg/g. For this, the milled suspension sample was
dried at 40 ºC for 24 h in a convective drier, and the dried particles were finely grounded
with the help of a mortar and pestle. Then, 1 g of dried powder was added to 40 ml of
water, followed by addition of 40 ml of 65 % nitric acid. The mixture was then heated up
until a clear solution was observed. The resultant clear solution was cooled down to room
temperature and diluted further with water for ICP-MS analysis. The measurements were
performed thrice and the average value was reported.

5.3 Results and Discussion

5.3.1 Effect of Bead Size on the Temporal Evolution of GF Particles
Proper selection of bead size can help to improve the efficiency of wet media milling
operation by producing fine size nanoparticles with low energy consumption. In this
chapter, the effect of bead size on the preparation of GF particles was first studied by
milling the as-received GF particles with varying bead size of 800, 400, 200 and 100 µm
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(refer Table 5.2, Runs 1–4). Yttrium stabilized zirconia (YSZ) bead were selected for this
study as they tend to exhibit low level contamination of the final drug product due to its
high hardness of 19 GPa and a reduced modulus of about 218 GPa (Lian et al., 2007).
The mill tip speed u, bead volumetric concentration c, and suspension flow rate Q were
kept constant at 11.7 m/s, 0.4 and 126 ml/min, respectively (baseline process condition).
Figure 5.1 shows the temporal evolution of the median size d50 of the GF particles. The
median size d50 decreased exponentially and slowly approached an asymptote near 360
min of milling, illustrating that the size reduction slowed down during milling
monotonically. After 360 min milling, the median sizes attained with 800, 400, 200 and
100 µm beads were 176, 140, 124 and 98 nm, respectively. The corresponding d10 and d90
values are given in Table 5.3. The poly dispersity index, PI of all the measured particles
was less than 0.2. Thus, the use of smallest beads (100 µm) resulted in 98 nm median
size, implying that sub-100 nm particles can be produced with use of small beads in wet
stirred media milling provided the process can be intensified (see Section 5.3.2).
To establish the reproducibility of the milling process, repeat experiments of Runs
1–4 were performed. The d50 and d90 sizes attained with 800, 400, 200 and 100 µm beads
were 174 and 295 nm, 144 and 261 nm, 121 and 245 nm, and 99 and 210 nm,
respectively. The (absolute) percent deviations from the d50 and d90 values were
negligibly small: 1.14 and 0.34%, 2.86 and 1.56%, 2.42 and 0.81%, and 1.02 and 1.87%,
respectively. Hence, milling process and the particle size measurements were fairly
reproducible. Good reproducibility has also been established in our recent work on wet
stirred

media milling of several other poorly water-soluble drugs such as

azodicarbonamide, fenofibrate, griseofulvin, and naproxen with HPC ( hydroxypropyl
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cellulose) or HPMC in the presence of SDS (Bhakay et al., 2013; Bilgili and Afolabi,
2012; Knieke et al., 2013; Monteiro et al., 2013; Sievens-Figueroa et al., 2012).

Figure 5.1 Temporal evolution of the median size d50 of GF particles for Runs 1–4. Runs
1, 2, 3 and 4 refer to milling of GF with 800, 400, 200 and 100 µm YSZ beads
respectively, at baseline mill conditions of mill tip speed u = 11.7 m/s, bead volumetric
concentration c = 0.4 and suspension flow rate Q = 126 ml/min. At t = 0 min, the GF
particles have d50 = 21.85 ± 1.25 m and d90 = 57.77 ± 4.35 m.
Table 5.3 Particle Size Statistics of the Suspensions for Runs 1–9 after Milling
and After 7 Day Storage
Run
Milling
After Milling
7 day storage
No.
Time
d10 (nm), d50 (nm), d90 (nm) d10 (µm), d50 (nm), d90 (nm)
(min)
1
360
110, 176, 294
NMa
2
360
84, 140, 257
NMa
3
360
72, 124, 247
NMa
4
360
57, 98, 214
60, 101, 298
5
120
57, 95, 209
NMa
6
120
41, 85, 180
NMa
7
120
38, 83, 164
41, 90, 214
8
360
35, 87, 154
NMa
9
120
26, 82, 139
32, 95, 165
a

NM: not measured.

112

Before delving into analyzing the results presented above, it is of utmost
importance to establish the aggregation state of the milled suspension. In the present
work, HPMC and SDS stabilizer combination was used for stabilization of GF particles
based on a previous formulation optimization study, which showed an excellent
stabilization for several BCS II drugs such as fenofibrate, naproxen, ibuprofen etc (Bilgili
and Afolabi, 2012; Knieke et al., 2013; Monteiro, et al., 2013). Figure 5.2 shows the
SEM images of 4, 32, 120, 240, and 360 min milled GF particles with 100 µm beads
(Run 4), capturing the evolution of the particle size and morphology. GF particles got
smaller and more spherical as milling progressed. The calculated average size for the 360
min milled particles (Figure 5.2f) from SEM was 90 nm, which is very close to the
median particle size obtained from light scattering measurements technique. Image J
software was used to count and compute the particle size from SEM image, and a total of
1450 particles were used for the particle size analysis. These findings suggest that even
the suspension with the smallest particles (Run 4) is not significantly aggregated at the
time scale of the milling process, and the electrosteric stabilization mechanism imparted
by the HPMC–SDS combination was quite effective (Run 4).
Short term physical stability of Run 4, Run 7 and Run 9 milled suspensions were
performed for a period of 7 days at 8 °C. Table 5.3 shows the particle size statistics of 7
day storage of the milled suspension. After 7 day storage, d50 and d90 of the milled
suspensions did not change significantly; the suspensions were physically stable and
remained colloidal mainly due to the synergistic stabilizing action of the HPMC–SDS
combination. Long term physical stability of these suspensions was not investigated in
the present study.
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Figure 5.2 SEM images showing the evolution of GF particle size for Run 4: (a) as
received, (b) 4 min, (c) 32 min, (d) 120 min, (e) 240 min, (f) 360 min of milling. Run 4
refers to the use of 100 µm YSZ beads at the baseline mill conditions (u = 11.7 m/s, c =
0.4 and Q = 126 ml/min). At t = 0 min, the GF particles have d50 = 21.85 ± 1.25 m and
d90 = 57.77 ± 4.35 m.
In general, the observed slow-down of the size reduction during the milling (see
Figure 5.1) may be explained mainly by particle breakage and aggregation mechanisms.
Of course, as milling progressed long enough, aggregation ra te may have increased upon
production of finer (colloidal) drug particles, which could be a reason for the equilibrium
(plateau), approached near 360 min. As the drug particle size decreases, number
concentration in the suspension increases and the interparticle distance decreases, leading
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to more frequent collisions and potentially higher aggregation rate (Bhakay et al., 2011;
Sommer et al., 2006). The similarity of the primary particle sizes from the SEM image
and the particle size measured by DLS suggests that particle breakage was the dominant
mechanism and aggregation of the particles occurred at a smaller rate than the breakage
in the presence of stabilizers during most of the milling process.
On the other hand, as milling progressed, finer particles were produced, which
have a much lower specific breakage rate (breakage probability) than the coarser particles
and thus are harder to break (Bilgili et al., 2004, 2006, 2008). In addition, smaller
particles are more difficult to capture between the beads d uring the bead–bead collisions,
further reducing the specific breakage rate. In fact, population balance models without
any aggregation terms (Bilgili et al., 2007; Bilgili and Capece, 2011) were able to capture
the sharp decrease in breakage rate even during the breakage of large microparticles.
Considering that nanoparticles are even less likely to break than microparticles (Bilgili et
al., 2004, 2006) a claim can be made that the approach to or attainment of a plateau size
observed in Figure 5.1 is mainly explained by extremely the low breakage probability of
nanoparticles and the lower capture efficiency of such particles, and, to a minor extent,
by the aggregation of the produced nanoparticles in the presence of HPMC-SDS.
Figure 5.3 shows the XRD patterns of as-received and 360 min milled GF (Run 4). The
peak positions of both patterns are identical, which confirms that the crystallinity of GF
was not altered even after long hours of milling.
5.3.1.1 Quantification of Wear from Different Size Beads.

Generation of wear

from beads during milling leads to undesirable contamination of the milled drug product.
To investigate the effect of bead size on bead wear contaminants levels [zirconium (Zr)
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and yttrium (Y)], GF particles milled with use of 800 and 100 m beads were analyzed
using ICP-MS.

Intensity (a.u.)

As received Griseofulvin
Milled Griseofulvin

10

20

30

40

2 (degree)

Figure 5.3 XRD patterns of as-received and 6 h milled GF particles (Run 4). Run 4 refers
to the use of 100 µm YSZ beads at the baseline mill conditions (u = 11.7 m/s, c = 0.4 and
Q = 126 ml/min).
As-received GF and stabilizers (HPMC and SDS) showed no elemental levels of Zr and
Y. The elemental Zr and Y levels [mass of contaminant/mass of milled drug in dry form]
of 6 h milled GF with 800 µm beads (Run1) and 100 µm beads (Run 4) were 607 ± 35
µg/g Zr, 32 ± 2 µg/g Y and 357 ± 7 µg/g Zr, 20 µg/g Y respectively. Approximately, 1.7
times reduction in both Zr and Y were observed by using 100 µm beads. Similarly,
Juhnke et al., (2012) also observed reduced contaminant levels with use of sma ller size
beads. Hence, the use of smallest beads (100 µm) helps in achieving final drug product
with low level contamination compared to the use of larger bead sizes.
5.3.1.2 Effects of Bead Size on Specific Energy Consumption and Applied Powe r.
Figure 5.4 shows the specific energy consumption E* and the average power applied per
unit volume of slurry P w for varying bead sizes up to 360 min of milling. Both E* and Pw
were low for 100 µm beads and increases with increasing bead sizes. With this low
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specific energy consumption, 100 µm beads were effective in producing the smallest GF
particle size (refer to Figure 5.1), suggesting high grinding efficiency from an energetic
perspective. From literature, it is understood that the specific energy consumption is
proportional to the particle fineness (Breitung-Faes and Kwade, 2013). However, the
particle size observed at higher specific energies is large (for 800 µm beads) as compared
to small size particles obtained using 100 µm beads, accounting only low specific energy.
Hence, a conclusion can be made that specific energy consumption is not a direct
measure of particle fineness during wet media milling because only a small fraction of
the specific energy is actually spent on deforming/breaking the drug particles, which is

0.32

Specific Energy Consumption
(t =360 min), E* (MJ/kg)

11

0.30

10
E*
Pw

9

0.28
0.26

8

0.24

7

0.22
0

200

400

600

Stirrer Power per unit Volume,
Pw (MW/m3)

largely controlled by the microhydrodynamics.

800

Bead sizes (m)
Figure 5.4 Specific energy consumption (E*) and power applied by the mill stirrer per
unit volume (Pw) for various bead sizes during 360 min of milling at the baseline mill
conditions (u = 11.7 m/s, c = 0.4 and Q = 126 ml/min).

5.3.1.3 Microhydrodynamic Analysis of Beads.

To

develop

a

fundamental

understanding of the bead size effect on the observed smallest GF particle size, reduced
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energy

consumption

and

reduced

contaminant

levels

(bead

wear),

the

microhydrodynamic parameters , , ub, bmax , F, and a were calculated and plotted as a
function of bead size (see Figures 5.5a and 5.b). At constant mill tip speed, bead load and
suspension flow rate, the fluctuating motion of beads ( ) becomes less vigorous with a
decrease in bead size. This low fluctuating velocity led to low impact force and low
compressive stresses (bmax) i.e., a low stress intensity, for smaller beads (refer Figure
5.5b). On the other hand, the frequency of bead oscillations,  (number of stressing
events) and the average frequency of drug particle compression, a is seen higher with a
decreasing bead size (Figure 5.5b). Smaller size beads constitute more in number causing
a dramatic increase in the bead–bead collisions (increasing  ) which also allowed
capturing of more drug particles (increasing a) due to less inter-bead distances. Thus,
increase in v led to faster breakage rate and increase in a helped in achieving sub-100 nm
particles with the use of 100 µm smallest bead size. Also, a decrease in Pw is observed
(see Figure 5.5b and Table 5.3) with decreasing bead size which is due to low ub and

This resulted in reduced specific energy consumption for decreasing bead sizes. The
observed reduced contaminants levels with the use smallest bead size (100 µm) can be
explained in terms of compressive stresses (b max). Smaller beads undergo less impactful
collision (lower bmax) and results in less bead wear. On comparing the bmax for 800 µm
(Run 1) and 100 µm (Run 4) beads (Table 5.3), a 1.6 times reduction in b max was
observed with use of 100 µm beads, yielding low levels of contamination. To better
understand the impact of particle breakage rate of different size beads, the milling
intensity factor F, which is proportional to the energy spent during the deformation of the
drug particles per unit volume, was calculated using Eq.5.4. The milling intensity factor
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F captures all of the above effects on the number and intensity of stressing events in a
single parameter (Afolabi et al., 2013).

ub

20

2.5



2.0

15
1.5
10
1.0
5

0.5

0
0

200

400

600

8
7
6
5
4

Frequency of Single-Bead
Oscillations, (KHz)

Granular Temperature,
 x 103(m2/s2)

3.0



a)

Average Bead Oscillation
Velocity, ub x 10 (m/s)

25

0.0

3

4

0.40

800

b)
2.0

bmax
F
a

1.8

3

2
1.6
1

1.4
1.2

0
0

200

400

600

800

0.35
0.30
0.25
0.20
0.15
0.10

Average Frequency of Drug Particle
Compressions, a (mHz)

Maximum Contact Pressure,
bmax (GPa)

2.2

Milling Intensity Factor, F x10-14
(m0.6/s2.6)

Bead sizes (m)

Bead sizes (m)

Figure 5.5 Effect of bead size on microhydrodynamic parameters: (a) granular
temperature, average bead oscillation velocity ub and frequency of single bead
oscillation  . (b) Maximum contact pressure bmax , milling intensity factor F, and average
frequency of drug particle compressions a. Milling conditions: u = 11.7 m/s, c = 0.4 and
Q = 126 ml/min.
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In Figure 5.5b, an increase in F is seen for decreasing bead sizes which implicates that
smaller bead size possess faster breakage rate due to more number of stressing events.
Thus, microhydrodynamic analysis justifies or rationalizes the use of smaller beads for
finer particle preparation, and so 100 µm beads were further used in experiments.
In the planned experiments, an attempt to use less than 100 µm bead size resulted
in inefficient operation of the mill. For example, when 50 µm beads were used for milling
by having screen with pore size of 25 µm (recommended), the presence of large initial
GF particle size (d90 = 57.77 µm) resulted in clogging of screen pores and the suspension
was not even allowed to flow out of the milling chamber. Very small size beads are
generally not employed for milling due to their difficulty in handling, high cost, and
problems associated with separation of beads from the suspension (Haskell, 2003).
Hence, due to practical limitation of the mill, 100 µm beads were used as the least size in
this study.

5.3.2 An Intensified Process with 100 µm Beads
From the bead optimization study, it can be seen that 100 µm beads are effective in
producing < 100 nm particles. However, the mill operating conditions employed in the
bead optimization study took almost 360 min (6 h) to obtain GF particles with a median
size of 98 nm (Run 4). The microhydrodynamics analysis suggests that the breakage rate
of the GF particles was higher resulting in faster production of fine nanoparticles, when
the milling intensity factor F was higher. Equation (5.4) suggests that F depends on
parameters  andc besides Rb, which can be directly increased by increasing the rotor
(mill stirrer) tip speed and bead load, respectively (Afolabi et al., 2013). In addition to the
above, it is also reported that an increase in suspension flow rate also leads to increased
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breakage rate as high suspension flow rate results in tighter residence time distribution
(RTD) (no back-mixing) of suspension in mill chamber (Monteiro, et al., 2013; Stehr,
1984). Hence, the combination of higher mill tip speed, higher bead load, and higher
suspension flow rate may allow for the development of an intensified process.
Developing such an intensified process is important as it helps to increase the
particle breakage rate, thereby achieving faster production of fine nanoparticles with
reduced bead wear contamination level. Figure 5.6 shows the schematic of the
methodology followed in development of an intensified process with 100 µm beads to
produce sub-100 nm particles, with the objective of reducing the milling time and bear
wear contamination level.

Small size bead

Bead Wear Contamination

Sub-100 nm

+

after 360 min

High mill tip speed

+
High bead load

+
High suspension
flow rate

Sub - 100 nm
< 30 min

Milling Time

Figure 5.6 Schematic of the methodology followed for the development of an intensified
wet stirred media milling process with the use of 100 µm YSZ beads for the faster
production of sub-100 nm drug particles.
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The effect of each process parameter on the reduction of milling time and particle size
was studied by varying one process parameter at a time. From a specific parameter
variation study, the intensified mill parameter was selected and subsequently used for
other parameter intensification studies.
5.3.2.1 Effect of High Mill Tip Speed.

To investigate the effect of mill tip speed on

reduction in particle size and milling time, the mill tip speed u was increased to 14.7 m/s.
It is to be noted that the maximum tip speed allowed per mill design is 15.4 m/s, and to
avoid reaching the limitation of the mill, a mill tip speed of 14.7 m/s was used as
maximum in this study. Figure 5.7a shows the temporal evolution of GF median particle
size, milled at u = 14.7 m/s at c = 0.4, and Q = 126 ml/min (Table 5.2, Run 5). For the
sake of comparison, experimental result of lower mill tip speed (Run 4, u = 11.7 m/s) is
also plotted in Figure 5.7a. With an increase in mill tip speed (Run 5), a faster particle
breakage rate is observed and a dynamic equilibrium was achieved from 120 min of
milling (plateau not shown). The d50 particle size obtained at 120 min was 95 nm, and
further size reduction was not observed even up to 6 h of milling (refer to Table 5.3 for
the particle size statistics). Reduction in only milling time by increasing the mill tip speed
was also observed by Afolabi et al., 2013; Fadhel and Frances, (2001). Therefore, a
higher mill tip speed of 14.7 m/s was used in the further process intensification
experiments.
5.3.2.2 Effect of High Bead Load at High Mill Tip Speed.

Increasing the bead

load (amount of grinding beads) reduces the volume of empty spaces between the
colliding beads, and helps to increase the frequency of particle capture during bead-bead
collisions. Better grinding performances were achieved especially at higher media fillings

122

as in Afolabi et al., (2013), Persson and Forssberg (1994), and Sadler et al. (1975).
Therefore, the effect of bead load on reduction in particle size and milling time was
investigated by increasing the bead load to c = 0.543, which corresponds to 90% of the
total mill volume.

(a)

(b)

Figure 5.7 (a) Temporal evolution of the median size d50 of GF particles for the Runs 4–
7 with the use of 100 µm YSZ beads, (b) SEM of GF nanoparticles prepared using
intensified process conditions (Run 7: u = 14.7 m/s, c = 0.543 and Q = 343 ml/min). Inset
SEM shows magnified GF nanoparticles. At t = 0 min, the GF particles have d50 = 21.85
± 1.25 m and d90 = 57.77 ± 4.35 m.
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Bead load above 90 % resulted in pressure build-up, and hence a maximum bead load of
c = 0.543 was used in this study. Other operating process parameters, mill tip speed and
suspension flow rate were kept at u = 14.7 m/s and Q = 126 ml/min (Table 5.2, Run 6)
respectively. In Figure 5.7a, Run 6 shows a much faster breakage rate compared to Run 5
and a least size of 85 nm were produced within 60 min of milling (Table 5.3 shows the
particle size statistics).. Hence, the intensified process with combined effect of higher
bead load and higher mill tip speed was used in further studies.
5.3.2.3 Effect of High Suspension Flow Rate at High Bead Load and Tip Speed.
In an attempt to further reduce the milling time, the suspension flow rate Q was increased
from 126 ml/min to a maximum of 343 ml/min at c = 0.543, u = 14.7 m/s (Table 5.2, Run
7). From Figure 5.7a, higher suspension flow rate (Run 7) resulted in much faster
breakage rate compared to lower suspension flow rate (Run 6), and a particle size of 83
nm was achieved within 32 min of milling (Table 5.3 shows the particle size statistics).
Further reduction in particle size was not observed even after prolong milling. SEM of
the GF particles prepared with this condition (Figure 5.7b) shows the primary GF
particles (refer inset of Figure 5.7b), with an average particle size of 74 nm. Higher
suspension flow rate leads to reduction in cycle time (i.e., faster breakage rate) due to
plug flow like behavior of the suspension in mill chamber resulting in tighter RTD (no
back-mixing). Detailed study on the reduction in cycle time by increasing the suspension
flow rate in terms of increasing Péclet number is given in Monteiro, et al. (2013) and
Stehr (1984). Hence, the milling process was further intensified which resulted in a final
GF nanoparticle size of 83 nm attained within 32 min of milling.
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5.3.2.4 Reduction in Cycle Time, Specific Ene rgy Consumption, and Bead Wear.
Considering some potential end points in industrial scale milling operations, the milling
time required to produce GF median particle size of 100 nm was predicted by
interpolating (Hermite interpolation) the experimental data of Runs 4–7. The predicted
cycle time to achieve 100 nm GF particles for the Runs 4–7 were 300 min, 98 min, 41
min, and 22 min respectively. The cycle time was greatly reduced upon intensifying the
mill process, and a comparative analysis of cycle time of the intensified process having
high rotor speed at high bead load and suspension flow rate (Run 7) with the base line
process (Run 4) show a 13.6 times reduction in cycle time. Thus the cycle time was
largely reduced with the help of intensified process conditions compared to the baseline
process conditions to get median GF size of 100 nm. Similarly, the specific energy
consumption E* up to the predicted time for all the Runs was also calculated. The E*
values for Runs 4–7 were 6.69 MJ/kg, 6.56 MJ/kg, 6.47 MJ/kg, and 3.81 MJ/kg
respectively. It is to be noted that upon intensifying the process conditions, the power
(Pw) spent on the slurry (Table 5.3) was higher. However, a steady decrease in specific
energy consumption values was seen due to the reduction in cycle time. On comparing
the Run 7 and Run 4, for a 13.6 time reduction in cycle time, the specific energy
consumption was reduced to 1.6 times and is proportional to 43 % energy savings.
Scant information is available on the bead wear contaminant level in terms of
cycle time, and varying process conditions (Hennart et al., 2010; Juhnke et al., 2012;
Stein, et al., 2010). Figure 5.8 shows elemental level of zirconium and yttrium for Runs
4–7, milled with the use of 100 µm beads up to the predicted time to achieve GF median
particle size of 100 nm. Recall that the predicted cycle time to achieve 100 nm GF
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particles for Runs 4–7 were 300 min, 98 min, 41 min, and 22 min respectively. In Figure
5.8, the elemental zirconium (Zr) and yttrium (Y) levels contaminations for Runs 4–7
were 298 ± 4 µg/g Zr, 20 µg/g Y, 132 ± 6 µg/g Zr, 12 µg/g Y, 71 ± 4 µg/g Zr, 5 µg/g Y,
and 40 ± 2.3 µg/g Zr, 3 µg/g Y respectively. From Figure 5.8, about 86.5% reduction in
Zirconium level can be observed with the use of the intensified process (Run 7) compared
to the baseline process condition (Run 4). Decrease in contaminants levels (from Runs 4 –
7) with respect to decrease in the cycle time to reach 100 nm GF particles, suggests that
contaminant level is proportional to the milling time irrespective of the process
conditions. It is also to be noted that if the milling time is kept constant for both baseline
and intensified process conditions; an increase in contaminant levels with the intensified
process conditions can be observed.
To prove this, we have also milled GF with the baseline process condition (u =
14.7 m/s at c = 0.53, and Q = 343 ml/min) and the intensified process condition (u = 14.7
m/s at c = 0.53, and Q = 343 ml/min) for a constant mill time up to 2 h with the use of
100 m beads. The contaminants levels for baseline and intensified process conditions
were 33 ± 5 µg/g Zr, 8 µg/g Y and 147 ± 18 µg/g Zr, 10 µg/g Y respectively. Compared
to the baseline process, an increase in contaminant levels up to 4.5 times was observed
with the intense process conditions for a constant mill time of 2 h. However, it is not
required to run the intensified process for a long time, as the process leads to fine particle
size at a much shorter time with reduced contamination levels. Hence, the assessment on
cycle time and specific energy consumption suggests that one can use the intensified
process conditions to achieve faster production of small size drug nanoparticles with
significant energy savings and reduced product contamination by the beads. It is to be
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mentioned that shortening of cycle time with reduced energy consumption and bead wear
with the intensified process is mainly due to faster breakage rate of particles which is a
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resultant of increased bead-bead collisions (see Section 5.3.2.5).

Run 7

Figure 5.8 Elemental level (g/g) of zirconium and yttrium from YSZ beads determined
by induced couple plasma mass spectroscopy (ICP-MS) along with the time required to
reach a median size of 100 nm at different mill process conditions for Runs 4–7. Run 4 at
the baseline conditions (u = 11.7 m/s, c = 0.4 and Q = 126 ml/min); Run 5 (u = 14.7 m/s,
c = 0.4 and Q = 126 ml/min); Run 6 (u = 14.7 m/s, c = 0.543 and Q = 126 ml/min); Run 7
(u = 14.7 m/s, c = 0.543 and Q = 343 ml/min). 100 µm YSZ beads were used for all the
Runs from 4–7.

5.3.2.5 Microhydrodynamic Analysis of the Intensified Process. Table 5.4 shows the
calculated MHD parameters for the baseline and intensified process conditions (see Runs
4–7). At higher tip speed (Run 5), all calculated MHD parameters (,  , ub, bmax , F, and
a) show higher values as compared to Run 4, and especially one order of magnitude
increase in the milling intensity factor F is seen. At higher rotor tip speed, more
mechanical energy was imparted on the slurry, which led to more impactful bead
collisions (higher and higher compressive stresses (higher bmax ), i.e., a greater stress
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intensity. This effect led to a reduction in milling time (i.e., reduced bead wear) and
reduced specific energy consumption. At combined conditions of both high tip speed and
high bead load, a counteracting effect was observed:  , ub,, bmax were smaller, whereas
, a, and F were greater (Run 6, Table 5.4) as compared to Run 5. In other words, the
amount of stress intensity decreased, but the number of stressing events dramatically
increased due to higher bead load. This led to small clearance between the beads causing
a dramatic increase in the bead–bead collisions and the average number of drug particle
compressions per unit time ( and a), i.e. higher particle capture efficiency than Run 5.
The increase in the capture efficiency led to a further reduction in cycle time, specific
energy consumption, and bead wear. Finally with the above intensified process, when the
suspension flow (Run 7) rate was increased, the overall breakage rate was further
increased due to tighter RTD and plug- flow like behavior of the suspension in the mill
chamber. The increase in the suspension flow rate influenced the input MHD parameters:
an increase in the rotor power and the decrease in the suspension viscosity (Table 5.4).
This was due to the higher number of inelastic bead–bead collisions and liquid- film
squeezing events coupled with an increase in the effective drag coefficient Rdiss which led
to greater energy dissipation. It is worth- mentioning that the increase in the energy
dissipation further led to an increase in both MHD parameters and the overall breakage of
the drug particles. Overall, 8.7 times increase in F can be observed with intensified
condition (Run 7) compared to the baseline condition (Run 4) which led to a 13.6 times
reduction in cycle time as compared to the predicted baseline mill time of 300 min with
energy savings up to 43%, and 86.5% less zirconium wear from the beads. It is to be
noted that the use of 100 m beads enabled us to reduce the cycle and particle size due to
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relatively higher particle capture frequency compared to other larger size beads. Though
the compressive stresses (b max) of 800, 400, 200 m beads are higher compared to 100
m beads, the mill intensity factor (grinding efficiency) is higher for 100 m beads.
Therefore, an effective intensification of the mill process can be achieved only by using
smaller size beads.

5.3.3 Milling of Naproxen with Intensified Process
It is important to demonstrate our intensified process with other drug, so as to confirm
that the methodology developed results in fine nanoparticles at a shorter milling time. For
this, we have selected naproxen (NAP), milled with baseline (Table 5.2, Run 8) and
intensified process Table 2, Run 9) conditions. Naproxen loading of 10 % (w/w) and a
combined stabilizer having 2.5% (w/w) HPMC, and 0.2% (w/w) SDS were used. Figure
10 shows the temporal evolution of Naproxen median particle size, milled with use 100
µm beads at the baseline conditions (Run8: u = 11.7 m/s, c = 0.408, and Q = 126 ml/min)
and intensified process conditions (Run 9: u = 14.7 m/s, c = 0.543, and Q = 343 ml/min).
Similar to GF milling, NAP also resulted in sub-100 nm range for both Run 8 and Run 9.
In this case too, the baseline process condition (Run 8) took almost 6 h (data shown till
mill time of 120 min) to reach 87 nm whereas, intensified condition (Run 9) resulted in
82 nm within 32 min of milling. XRD analysis also confirmed that crysta llinity of milled
NAP was not altered (Figure not shown).
Upon assessing the cycle time, specific energy consumption, and bead wear
between Runs 8 and 9, the predicted cycle time to achieve 100 nm NAP particles were
194 min and 18 min respectively. Reduction in cycle time about 10.7 times was achieved
upon intensifying the process, and the calculated energy savings and reduced zirconium
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bead wear at this reduced cycle time were up to 21% and 76%, respectively. This
observation is similar to the milling of GF particles as shown in Section 5.3.2.4, thus
proving that the methodology followed in the intensified process works well for other
drugs. Table 5.4 shows the calculated MHD parameters for Runs 8 and 9. Similar to GF,
the intensified process conditions (Run 9) shows 8 times high F compared to the baseline
process condition (Run 8). Overall most of the MHD parameters values were high for the
intensified process which led to an increase in F (i.e. faster breakage of NAP particles).

Figure 5.9 Temporal evolution of the median size d50 of the naproxen (NAP) particles
milled with the use of 100 µm YSZ beads. Run 8 at the baseline conditions (u = 11.7 m/s,
c = 0.4 and Q = 126 ml/min) and Run 9 at the intensified process conditions (u = 14.7
m/s, c = 0.543 and Q = 343 ml/min). At t = 0 min, the NAP particles have d50 = 16.60 ±
1.27 m and d90 = 77.12 ± 2.10 m.
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Table 5.4 Power Applied per Unit Volume of Slurry (Pw), Measured Viscosity (µL) and Density (L) of the Milled Drug
Suspensions, and the Calculated Microhydrodynamic Parameters (  , ub, , bmax , a, and F ) for Different Runs
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Run
No.

Pw
(W/m3 )

µL
(cP)

ρL
(kg/m3 )

1
2
3
4
5
6
7
8
9

3.13105
2.92105
2.71105
2.29105
6.88105
1.25106
1.38106
2.08105
1.38106

5.97
5.73
5.51
5.63
5.04
4.83
4.56
4.93
4.78

1034
1026
1028
1040
1036
1038
1037
1008
1007


(m /s )

ub
(m/s)

ν
(KHz)

2.2510–2
1.2410–2
5.3010–3
2.0610–3
5.9010–3
3.7010–3
4.2010–3
2.0910–3
4.1010–3

2.4010–1
1.7810–1
1.1610–1
7.2410–2
1.2210–1
9.7610–2
1.0310–1
7.2910–2
1.0210–1

3.98
5.47
7.17
7.58
12.8
27.1
28.7
7.63
28.4

2 2
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bmax
(GPa)

a
(mHz)

F
(m0.6 /s2.6 )

2.19
1.95
1.64
1.36
1.68
1.53
1.57
1.36
1.56

1.2410–1
1.9910–1
3.2810–1
3.2210–1
8.9910–1
2.10
2.45
3.7510–1
2.30

5.261012
2.871013
1.531014
3.701014
1.461015
2.811015
3.311015
3.771014
3.211015

5.4 Summary and Conclusions
Wet stirred media milling is considered as the robust process for the production of poorly
water-soluble drug nanoparticle suspensions. Besides its advantage in large scale
production, the process is limited by long hour of operation, intense energy consumption
and bead wear. In the present work, an intensification process methodology for WSSM
has been developed with the objective of producing sub-100 nm particles at a reduced
mill time, energy consumption, and bead wear. Two model poorly water- soluble drugs,
Griseofulvin (GF) and Naproxen (NAP) were selected for this study, milled at a bench
scale process having 200 ml batch volume with 10 wt% drug loading. The use of smallest
beads (100 µm) in our base line process conditions enabled us to produce stable
suspensions containing sub-100 nm (98 nm) GF particles after 6 h of milling with
reduced energy consumption and reduced bead wear. Microhydrod ynamic theory of
beads clearly explains the following within the context of 100 µm beads (i) fastest
particle breakage rate due to more number of stress events (ii) production of sub-100 nm
particle due to high particle capture frequency (iii) reduced energy consumption due to
low fluctuating motion of beads and (iv) reduced bead wear contamination due to low
compressive stress between the beads. A milling intensity factor, which is proportional to
the energy dissipation rate during deformation of the drug particles, explained the overall
positive effects of the smaller beads. Further, an increased mill intensity factor was
achieved by increasing the particle breakage rate via combined use of intense mill
parameters such as rotor tip speed, bead load, and feed flow rate, which finally led to the
production of 83 nm GF particles within 30 min of milling. Further reduction in both
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particle size and milling time was not achieved due to the practical limitation of our mill
such as maximum stirrer speed and difficulty to use/separate less than 100 µm beads.
A comparative analysis between the baseline and intensified process conditions to
produce GF particle size of 100 nm showed a 13.6 times reduction in cycle time with
energy savings up to 43% with use of intensified process conditions. Bead wear
contamination levels of zirconium and yttrium in the milled drug particles was found to
be proportional to the milling time, and 86.5% less bead wear (zirconium) contamination
was observed with the reduced milling time. S imilarly, milling of NAP with intensified
process conditions also led to the faster preparation of sub-100 nm particles with reduced
specific energy consumption and bead wear. Thus, the intensified process methodology
developed in this Chapter presents an opportunity for formulators/engineers to design an
intensified wet-milling process for faster production of sub-100 nm drug particles with
energy savings and reduced bead wear contamination of final drug product.
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CHAPTER 6
CONTINUOUS PRODUCTION OF DRUG NANOPARTICLE SUSPENSIONS
VIA WET STIRRED MEDIA MILLING: A FRESH LOOK AT THE
REHBINDER EFFECT

6.1 Introduction
Fast and efficient development of pharmaceutical formulations containing poorly watersoluble drug particles is of great interest to the pharmace utical industry (Date and
Patravale, 2004). By some estimates, 60% of drug candidates currently under
investigation can be classified as Biopharmaceutical Classification System (BCS) Class
II, for which the bioavailability is limited by solubility rate. Recent advances in
combinatorial chemistry aided the discovery of new drug molecules with such low
solubility characteristics (Muller and Peters, 1998; Niwa et al., 2011). Production of
nanoparticles and microparticles of poorly water-soluble drugs can enhance the
dissolution rate through the significant increase of the surface area (see e.g. the Noyes–
Whitney equation (Noyes and Whitney, 1897)). Such small particles can be produced
either by the so-called top-down approach, which includes jet milling (Chan et al., 2002),
high pressure homogenization (Kamiya et al., 2009), and stirred media milling (Bilgili et
al., 2004, 2006); or by the bottom- up approach (Anais et al., 2009; Chiou et al., 2008;
Date and Patravale, 2004) which involves building up particles by precipitation of
dissolved

molecules.

Both approaches

have been

widely

used

to

produce

microsuspensions (suspensions with particles having a mean or median size in the range
1–10 μm) and nanosuspensions (suspensions with particles having a mean or median size
less than 1 μm) (Ain- Ai et al., 2008; Basa et al., 2008; Hu et al., 2004; Kesisoglou et al.,
2007; Liversidge et al., 1995; Park et al., 2009; Tanaka et al., 2009).
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A thorough search of pharmaceutical literature for the wet media milling of BCS
Class II drugs shows that a great majority of the experimental data was obtained with t he
batch/recirculation operation mode. In batch operations, the mill is operated either
vertically or horizontally, where agitation of the milling media (beads) is performed by a
main rotating shaft, with the possibility of sub-shafts branching off. Batch mills are not
widely used in large scale production due to scale-up issues; however, nanomilling of
pharmaceuticals in small-scale batch operations has been documented (Bhakay et al.,
2011; Lee et al., 2008; Sepassi et al., 2007). Recirculation mode uses a small milling
chamber, recirculation pump, holding tank, and milling media containment screen to
facilitate particle breakage. Similar to standard batch milling, particle breakage originates
from the intense agitation of the beads and product suspension. A pump is employed to
circulate the suspension from the holding tank, through the mill, and back into the
holding tank (see Figure 6.1a). Elan’s Nanocrystal Technology™ makes use of
recirculation media milling to produce drug nanosuspensions in marketed products like:
Rapamune (Wyeth), Emend (Merck), Tricor (Abbott), and Megace (Par Pharmaceutical)
(Bruno et al., 1996), with a couple of review papers (Merisko-Liversidge et al., 2002;
Merisko-Liversidge and Liversidge 2011) thoroughly discussing the recirculation milling
process. Several research groups (Cerdeira et al., 2011; Ghosh et al., 2011; Singh et al.,
2011) have recently used the recirculation milling mode to produce drug nanosuspensions
in small batch sizes; however, a comparison to other milling modes was not performed. A
comparison study of standard batch mode and recirculation mode of milling of drug
nanosuspensions was performed using a planetary mill (Juhnke et al., 2010); however, no
comparison or discussion of multi-pass (or cascade continuous mode) was presented.
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Some researchers (Adjei et al., 1995; Annapragada et al., 1996; Verhoff et al.,
2003; Czekai and Seaman, 1996, 1998) refer to the recirculation operation mode as a
continuous milling process. Although the milling is performed ‘continuously’ in a milling
chamber, no product is withdrawn continuously from the mill as 100% of mill output is
circulated back to a holding tank, which allows the production of a fixed batch size as
determined by the capacity of the holding tank (Figure 6.1a). The milling dynamics is
partly coupled to the mixing dynamics in the holding tank that is usually assumed wellmixed. Figure 6.1b depicts a multi-pass continuous milling process: unmilled suspension
is loaded into the holding tank, pumped to pass through the mill, and collected into the
receiving tank. Using this milling mode, multiple passes can be performed by repeating
the said procedure. It is possible to automate the multi-pass mode using two separate
holding tanks with interconnected valves and pumps by which the suspension can be
processed from one tank to the other in a swing or pendulum motion. Figure 6.1c depicts
a true (cascade) continuous milling process where unmilled suspension is loaded into the
holding tank and allowed to pass through n number of mills in series before being
collected in the receiving tank. The multi-pass mode (Figure 6.1b) is intended to simulate
the operation of true (cascade) continuous milling (Figure 6.1c). Since it is expensive to
acquire n (usually 6–12) number of mills for research/development purposes at the labscale, the investigation of continuous milling was carried out using the multi-pass mode
in this chapter.
In all major chemical industries, continuous processing is widely used for largescale production. There is a growing interest in moving all pharmaceutical unit operations
in drug product manufacture from batch processes to continuous processes. Recent
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publications on continuous mixing have made the case for the feasibility of continuous
drug product manufacture (see e.g. Berthiaux et al., 2008; Vanarase et al., 2010a, 2010b).
This manufacturing strategy could bring the pharmaceutical industry advantages such as
consistent and improved product quality, reduced waste, lower inventory and equipment
costs, easy scale- up, flexibility, and short cycle times. Pharmaceutical unit operations
such as tabletting, roller compaction, and capsule filling are already performed semicontinuously; whereas mixing, wet milling, most granulations, drying, and tablet coating
are usually performed in the batch/recirculation mode. Although ample experimental
studies of batch and recirculation mode of wet media milling exist in literature, little
effort has been devoted to the cascade or multi-pass continuous modes. In the area of
continuous wet stirred media milling of drugs, there are only a couple of patents available
(Holland et al., 2006; Verhoff et al., 2003). Initial discussion on the feasibility of
nanomilling Fenofibrate using a wet stirred media mill operating in single-pass mode was
presented (Holland et al., 2006); however, the figures and examples provided only
described recirculation milling. Another patent (Holland et al., 2006) presents what is
believed to be the first documentation of cascade continuous mode of wet media milling
of drugs, where Nabumetone nanoparticles were produced using five media mills in
series. In both cases, only the final median particle size was provided; procedural details
were missing, and the breakage dynamics was not studied.
Wet stirred media milling of poorly water-soluble drugs has been commonly
performed in recirculation/batch mode (see preceding chapters) to understand the impact
of formulation and processing parameters, and scant information is available on the
continuous mode of operation.
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Figure 6.1 Schematic of recirculation, multi-pass continuous, and cascade continuous
modes of wet media milling. ‘P’ represents pressure gauge and ‘T’ represents
thermometer. (a) Recirculation – Suspension recirculates through the mill. (b) Multi-Pass
Continuous – Suspension flows from holding tank, through mill, and into receiving tank.
(c) Cascade Continuous - Suspension flows from holding tank, through mills in series,
and into receiving tank (coolant flow for cascade continuous mode is not shown for
clarity).Figures are not drawn to scale.
An objective of the current chapter is the continuous production of nanosuspensions of
two BCS Class II drugs, i.e. Griseofulvin (GF) and Naproxen (NAP), using a single wet
stirred media mill (Netzsch Microcer) in the multi-pass mode. Evolution of the particle
size distribution (PSD) during recirculation and multi-pass continuous modes of
operation was studied to describe the breakage dynamics along with the effects of a
reduced suspension flow rate. Another objective of the present chapter is the elucidation
of the so-called Rehbinder effect on fine milling. The Rehbinder effect is described as the
facilitation of crystal cleavage and decrease in hardness of crystals caused by surface-
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active agents. Adsorption of the surface-active agents can weaken the bonds in the crystal
surface layer and lower the specific surface free energy ( Butyagin, 1999; Rehbinder,
1958; Rehbinder and Shchukin, 1972; Shchukin, 2006). When GF particles were milled
in the presence of hydroxypropyl methyl cellulose (HPMC) as the only stabilizer in a
Micros batch mill, limited analysis (Bhakay et al., 2011) did not reveal a significant
Rehbinder effect. Here, GF and NAP particles were milled in the presence/absence of a
stabilizer combination, i.e., a polymer (hydroxypropyl cellulose, HPC) and an anionic
surfactant (sodium lauryl sulfate, SLS), toward elucidating the Rehbinder effect. Laser
diffraction, BET nitrogen adsorption, SEM imaging, and a microhydrodynamic analysis
were used as tools to investigate the roles of the stabilizers. Milling the drugs in the
absence of stabilizers produced primary nanoparticles and their aggregates, while milling
in the presence of stabilizers produced smaller primary nanoparticles with minimal
aggregation. This is the first study in pharmaceuticals literature that provides sufficient
evidence for the existence of the Rehbinder effect. Not only do the stabilizers allow
proper stabilization/dispersion of the milled suspensions, but they also do facilitate t he
breakage of the drug particles.

6.2 Experime ntal

6.2.1 Materials
GF (BP/EP micronized grade) and NAP (USP grade), were used for all wet media milling
as reported in Chapter 5. SEM images of as-received drug particles are shown in Figure
6.2. An anionic surfactant, sodium lauryl sulfate (SLS), and a neutral polymer,
hydroxypropyl cellulose (HPC, SL grade), were used as stabilizers.
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Figure 6.2 SEM images of BCS Class II drugs as received from the manufacturer: (a)
Griseofulvin (GF) at 2 kX, (b) Naproxen (NAP) at 1 kX.

6.2.2 Methods
6.2.2.1 Preparation of Feed Suspensions. Feed drug suspensions were prepared by
first weighing de- ionized water (Di- H2 O) inside a clean beaker. SLS was weighed and
added to the water gradually for 15 min while mixing. HPC was then weighed and added
gradually for 30 min while mixing. The HPC/SLS solution was then mixed for an
additional 15 min to ensure that the HPC and SLS particles were properly dissolved. SLS
and/or HPC addition steps were skipped for runs that do not use the stabilizer(s) (see
Table 6.1). The drug particles were then weighed and added gradually for 40 min while
mixing. Two samples (1 mL) were taken after 40 min of mixing for PSD analysis,
corresponding to the 0th turnover or pass sample in the dynamic stud y (see below). All
mixing was performed using the low shear laboratory stirrer. To defoam and pre-cool the
suspension, feed suspensions were kept in a refrigerator at about 8 o C for 1 h prior to
milling.
Table 6.1 shows the formulations used for the wet media milling experiments.
The drug loading was 10% for all runs performed. Unless otherwise specified, all weight
percentages are with respect to water.
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Table 6.1 Operating Conditions and Formulations of the Wet Media Milling Experiments
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Run
No.

Drug

Flow
Rate
(mL/min)

Milling
Mode

Di-H2 O
(mL)

Drug
Loading
(% w/w)a

HPC
Concentration
(% w/w)a

SLS
Concentration
(% w/w)a

1

GF

110

Recirculation

400

10

2.5

0.5

2

GF

110

Multi-Pass

445

10

2.5

0.5

3

GF

55

Recirculation

400

10

2.5

0.5

4

GF

55

Multi-Pass

445

10

2.5

0.5

5

GF

110

Multi-Pass

457

10

—

—

6

NAP

110

Recirculation

400

10

2.5

0.5

7

NAP

110

Multi-Pass

445

10

2.5

0.5

8

NAP

55

Recirculation

400

10

2.5

0.5

9

NAP

55

Multi-Pass

445

10

2.5

0.5

10

NAP

110

Multi-Pass

454.5

10

—

0.0825

% w/w with respect to Di-H2O (de-ionized water).
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A suspension of 440 mL was used when operating in the recirculation mode. About 50
mL residual suspension must be retained within the milling chamber during each pass of
the multi-pass mode of operation because running the mill empty could cause serious
damage. Therefore, the suspension volume was increased to 490 mL when milling in
multi-pass continuous mode to account for the 50 mL residual suspension. In the first part
of this Chapter (Runs 1–4 and 6–9), HPC and SLS loading were 2.5% and 0.5%,
respectively. Experiments were performed with both 110 and 55 mL/min flow rate. After
milling, samples from Runs 1, 2, 6, and 7 were refrigerated at about 8 o C for 7 days. The
refrigerated samples were analyzed using laser diffraction to assess the short-term
physical stability of the suspensions. Stability studies were not performed for the other
runs with identical formulations despite the difference in the suspension flow rate.
In the second part of this chapter, Runs 5 and 10 were designed to elucidate the
effect of stabilizers on particle breakage by milling the drugs in the absence of stabilizers.
No processing issue was encountered during GF milling and subsequent characterization.
On the other hand, a thick foam was formed while attempting to prepare the NAP
suspension without HPC/SLS (Run 10). Since the foam could not be milled as prepared,
small batch size experiments were performed to determine the minimum amount of SLS
required to properly wet the particles and to fac ilitate milling. It was determined that at
0.0825% SLS, the foam was reduced to such a level and consistency that milling could be
performed. Such a small addition of SLS was not expected to significantly affect the
analysis since the amount of SLS added was substantially less than the critical micelle
concentration (CMC) of SLS (2.36 g/L CMC vs. 0.825 g/L SLS added). However, a
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confounding effect cannot be completely ruled out due to this small SLS amount in NAP
milling.
6.2.2.2 Milling Procedure. The mill was set up to operate either in recirculation mode
(Figure 6.1a) or in multi-pass continuous mode (Figure 6.1b) by choice. In recirculation
milling, the unmilled feed suspension was loaded into the 500 mL holding tank. The
suspension then circulates continuously from the holding tank, through the mill, and back
into the holding tank by a peristaltic pump. A complete passage of the bulk volume from
the holding tank, through the mill, and back into the holding tank is referred to as a
‘turnover’. The amount of time required to perform a single turnover was calculated by
dividing the batch volume in the holding tank by the suspension flow rate. The number of
turnovers performed during a milling experiment is given by the ratio of the total milling
time to the turnover time. A total milling time of 64 min was used for all milling
experiments performed in this study.
In multi-pass continuous milling, the unmilled suspension was loaded into the
holding tank and pumped through the mill by the peristaltic pump and collected in the
receiving tank; with each trip referred to as a ‘pass’. When the MicroCer mill was
operated in the multi-pass continuous mode, additional mixing and recirculation time had
to be introduced to deal with the 50 mL residual suspension that mus t remain inside the
milling chamber in between passes. The procedure was as follows: After the first pass of
milling, the receiving tank suspension was poured back into the holding tank and mixed
for 3 min with the paddle mixer set at 1000 rpm. A 1 mL samp le was taken after 3 min.
The suspension was then circulated for 8 min with the mill rotor off while the
paddle in the holding tank was rotated at 1000 rpm. This was performed to allow the
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milled suspension and 50 mL unmilled residual suspension to mix co mpletely. After 8
min, the well- mixed suspension was ready to pass through the mill and to be collected in
the receiving tank once again (the second pass). The procedure mentioned above was
repeated for all the remaining passes.
In both modes of milling, the mill rotor was rotated at 3600 rpm (tip speed of 13.2
m/s), with the suspension in the holding tank mixed at 400 rpm during milling. For runs
operating with a flow rate of 110 mL/min, 1 mL samples were taken after the 1 st , 2nd, 3rd,
4th , 7th , 8th , 12th , and 16th turnover or pass (64 min total, 4 min per turnover or pass).
When switching to runs operating at a flow rate of 55 mL/min, samples were taken after
the 1st , 2nd, 3rd, 4th , 5th , 6th , 7th , and 8th turnover or pass (64 min total, 8 min per turnover
or pass). Multi-pass mode with a flow rate of 55 mL/min required 16 min of additional
mixing/recirculating of the 50 mL residual suspensions with the produced suspension inbetween the passes. Particle size analysis was performed on all samples (see Particle Size
Analysis below).
Establishment of a steady-state operation in terms of particle size is important in
continuous milling. The rotor reaches the set speed usually within few seconds, the
peristaltic pump recirculates the suspension at a constant flow rate with small variability,
and the intensive cooling of the milling chamber allows maintenance of low temperature
in the suspension during milling. Therefore, in multi-pass continuous milling, it is
theoretically expected that the process will reach a steady-state in each pass within a short
period of time, as compared with the duration of the whole pass. Each pass (1 st , 2nd, and
so on) corresponds to a different steady-state condition, which will emulate responses
from different mills in series in a large-scale cascade operation. To prove that the steady-
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state was achieved relatively fast, samples were taken at the outlet of the mill at 15, 30,
60, 120, and 240 s during the 2nd pass of a GF suspension (110 mL/min flow rate), as
opposed to the usual sampling done on the whole milled suspension obtained from the 2 nd
pass. The median particle sizes of the samples were measured by laser diffraction (see
below) to be 684, 494, 498, 497, and 472 nm, respectively, with an average value of 529
nm (490  13 nm excluding the 15 s sample). The 2nd pass sample collected cumulatively
in the beaker (usual sampling) had a median size of 525 nm. These findings suggest that a
steady-state was established within 15–30 s during the 2nd pass of the GF suspension.
Considering the fact that the total duration of the 2 nd pass was 4 min, the steady-state was
indeed established fast. In addition, there was no need to discard the milled product
obtained during the early 0–30 s period because the amount of suspension produced was
small compared with the whole milled product during the 2 nd pass. This approach was
justified by the similarity between the averaged median size of the multiple time samples
(490 nm, excluding the 15 s sample) and that from the whole sample accumulated in the
beaker during the 2nd pass (525 nm). Of course, process engineers will opt to divert the
product stream until a steady-state is established during cascade-continuous operation in
manufacturing. Formulation and processing parameters may affect the attainme nt of
steady-state and steady-state particle size, which is of practical importance; however, this
aspect will not be treated here extensively.
6.2.2.3 Particle Size Analysis and SEM.

Particle

size

analysis

of

the

milled

suspensions was performed by laser diffraction using a Coulter Beckmann LS 13-320
(Brea, CA, USA) as reported in previous chapters. Samples were taken during milling
after the various turnovers or passes mentioned above and were diluted with 10 mL of the
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relevant solution: HPC/SLS solution (Runs 1–4 and 6–9), de- ionized water (Run 5), and
SLS solution (Run 10) prior to particle size measurements. To measure the particle size
of the refrigerated samples after 7 days of storage, content of the sample vials was gently
mixed by a stir bar to redisperse and homogenize the samples. All given sizes are
volume-weighted values. Besides the usual 50% and 90% passing sizes (d50 and d90 ), a
Sauter-Mean Diameter (SMD) was also calculated from the size distribution, which was
compared with the SMD calculated from the BET analysis. SEM imaging was performed
as reported in Chapter 3 and Chapter 4.
6.2.2.4 Differential Scanning Calorimetry (DSC). A Mettler-Toledo Polymer Analyzer
DSC (Model: PolyDSC) (Columbus, OH, USA) was used to obtain the onset melting
temperature, peak melting temperature, and heat of melting of GF and NAP as received
and after milling (Runs 5 and 10) as reported in Chapter 3.
6.2.2.5 Raman Spectroscopy and X-ray Powde r Diffraction (PXRD). In

order

to

verify the findings from the DSC analysis and elucidate any changes to the GF
crystallinity upon milling, as-received and milled/dried GF samples were subjected to
Raman Spectroscopy and X-ray Powder Diffraction (PXRD). Raman spectra were
collected using a Mesophotonics SE 1000 Raman spectrometer (Chilworth Science Park,
Southampton Hampshire, UK), which was calibrated to 2 cm–1 with a 250 mW nearinfrared laser operating at 785 nm with a 130 µm diameter spot size. Data acquired with
the Raman spectrometer represent an average of five scans, for a total of 50 seconds. All
Raman data were as-recorded by the instrument. During the spectra acquisition, powder
samples were placed on glass substrates. In PXRD, as-received and milled/dried GF
particles were analyzed using a wide-angle Philips X’pert MRD Diffractometer (7609
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RG, Almelo, Netherlands) with Cu K radiation ( =1.5406Å). The tube voltage and
amperage were set to 45 kV and 40 mA, respectively. The samples were scanned for 2θ
ranging from 5o to 40o at a speed of ~0.01 2θ/s. Data were collected using Philips X’Pert
DataCollector and analyzed using X’Pert Data Viewer.
6.2.2.6 BET Nitrogen Adsorption. Powder samples for the BET experiments were
obtained from the suspension samples following the same drying procedure as that used
for the preparation of the DSC samples. The dried samples were then degassed under
vacuum at 80 o C for 24 h to remove atmospheric moisture bound to the particle surface
prior to nitrogen adsorption. The powder specific surface area (SSA) of Runs 5 and 10
samples were determined from an 11-point nitrogen adsorption isotherm using a Nova
3200 BET analyzer (Quantachrome Instruments, Boynton Beach, Florida, USA).
Assuming spherical primary particles, the Sauter-Mean Diameter (SMD) was calculated
using SMD = 6/(×SSA), where  is the true density of the drug (1.4 g/cm3 for GF and
1.2 g/cm3 for NAP).
6.2.2.7 Viscosity and Density of the Milled GF Suspensions.

To be able to perform

a microhydrodynamic analysis, the apparent shear viscosity of some of the milled GF
suspensions (Runs 2 and 5) was determined using an R/S plus Rheometer (Brookfield
Engineering, Middleboro, MA, USA) as reported in Chapter 3 and Chapter 4.
Measurements were performed in duplicate to check for reproducibility. Density of the
above suspensions (L) was determined as reported in Chapter 3 and chaprter 4.
Measurements were performed in triplicate to check for reproducibility and the average
was calculated.
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6.3 Results and Discussion

6.3.1 Recirculation vs. Multi-Pass Continuous Operation
6.3.1.1 Characteristics of the Final GF and NAP Suspensions. GF and NAP particles
were separately milled in the recirculation mode for 16 turnovers (Runs 1 and 6). They
were also milled in the multi-pass continuous mode for 16 passes (Runs 2 and 7), while
keeping formulation and process conditions the same (Table 6.1). For all these different
runs, the total milling time was 64 min and the suspension flow rate was 110 mL/min.
Irrespective of the milling mode, nanoparticles were obtained, and the final median
particle size after 16 turnovers or passes were similar for these runs (Table 6.2). The flow
rate was then reduced by half to 55 mL/min while leaving total milling time unchanged,
i.e., 64 min (Runs 3, 4, 8, and 9). GF and NAP were milled in recirculation mode (Runs 3
and 8), with the turnover time increased from 4 to 8 min to account for the decreased
flow rate. They were also milled in multi-pass continuous mode (Runs 4 and 9) while
keeping formulation and process conditions the same. Table 6.2 shows that even after
reducing the flow rate by half, nanoparticles with similar median sizes were obtained
using both modes of milling after the completion of 8 turnovers or passes.
Overall, these results suggest that given sufficient total milling time (64 min),
both the recirculation and multi-pass continuous modes led to similar particle sizes,
irrespective of the suspension flow rate used. To gauge the reproducibility of the wet
media milling process, GF runs (Runs 1 and 2) were repeated. It was observed that a
repeat of Run 1 produced a final median particle size of 0.157 µm, yielding a 1.3 %
difference when compared to the data shown in Table 6.2. Similarly, a repeat of Run 2
produced a final median particle size of 0.159 µm (a 0.6 % difference).
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Table 6.2 Particle Size Statistics of the Suspensions Before and After Milling As Well
As After 7-Day Storage
Run
No.
1

Before Milling
d50 (µm), d90 (µm)
18.8, 54.8

After Milling
d50 (µm), d90 (µm)
0.159, 0.223

After 7-Day Storage
d50 (µm), d90 (µm)
0.157, 0.224

2

16.3, 46.0

0.160, 0.229

0.157, 0.233

3

18.3, 53.3

0.157, 0.228

—

4

13.9, 34.9

0.154, 0.238

—

5

15.4, 31.4

6.04, 8.76

5.33, 8.80

6

12.9, 34.2

0.143, 0.238

0.137, 0.269

7

10.4, 29.0

0.147, 0.253

0.145, 0.286

8

15.7, 51.0

0.138, 0.229

—

9

14.6, 33.8

0.146, 0.327

—

10

17.8, 39.0

5.78, 15.3

14.5, 29.6

Note: 7 day stability testing was not performed on Runs 3, 4, 8, and 9.
Good reproducibility of the particle size of final drug suspensions has also been
established in earlier work (Bhakay et al., 2013; Bilgili and Afolabi, 2012; SievensFigueroa et al. 2012), regardless of the variability in the initial as-received drug particle
size provided that the suspensions had a wetting agent (e.g. SLS) and some stabilizers
(e.g. HPC and SLS). A short-term physical stability study of several suspensions (Runs 1,
2, 5, 6, 7, and 10) was performed by analyzing particle size after seven days of storage
(Table 6.2). Results indicate the amount of polymer and surfactant used was sufficient to
stabilize the suspensions against both aggregation and ripening, as deduced from a
comparison of the d50 and d90 values after milling and 7-day storage (similar particle
sizes).
To develop a more fundamental understanding of the HPC–SLS synergy and the
interactions with the specific drugs considered here, HPC–SLS adsorption on the
respective drug surfaces must be studied (see Chapter 3). In the absence of stabilizers
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(Run 5) or with minimal amount of surfactant (Run 10), aggregates of smaller particles
formed during milling, rendering the suspensions unstable. A stability study was not
performed on runs operating at the reduced flow rate as the formulation remained
unchanged. In addition, a long-term stability was not performed as the suspensions were
intended to be dried shortly after media milling in various drying applications (as in
Bhakay et al., 2013; Sievens-Figueroa et al., 2012). Readers are referred to Bhakay et al.,
(2013) and Sievens-Figueroa et al., (2012) for the effects of drying of the drug
nanosuspensions on the reconstitution of the nanoparticles. In aqueous dispersion of the
dried products (coated microparticles and films), the formulations used in this study led
to stable, well-dispersed suspensions with effective recovery of the drug nanoparticles.
A DSC study was performed on various samples to investigate the effect of
milling on the drug crystallinity. DSC thermograms (Figure 6.3) exhibited sharp
endothermic peaks associated with the melting of the crystalline drugs; no other thermal
event was encountered. It should be noted that milling, especially dry milling and
cryomilling, can induce defects in crystals as well as amorphous regions, which can lead
to appearance of exothermic response like recrystallization and glass transition (see e.g.
Feng et al., 2008; Sharma et al., 2009; Zarow et al., 2011). If crystal defects accumulate
to a significant extent and/or amorphous content becomes appreciable, the melting
temperature and the heat of melting can be reduced significantly (Feng et al., 2008).
Polymorphic changes can also lead to such changes.
As presented in Table 6.3 for GF and NAP, both the onset and peak melting
temperatures of the as-received samples remained the same after milling of GF (Run 5)
and NAP (Run 10). No broadening of the melting point range was observed. Only a slight
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decrease (5.4%) in the heat of melting (fusion) was observed for GF, whereas a 5.1%
increase was observed for NAP.
1

Exo up

1
0

-1

Heat Flow (W/g)

Heat Flow (W/g)

0

As-received GF
Milled GF, w/o HPC/SLS

-2
-3
-4
-5

Exo up

a)

-1
As-received NAP
Milled NAP,
w/o HPC/0.08% SLS

-2
-3
-4
-5

b)

-6

-6
50

100

150

200

250

50

300

100

150

200

250

300

o

Temperature (oC)

Temperature ( C)

Figure 6.3 DSC thermograms of (a) as-received GF and milled/dried GF w/o stabilizers
(Run 5), (b) as-received NAP and milled/dried NAP w/o HPC/0.08% SLS (Run 10).

Table 6.3 Melting Points and Heat of Melting of As-Received and Milled GF and NAP
Onset Melting Point
(o C)

Peak Melting Point
(o C)

ΔHm
(J/g)

As-received GF

218.0

220.1

111.1

Milled GF, w/o HPC/SLSa

217.3

219.2

105.1

As-received NAP

155.0

158.6

136.0

Milled NAP, w/o HPC/0.08% SLS b

153.9

157.9

142.9

Sample

a

Run 5
Run 10

b

These small deviations in the heat of melting could be attributed to experimental errors
(sample weight, bulk density, and particle size differences in the samples as well as
presence of SLS in NAP sample, etc.). Overall, the DSC results suggest that the
crystalline nature of GF and NAP was largely preserved after milling and no polymorphic
form change has occurred during milling; a cautionary note that small amount of
amorphous content may not be accurately determined using the DSC.
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Figure 6.4 Raman spectra of as-received and milled/dried GF w/o HPC/SLS (Run 5): (a)
the 0 to 3500 cm-1 region, (b) expanded view of the 0 to 1000 cm-1 region.
In order to support the findings from the DSC analysis, an extensive
characterization was performed on as-received and milled/dried GF samples using Raman
spectroscopy and PXRD. The Raman spectra of the as-received and milled/dried samples
of GF were very similar, with characteristic peaks occurring at similar frequencies
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(Figure 6.4). The occurrence of a doublet peak in the ~640 cm–1 region is attributed to the
C–Cl stretching mode in the GF molecule (Feng et al., 2008; Zarow et al., 2011). Only a
single peak would appear at this frequency if the samples were amorphous. More
importantly, the ~820 cm–1 line, attributed to the cyclohexanone ring stretching vibration,
is well-known to disappear upon a decrease in GF crystallinity (Zarow et al., 2011), while
a sharp peak is still visible after milling in the milled sample.
The PXRD pattern of the milled/dried sample was similar to that of the asreceived GF sample (Figure 6.5), with some reduction in peak heights. The peak
positions were very similar to the published experimental and computed PXRD patterns
of pure, crystalline GF in the literature (Feng et al., 2008; Zarow et al., 2011). Therefore,
Raman spectra and PXRD patterns appear to support the findings from the DSC analysis
in that wet media milling did not significantly change the crystalline nature of GF within
the detection limits of the respective equipment. The reduction in PXRD peak heights
could be attributed to small amount of defects formed at the particle surfaces and
nanocrystalline nature of the particles produced by the wet media milling (Feng et al.,
2008; Zarow et al., 2011). In the absence of water, cryomilling of GF and indomethacin
led to significant reduction in crystallinity: transformation to amorphous form and crystal
defects (Feng et al., 2008; Sharma et al., 2009; Zarow et al., 2011). Interestingly, in the
presence of water, cryogrinding did not produce amorphous phase for indomethacin
(Sharma et al., 2009). Plasticizing action of water on the newly formed amorphous
content and ensuing rapid recrystallization could be one mechanism (Sharma et al.,
2009). In wet media milling, besides having a plasticizing effect, water allows fast and
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effective cooling during particle breakage, which can minimize formation of local hot
spots on particle surfaces and thus reduce the extent of surface amorphization.
500
As-received GF
Milled GF, w/o HPC/SLS

Intensity (arb units)

400

300

200

100

0
10

20

30

40

2(degree)

Figure 6.5 PXRD patterns of the as-received GF and milled/dried GF w/o HPC/SLS
(Run 5).

6.3.1.2 Evolution of Particle Size during Milling: Effects of Operation Mode .
Samples were periodically taken from the holding tank at various turnovers or passes
corresponding to different processing times. Note that the processing time is typically
much larger than the total mean residence time, which is equal to the mean residence time
during a single pass multiplied by the number of passes in the multi-pass mode
(excluding the remixing time associated with the 50 mL residual suspension). The
samples were analyzed using laser diffraction to study the evolution of the PSD. Since
the analysis and discussion of the wet stirred media milling dynamics of drugs is scarce
(see Bhakay et al., 2011), a thorough analysis will be given here. Figure 6.6 presents the
d50 and d90 evolution during recirculation and multi-pass continuous milling of GF (Runs
1 and 2) and NAP (Runs 6 and 7) at a flow rate of 110 mL/min. For both GF and NAP
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cases with either operation mode, upon an increase in processing time, the particle size
was reduced almost monotonically and no apparent size increase was observed while an
equilibrium (plateau or limiting) particle size was approached or attained after a high
number of turnovers or passes (about 8 for GF and 12 for NAP). A size increase may
occur in poorly stabilized suspensions during milling if the aggregation rate of produced
fine particles exceeds the rate at which large particles and aggregates break (Bhakay et
al., 2011). In view of this, the results suggest that particle breakage was the dominant
mechanism and aggregation of the particles occurred at a smaller rate than the breakage
in the presence of stabilizers during most of the milling process. Of course, as milling
progressed long enough, aggregation rate increased upon production of finer (colloidal)
drug particles, which could be a reason for the equilibrium (plateau) approached at the
high number of turnovers/passes (Knieke et al., 2008, 2009). As the drug particle size
decreases, number concentration in the suspension increases and the interparticle distance
decreases, leading to more frequent collisions and potentially higher aggregation rate
(Bhakay et al., 2011; Sommer et al., 2006). On the other hand, the drastic decrease in
breakage rate and observed approach to a plateau size in Figure 6.6 can be partly
explained by another factor: as milling progressed, finer particles were produced, which
have a much lower specific breakage rate (breakage probability) than the coarser particles
and thus are harder to break (Bilgili et al., 2004, 2006, 2008). Population balance models
without any aggregation terms (Bilgili, 2007; Bilgili and Capece, 2011) were able to
capture the sharp decrease in breakage rate even during the breakage of large
microparticles. Considering that nanoparticles are even less likely to break than
microparticles (Bilgili et al., 2004, 2006), it can be argued that the approach to or
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attainment of a plateau size observed in Figure 6.6 is not solely explained by the
aggregation of fine particles (especially nanoparticles), but also by the extremely low
breakage probability of such particles.
Recirculation and multi-pass operation modes of GF milling seem to result in a
similar evolution of the particle size at 110 mL/min (Figure 6.6). In the case of NAP, the
recirculation mode had a slightly faster breakage rate than the multi-pass continuous
mode after the first few turnovers/passes. Initially, larger particle size observed in the
recirculation mode prior to milling (due to as-received PSD variability) caused a larger
particle size in this mode as compared with the multi-pass mode during the first turnovers
or passes. In general, at this high flow rate, the evolution of the PSD and final pa rticle
size after 16 turnovers or passes were very similar. Figure 6.7 illustrates the particle size
evolution during GF (Runs 3 and 4) and NAP (Runs 8 and 9) milling at a reduced flow
rate of 55 mL/min. Again, after the first or second turnover/pass, recirculation mode had
a greater breakage rate than the multi-pass mode. The impact of the initial size difference
seems to disappear after the second turnover/pass.
A cursory look at Figures 6.6 and 6.7 suggests that a larger disparity between the
milling modes occurred when milling was performed at a reduced flow rate. This could
be partly explained by the presence of 50 mL residual (unmilled) suspension (about 10%
of the total suspension) that had to be left unprocessed in the milling chamber and tubing
during each pass of the multi-pass mode. This residual suspension was mixed later on
with the milled suspension in the receiving tank (see Figure 6.1b), and the mixed
suspension was then used as the feed to the subsequent pass.
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Figure 6.6 Evolution of d50 and d90 during recirculation and multi-pass continuous modes
of wet media milling with 110 mL/min suspension flow rate: (a) Griseofulvin (GF) (Runs
1 and 2), (b) Naproxen (NAP) (Runs 6 and 7).
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Figure 6.7 Evolution of d50 and d90 during recirculation and multi-pass continuous modes
of wet media milling with 55 mL/min suspension flow rate: (a) Griseofulvin (GF) (Runs
3 and 4), (b) Naproxen (NAP) (Runs 8 and 9).
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Hence, some 10% of the particles were subjected to no milling action in a given pass
during the multi-pass mode, which may have contributed to the observed smaller
breakage rate for both GF and NAP. This may also explain the larger d90 for NAP even
after 8 turnovers in the multi-pass mode as compared with that in the recirculation mode
(see Runs 8 and 9 in Table 6.2). This effect of the residual suspension is expected to
disappear as the number of passes increases because further mixing of the residual
suspension and the milled suspension takes place. There were 8 passes associated with 55
mL/min flow rate as opposed to 16 passes at 110 mL/min, leading to a reduction of the
number of times the residual suspension in the milling chamber was mixed with the
milled product in the holding tank and subsequently milled for the former case. It should
be noted that the effect of the residual suspension will completely disappear as the ratio
of residual suspension to total suspension volume decreases (larger scales and/or larger
product volumes).
6.3.1.3 Effects of the Suspension Flow Rate.

To analyze the milling dynamics

more quantitatively, the median particle size (d50 ) data presented in Figures 6.6 and 6.7
were fitted by the following two-parameter empirical model shown in Eq. (2.7) (See
Chapter 2.3).Table 6.4 presents the values of the parameters dlim and τp as well as some
fitting statistics. The coefficient of determination (R2 ) and the sum of squared-residuals
(SSR) gauge the accuracy with which the model explains the deviations from the
experimental data. An R2 value approaching 1 and small SSR values reflect good
accuracy. Table 6.4 shows an acceptable fit of the data (R2 values greater than or equal to
0.92). COV% is defined as the ratio of the standard deviation to the mean of the
estimated parameter, where a lower value makes the parameter more precise and more
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certainly non-zero. In addition, p-values less than 0.05 indicate that the parameters are
non-zero and statistically significant. All p-values (not shown in table) for the parameters
shown in Table 6.4 were found to be less than 0.006, signifying the statistical
significance of the model parameters.
The estimated dlim values (Table 6.4) are almost identical to the experimental
median particle sizes obtained after total milling time of 64 min (Table 6.2), except for
Runs 4 and 8, thus giving some credence to the purely empirical model (Eq. (2.7)). Even
for Runs 4 and 8, the experimental median size was within two standard deviation of the
estimated dlim.
Table 6.4 Parameter Estimates from the Empirical Model Fit (Eq. (2.7)) to the
Milling Data with Statistical Analysis
Run
dlim , COV%
τp , COV%
R2
SSR
a
No.
(µm), (–)
(min), (–)
(–)
(–)
1
0.159 (5.98)
5.59 (8.93)
0.980
1.32×10-2
2
0.156 (6.37)
6.06 (8.93)
0.980
1.39×10-2
3
0.155 (4.75)
6.45 (9.25)
0.983
9.76×10-3
4
0.128 (12.8)
16.3 (12.1)
0.978
9.66×10-3
6
0.148 (8.84)
4.67 (10.8)
0.969
3.16×10-2
7
0.179 (12.0)
5.88 (17.8)
0.920
5.09×10-2
8
0.136 (3.40)
5.78 (7.29)
0.990
5.50×10-3
9
0.145 (18.5)
12.5 (17.7)
0.925
4.20×10-2
a

Note: Data for Runs 5 and 10 were not fitted as the suspensions were not physically stable.

The main interest lies in the time constant (τp ). Comparing τp values of different milling
modes at a flow rate of 110 mL/min (Runs 1 vs. 2 for GF and Runs 6 vs. 7 for NAP),
analysis from the model fit illustrate that the breakage in the recirculation mode of
milling was slightly faster than the breakage in the multi-pass continuous mode.
Comparing the same processes at a reduced flow rate (Runs 3 vs. 4 and Runs 8 vs. 9) led
to confirm this finding. Moreover, an additional evidence for the increased disparity
between the recirculation and multi-pass continuous modes of milling at the lower
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suspension flow rate (55 mL/min) can be observed. This was partly ascribed to the 50 mL
residual suspension in the multi-pass mode, but it could also be related to the degree of
back-mixing taking place in the milling chamber (see below).
A comparison of the empirical model fit parameters from Runs 1 vs. 3, Runs 2 vs.
4, Runs 6 vs. 8, and Runs 7 vs. 9 in Table 6.4 shows that the runs with a suspension flow
rate of 55 mL/min had a larger characteristic time constant than the runs with a
suspension flow rate of 110 mL/min. This suggests a slower overall breakage rate at the
lower suspension flow rate. Comparing Figures 6.6 and 6.7 suggests a wider PSD at the
reduced flow rate. Since a study of the residence time distribution (RTD) of particles in
the mill is beyond the scope of this chapter, few limited studies will be mentioned from
the literature to discuss the effects of the suspension flow rate from the RTD perspective.
During wet media (bead) milling of various materials, an increase in the suspension flow
rate caused a tightening of the RTD (Deutsche Keramische Gesellschaft, 2009; Kula and
Schütte, 1987; Stehr, 1982) (less back- mixing) or that a decrease led to widening of the
RTD (Stehr and Schwedes, 1983). Within the context of the convection–dispersion model
(Schwedes and Bunge, 1993; Stehr, 1984), the RTD in a wet stirred media mill may be
described by a single dimensionless number called Péclet (Pe) number: Pe = VL/D. Here,
V is the average axial velocity of the suspension, L is the length of the horizontal mill
chamber, and D is the axial dispersion coefficient. A Pe value of 0 describes an ideal,
perfectly well- mixed vessel (perfect back-mixing), whereas a Pe value of ∞ describes
ideal, plug- flow vessel (no back- mixing). Obviously, real systems operate somewhere in
between these two extreme, idealized back-mixing scenarios: Pe for stirred bead mills
usually varies from 0.6 to 5 depending on the operational conditions (Schwedes and
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Bunge, 1993). This suggests that the mixing condition in stirred media mills is closer to
that of a perfectly well- mixed vessel (Folger, 1999). From the definition of Péclet (Pe)
number, one can see that an increase in the suspension flow rate leads to a larger Pe
(tighter RTD) through a proportional increase in V (with negligibly small increase in D),
which in turn leads to a tighter and usually finer PSD during milling (Deutsche
Keramische Gesellschaft, 2009; Schwedes and Bunge, 1993; Stehr, 1982, 1984; Stehr
and Schwedes, 1983). Population balance modeling of continuous mills demonstrated
that the PSD is tighter and finer for a mill with no back- mixing (plug- flow) than that with
perfect mixing (Bilgili and Scarlett, 2005), thus suggesting a higher overall breakage rate
for the plug- flow case. In summary, the wider PSD and reduced overall breakage rate
associated with the decrease in the suspension flow rate could be explained by a decrease
in the Péclet (Pe) number (widening of the RTD).

6.3.2 Role of Stabilizers in Wet Media Milling
During wet media milling of materials, stabilizers such as polymers and surfactants, also
known as grinding aids, can affect or play a major role in three phenomena: stabilization
of the suspension and proper dispersion of the product particles, microhydrodynamics
during media milling as affected by suspension rheology, and particle strength (El-Shall
and Somasundaran, 1984; Klimpel, 1999). In a suspension, electrically neutral polymers
like HPC stabilize particles by steric forces that are created by protruding large chains
after polymer adsorption onto the particle surfaces (steric mechanism); whereas anionic
surfactants like SLS can render the particles negatively charged after adsorption, which
increases the electrostatic repulsion among adjacent particles and thereby preventing
particle aggregation (electrostatic mechanisms) (El-Shall and Somasundaran, 1984;
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Klimpel, 1999). Combination of polymers (like HPC) and surfactants (like SLS) is
known to have synergistic stabilizing effects (Basa et al., 2008; Ryde and Ruddy, 2002).
It is interesting to note that most pharmaceuticals literature on wet media milling focused
on the first phenomena, i.e., stabilization and proper dispersion of the particles (e.g.
Bruno et al., 1996; Ghosh et al., 2011; Lee et al., 2008; Singh et.al., 2011), thus largely
neglecting the impact of the stabilizers on the microhydrodynamics and the particle
strength (associated with the Rehbinder effect). The so-called Rehbinder effect
(Rehbinder, 1958) is defined as the reduction in surface energy and surface structure
change upon adsorption of surface-active agents, which leads to an increase in ductility,
reduced hardness, and enhanced crack propagation in various materials (Butyagin, 1999;
Karpenko, 1974; Rehbinder and Shchukin, 1972; Shchukin, 2006), thus potentially
enhancing the breakage of particles during wet milling operations (Butyagin, 1999;
Rehbinder, 1958; El-Shall and Somasundaran, 1984). Unfortunately, up to now,
sufficient experimental data are not available to prove or disprove the Rehbinder effect
during milling processes (Kissa, 1999; Tadros, 1994) perhaps due to the aforementioned
confounding effects of the stabilizers.
6.3.2.1 Stabilization and Rehbinder Effect.

Milling experiments were carried out

under identical conditions (same set points for the process variables) in the presence and
absence of stabilizers (HPC/SLS) toward elucidating the roles of stabilizers. To this end,
particle sizing via laser diffraction (LD), SEM imaging, and BET nitrogen adsorption
were used. The Sauter-Mean Diameter (SMD) was calculated separately from the LD
particle size distribution data on milled suspension samples and the specific surface area
(SSA) (BET adsorption on dried suspension samples). No BET adsorption was performed
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on samples with the stabilizers as the particle surfaces were covered by excessive
amounts of the stabilizers, which could prevent accurate measureme nt of the SSA
without yielding a good estimate of the primary particle size. Table 6.5 summarizes the
calculated SMD values. A suspension of GF without the stabilizers (HPC/SLS) was
prepared and milled in the multi-pass continuous mode (Run 5). The PSD was obtained
and compared to that of the milled GF in the presence of the stabilizers (Run 2).
Table 6.5 Sauter-Mean Diameter (SMD) of the Milled GF and NAP
Run
No.

Drug

Stabilizers Added
Before Milling

Stabilizers Added
After Milling

Measurement
Methoda

SMD
(µm)

2

GF

2.5% HPC/0.5% SLS

—

LD

0.153

5

GF

—

—

LD

1.48

5

GF

—

—

BET

0.522

5

GF

—

2.5% HPC/0.5% SLS

LD

0.479

7
10
10

NAP
NAP
NAP

2.5% HPC/0.5% SLS
0% HPC/0.08% SLS
0% HPC/0.08% SLS

—
—
—

LD
LD
BET

0.130
0.563
1.12

a

LD (laser diffraction) was performed on wet suspension samples, whereas BET nitrogen
adsorption was performed on oven-dried suspensions after degassing.

Figure 6.8 illustrates that in the absence of the stabilizers, GF suspension exhibits a
bimodal PSD, possibly indicating the presence of primary nanoparticles and their
aggregates of various sizes (to be confirmed with SEM imaging and BET adsorption
analysis). On the other hand, the PSD of GF suspension milled with the stabilizers shows
a tight, unimodal distribution of particle sizes in the range of about 100–200 nm. Figure
6.9 presents the SEM images of the dried samples from Runs 2 and 5. Figure 6.9a shows
GF milled in the absence of the stabilizers (Run 5) at low magnification, with mostly
aggregated particles sized between 1 and 20 µm in size. Further magnification of these
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particles (Figure 6.9b) shows the existence of primary nanoparticles with a size range of
150–600 nm. To compare these results, SEM images of the GF milled in the presence of
the stabilizers in both recirculation and multi-pass continuous modes (Runs 1 and 2)
(Figure 6.9c and 6.9d) are shown, where primary particles sized between 100–200 nm
can be observed.
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Figure 6.8.Effect of polymer/surfactant (HPC/SLS) on the particle size distribution of
milled GF (Runs 2 and 5).

The SEM imaging appears to corroborate the laser diffraction results: Run 5 suspension,
being unstable in the absence of the stabilizers, consists of some nanoparticles and their
aggregates (primary particle sizes in the size range of 150–600 nm), whereas Run 2
suspension, being stable in the presence of the stabilizers, consists of primary
nanoparticles in the size range of 100–200 nm (see both Figure 6.9d and Figure 6.8) with
minimal amount of aggregates. This suspension was also physically stable over 7-day
storage (see Table 6.2).
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Figure 6.9 SEM images of milled Griseofulvin (GF): (a) milled in multi-pass continuous
mode for 16 passes w/o HPC/SLS at 1.5 kX (Run 5), (b) milled in multi-pass continuous
mode for 16 passes w/o HPC/SLS at 100 kX (Run 5), (c) milled in recirculation mode for
16 turnovers w/ HPC/SLS at 137 kX (Run 1), (d) milled in multi-pass continuous mode
for 16 passes w/ HPC/SLS at 137 kX (Run 2).
In the absence of the stabilizers (HPC/SLS), the nanoparticles formed by the
breakage of GF particles in Run 5 aggregated extensively in the suspension due to their
large surface area, high number concentration, and strong attractive interparticle forces
(van der Waals and hydrophobic interactions (El-Shall and Somasundaran, 1984; Kissa,
1999). On the other hand, due to the synergistic stabilizing action of adsorbed HPC/SLS
(Basa et al., 2008; Ryde and Ruddy, 2002), the nanoparticles were protected against
aggregation during the milling and storage, and thus a stable suspension formed in Run 2.
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Besides its interaction with HPC, SLS helps wetting the particles and aggregates that may
have formed instantaneously during the milling. SLS also helps fluid penetration into
aggregate pores, which may in turn facilitate the deaggregation of these aggregates into
primary particles during the milling (Kissa, 1999).
All of these aspects that relate to the stabilization/dispersion phenomena are
widely recognized within the pharmaceuticals field. Polymers and surfactants have a
major role in wet media milling: they stabilize particles against aggregation and ensure
the production of a stable, properly dispersed suspension. On the other hand, a more
important conclusion can be drawn from the aforementioned SEM images: the primary
GF nanoparticles formed in the presence of the stabilizers (Run 2, 100–200 nm) appear to
be smaller than those formed in the absence of the stabilizers (Run 5, 150–600 nm). In
other words, the stabilizers facilitated the particle breakage and caused the formation of
smaller primary particles during the milling. This is the first piece of evidence for the
Rehbinder effect of HPC/SLS during the wet milling of GF particles. To gather additional
evidence, Sauter-Mean Diameter (SMD) values calculated from LD and BET analysis
were compared (see Table 6.5). The SMD values obtained from the LD data were 1.48
µm for Run 5 sample (no stabilizers) and 0.153 µm for Run 2 sample (with the
stabilizers). From the BET analysis, SSA and SMD values were 8.21 m2 /g and 0.522 µm
for Run 5 sample. The SMD calculated from SSA (BET nitrogen adsorption) is a good
measure of the true primary particle size in a powder with aggregates (Vital et al., 2008).
For Run 5 (without stabilizers), the SMD value of 0.522 µm (BET) vs. 1.48 µm (LD)
confirms that Run 5 particles in the suspension consist of nanoparticles and their
aggregates. More importantly, while noting the difference in the respective measurement
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techniques, with the SMD value of 0.522 µm (BET) and the observed primary particle
size range of 150–600 nm (SEM), it can be confirmed that Run 5 (no stabilizers) primary
particles are indeed larger than those of Run 2 (with stabilizers), thus giving credence to
the existence of the Rehbinder effect.
It is argued that stabilizers can be added to a milled drug suspension (without
stabilizers) at the end of the milling process, which may result in a similar PSD to that
obtained with initial addition of the stabilizers (standard procedure). If this were the case,
the Rehbinder effect could be refuted because the stabilizers would not appear to
facilitate the particle breakage (Bhakay et al., 2011). Toward testing this hypothesis,
HPC/SLS was dissolved in 50 mL Run 5 sample by mixing for 15 min (GF suspension
obtained from the 16 passes of the multi-pass continuous milling in the absence of the
stabilizers) to prepare a suspension with 2.5% HPC and 0.5% SLS while keeping GF
loading at 10%. This sample was then sonicated for 35 min to facilitate the efficient
deaggregation of the aggregates in Run 5 based on the learning from a comprehensive
redispersion study on drug nanoparticle deaggregation (Bhakay et al., 2013). PSD data
obtained from laser diffraction of Run 5 sample after HPC/SLS addition shows an SMD
of 0.479 µm (Table 6.5), which was much larger than the SMD value for the Run 2
sample (0.153 µm) with the stabilizers added at the beginning of the milling. Similar
information can be gained from a comparison of the SEM images in Figure 6.9d (Run 2)
and 10 (Run 5, after HPC/SLS addition): the primary particles appear to be smaller when
the stabilizers were added at the beginning of the milling (Figure 6.9d) as opposed to the
case where the stabilizers were added at the end of milling (Figure 6.10). Hence, the
Rehbinder effect cannot be refuted.
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Similar to the analysis performed on GF, the PSD of NAP milled with no
HPC/0.08% SLS (Run 10) was obtained and is shown in Figure 6.11, along with NAP
milled in the presence of HPC/SLS (Run 7). Figure 6.11 suggests that NAP milled with
no HPC/0.08% SLS produced a bimodal distribution, which indicates the presence of
primary nanoparticles and their aggregates (see also Figure 6.12), while the PSD of NAP
milled with stabilizers shows a tight, unimodal distribution with particle sizes in the range
of 50–250 nm. The LD analysis yielded SMD values of 0.130 µm and 0.563 µm for Runs
7 and 10 respectively (Table 6.5). BET adsorption analysis yielded an SMD value of 1.12
µm (SSA = 4.45 m2 /g). SEM image of Run 10 viewed under low magnification is
provided in Figure 6.12a: aggregated particles can be seen. Further magnification of these
aggregated particles (Figure 6.12b) shows evidence of primary particles with a size range
of about 200–1000 nm. Figures 6.12c and 6.12d (Runs 6 and 7) show primary
nanoparticles sized mostly between 100–200 nm when HPC/SLS combination was used
during the milling. The above results from SMD data and SEM imaging confirms the
presence of larger primary particles in the case of no HPC/0.08% SLS than in the case of
2.5% HPC/0.5% SLS, and that the suspension was not properly stabilized in the former
case. These findings provide evidence for the Rehbinder effect in NAP milling; however,
a cautionary note that the presence 0.08% SLS (albeit much smaller than the CMC of
SLS) may confound some of the above findings in NAP case. However, it was not
feasible to process NAP particles consistently and reproducibly due to poor wetting of
NAP in the absence of the surfactant.
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Figure 6.10 SEM image (magnification at 75 kX) of Griseofulvin (GF) particles after
milling in multi-pass continuous mode for 16 passes in the absence of HPC/SLS (Run 5)
followed by addition of 2.5% HPC and 0.5% SLS with sonication for 35 min.
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Figure 6.11 Effect of polymer/surfactant (HPC/SLS) on the particle size distribution of
milled Naproxen (NAP) (Runs 7 and 10).

6.3.2.2 Suspension Rheology and Microhydrodynamics. One may argue that the
aforementioned positive effects of the presence of stabilizers in the production of finer
primary drug particles and stable nanosuspensions could have resulted from the
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stabilizers’ impact on the suspension rheology and microhydrodynamics in the mill.
Toward testing this hypothesis, the apparent shear viscosity of the milled GF suspensions
(Runs 2 and 5) as a function of shear rate was measured (see Figure 6.13).

Figure 6.12 SEM images of milled Naproxen (NAP): (a) milled in multi-pass continuous
mode for 16 passes w/o HPC and with 0.08% SLS at 1.0 kX (Run 10), (b) milled in
multi-pass continuous mode for 16 passes w/o HPC and with 0.08% SLS at 75 kX (Run
10), (c) milled in recirculation mode for 16 turnovers w/ HPC/SLS at 137 kX (Run 6),
(d) milled in multi-pass continuous mode for 16 passes w/ HPC/SLS at 130 kX (Run 7).

The stabilized GF suspension with minimal aggregation (Run 2, with HPC/SLS) exhibits
a Newtonian fluid behavior above a shear rate of 150 1/s, whereas the unstable GF
suspension with aggregates (Run 5, without HPC/SLS) exhibits a strong shear-thinning
behavior due to extensive deaggregation of the aggregates with increasing shear rate. The
apparent viscosity of Run 5 suspension tends to plateau as the shear rate approaches 1000
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1/s. These observations are in line with other suspension rheology studies (Barthelmes et
al., 2010; Bernhardt et al., 2010; Vital et al., 2008). Although the shear rate in media
mills usually exceeds 1000 1/s, most earlier work considered 1000 1/s as a representative
value for the high shear rate in their analysis (Barthelmes et al., 2010; Bernhardt et al.,
2010; Knieke et al., 2010; Vital et al., 2008). As can be seen from Figure 6.13, for both
suspensions, the apparent shear viscosities approach a constant value near 1000 1/s;
hence, taking the viscosity value at a shear rate of 1000 1/s does not cause a serious flaw
within the context of the microhydrodynamic analysis presented below.
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Figure 6.13 Variation of the apparent shear viscosity as a function of the shear rate at 25
o
C for the milled Griseofulvin (GF) suspensions: with stabilizers (Run 2) and without
stabilizers (Run5).

A microhydrodynamic analysis of wet stirred media mills has been recently
developed to simulate the impact of mill rotor speed and bead type/size on the bead–bead
collisions and to relate the responses from these simulations to some general observations
from wet

media

milling

experiments
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(Eskin

et

al.,

2005a,

2005b).

The

microhydrodynamic analysis have been used to explain the experimentally observed
“viscous dampening” phenomenon (see Chapter 3) during the wet media milling of high
drug–polymer loaded suspensions (Bilgili and Afolabi, 2012). According to this
theoretical approach, the specific power applied to the mill rotor (P w) dissipates through
the fluctuating motions of the beads at the micro-scale, which is mathematically
expressed in Chapter 2.4. Table 6.6 presents the measured parameters Pw, L, and µL and
calculated values of, ub, and ν. Milling in the absence of the stabilizers (Run 5) led to
slightly higher , u b, and ν values than milling in the presence of the stabilizers (Run 2).
Table 6.6 Measured Parameters (P w, L, and µL) and Calculated Microhydrodynamic
Parameters (  ,  , and ub ) for Milling of GF
Run

Pw

L

µL





ub

No.

(W/m3 )

(kg/m3 )

(cP)

(m2 /s2 )

(1/s)

(m/s)

2

1.24×106

1037

31.0

2.28×10-2

6.47×103

2.41×10-1

5

7.89×105

1008

10.4

2.61×10-2

6.92×103

2.58×10-1

The microhydrodynamic analysis suggests that slightly faster particle breakage and finer
primary particles should have been observed in the absence of the stabilizers because the
higher values of , ub, and ν mean more intense and frequent bead–particle collisions in
the mill. However, the experimental findings presented earlier suggest otherwise.
Therefore, the aforementioned positive effects associated with the use of the stabilizers
(proper stabilization/dispersion and facilitation of the particle breakage or Rehbinder
effect) did occur despite the less favorable microhydrodynamics in the mill.
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6.4 Summary and Conclusions
Two poorly water-soluble drugs, Griseofulvin and Naproxen, were milled in a wet stirred
media vessel using the recirculation mode and the multi-pass continuous mode at two
different suspension flow rates. Breakage dynamics was assessed using an empirical
model fit of the median particle size. The roles of stabilizers (HPC and SLS) have been
elucidated by performing experiments in the presence/absence of stabilizers and
characterizing the milled suspensions and dried suspensions via laser diffraction, BET
nitrogen adsorption, and SEM imaging. Based on characterization with DSC (on both GF
and NAP), PXRD (on GF), and Raman spectroscopy (on GF), the crystallinity of the
drugs has been largely preserved after wet media milling. Continuous production of drug
nanoparticles and stable nanosuspensions has been successfully demonstrated in the
multi-pass continuous mode, which in general yielded similar PSDs to those obtained
from the recirculation mode especially at the high flow rate. The deviations observed
between the two operation modes is attributed to the 50 mL residual suspension in each
pass during the multi-pass operation mode. The observed decrease in the breakage rate
during the milling and approach to a plateau size upon prolonged milling were explained
thoroughly in view of the lower specific breakage rate (breakage probability) of produced
finer particles and the equilibrium between breakage and aggregation. When the flow rate
was halved keeping the same total milling time (half number of passes), the overall
breakage rate decreased and PSD widened because of a decrease in the Péclet number
(widening of the residence time distribution). This also led to more disparity between the
two modes of operation. The implications of the findings from a formulation/process
development perspective are
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a) Formulation development with nanosuspension formulations, even those intended for
continuous manufacturing, can be performed in the batch or recirculation mode. The
formulation, stabilization, and processing knowledge generated can be transferred to
continuous operations without major difficulty.
b) Multi-pass mode can be automated to allow passes between two holding tanks in a
swing/pendulum fashion, which will reduce development time significantly toward
predicting the number of mills required for true (cascade) continuous milling
operation.
c) In a true continuous milling process, a cascade of 6–12 media mills in series can lead
to production of drug nanosuspensions. The exact number depends on the drug
properties, formulation, and specific milling equipment as well as the desired/target
drug particle size.
Through a comparative analysis of laser diffraction data, SEM images, and BETbased Sauter-Mean Diameter, this study has provided sufficient evidence for the
existence of the Rehbinder effect during the milling of poorly water-soluble drugs. Not
only do polymers/surfactants allow proper stabilization/dispersion of the nanoparticles in
the suspensions (major effect), but they also facilitate drug particle breakage (minor–
moderate effect). These positive effects of the stabilizers did occur despite the less
favorable microhydrodynamics in the mill. In a future study, polymers and surfactants
with a wide concentration range will be separately studied to elucidate their individual
roles in the Rehbinder effect.
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CHAPTER 7
OVERALL SUMMARY AND CONCLUSIONS

In the preceding chapters, a comprehensive investigation of the production of
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the
recirculation and continuous modes has been carried out. From a process engineering
perspective, many important conclusions can be drawn. The findings in the preceding
chapters suggest that physically stable nanosuspensions of BCS Class II drugs can be
produced via wet stirred media milling (WSMM) with a judicious and synergistic use of
cellulosic polymers and surfactants. This solvent- free process appears to be robust,
yielding reproducible suspensions with high drug loading and minimal media
contamination. It can be carried out in batch, recirculation, and multi-pass continuous
modes successfully. The as-received and milled particles of two BCS class II drugs
namely Griseofulvin (GF) and Naproxen (NAP) were characterized to investigate the
crystalline state of the particles. Characterization with DSC (on both GF and NAP),
PXRD (on GF), and Raman spectroscopy (on GF), suggests that the crystallinity of the
drugs has been largely preserved after wet media milling.
The dissertation work also contributed to the fundamental understanding of the
preparation of stable drug nanoparticles suspensions; specifically it (1) indicated the need
for a minimum polymeric stabilizer-to-drug ratio for proper stabilization of drug
nanosuspensions as dictated by polymer adsorption and synergistic interactions between a
polymeric stabilizer and a surfactant, (2) demonstrated the existence of an optimum
polymer concentration from a breakage rate perspective in the presence of a surfactant,
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which results from the competing effects of viscous dampening and enhanced steric
stabilization at higher polymer concentration, (3) developed fundamental understanding
of the breakage dynamics–processing–formulation relationships and rationalized
preparation of a single highly drug- loaded batch (20% or higher) instead of multiple
dilute batches, (4) developed an intensified process for faster preparation of sub-100 nm
particles with reduced specific energy consumption and media wear (i.e. minimal drug
contamination), and (5) provided evidence for the proof of the Rehbinder effect during
the milling of drugs. Not only do the polymers and surfactants allow proper physical
stabilization of the nanoparticles in the suspensions, but they also do facilitate drug
particle breakage.
To understand the governing mechanism(s) during particle formation, a detailed
the roles of stabilizers, i.e., cellulosic polymers and surfactants, were investigated in
Chapter 3. Although polymers and surfactants are commonly used as stabilizers to impart
physical stability to the suspensions produced by WSMM of poorly-water soluble drugs,
scant information is available in pharmaceutical literature regarding their impact on the
breakage kinetics. A combined microhydrodynamics–polymer adsorption analysis was
implemented in Chapter 3 to elucidate the roles of stabilizers with a focus on the kinetics.
Griseofulvin (GF) was milled at various concentrations of hydroxypropyl cellulose
(HPC) in the presence–absence of sodium dodecyl sulfate (SDS). Particle sizing,
scanning electron microscopy, thermal analysis, and rheometry were used to determine
the breakage kinetics, adsorption isotherm, and apparent viscosity, which were then used
to analyze the aggregation state of the milled suspensions and the microhydrodynamics.
In the absence of SDS, an increase in HPC concentration slowed the particle aggregation
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leading to faster apparent breakage. On the other hand, due to a synergistic stabilizing
action of HPC with SDS, lower HPC concentration was needed to stabilize the
suspensions, and an optimum HPC concentration for the fastest apparent breakage was
identified. The microhydrodynamic analysis quantified, for the first time, the viscous
dampening effect of polymers, while only the combined analysis could explain the
observed optimum.
As the WSMM process is expensive and energy- intensive, it was important to
study the breakage kinetics, which determines the cycle time and production rate for a
desired fineness. To this end, the impact of stirrer speed, bead concentration, and drug
loading on the breakage kinetics was explored via a microhydrodynamic model for the
bead–bead collisions. Suspensions of GF were prepared in the presence of two
stabilizers: HPC and SDS. Laser diffraction, scanning electron microscopy, and
rheometry were used to characterize them. Various microhydrodynamic parameters
including a newly defined milling intensity factor was calculated. An increase in either
the stirrer speed or the bead concentration led to an increase in the specific energy and the
milling intensity factor, consequently faster breakage. On the other hand, an increase in
the drug loading led to a decrease in these parameters and consequently slower breakage.
While all microhydrodynamic parameters provided significant physical insight, only the
milling intensity factor was capable of explaining the influence of all parameters directly
through its strong correlation with the process time constant. Besides guiding process
optimization, the analysis rationalizes the preparation of a single highly drug- loaded
batch (20% or higher) instead of multiple dilute batches.
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Chapter 5 presents the design of an intensified WSMM process for the production
of truly nanosized drug particles (1-100 nm) with acceptable physical stability and
minimal bead wear. In pharmacutical literature, 100–300 nm particles were prepared by
several hours to days of milling with relatively high energy consumption. A combined
experimental and theoretical approach (microhydrodynamic model) was adopted with the
ultimate objective of achieving faster production of sub-100 nm BCS class II drug
particles with reduced energy consumption. The impact of media (bead) size on the
energy consumption and breakage kinetics GF and naproxe n (NAP) were elucidated. The
baseline process with the optimal bead size was intensified by increasing the stirrer tip
speed, bead loading, and suspension flow rate systematically, as guided by the
microhydrodynamic model of the process. In all milling experiments, the suspensions
were physically stabilized using a low molecular weight neutral polymer -hydroxypropyl
methyl cellulose (HPMC-E3) and SDS. Static light scattering, dynamic light scattering,
scanning electron microscopy, and powder X-ray diffraction were used to characterize
the milled drug particles. Experimental and microhydrodynamic analysis of the milling
beads showed that the smallest beads were effective in achieving sub-100 nm median size
particles at the end of 6 h, with reduced specific energy consumption due to their relative
high energy dissipation rate during the deformation of the particles (mill intensity factor).
As guided by the microhydrodynamic model, the mill intensity factor was further
increased by the combined use of intense mill parameters, which led to a GF particle size
of 83 nm within 30 min of milling. Experimental investigation to produce GF particle
size of 100 nm (ball-park size) with use of intensified process showed a 13.6 times
reduction in cycle time compared to the baseline process with energy savings up to 43%.
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This also led to 86.5% less bead wear (zirconium) contamination in the GF drug
suspension as measured by inductive coupled plasma mass spectrometry analysis.
Similarly, milling of NAP with intensified process conditions also led to the faster
preparation of sub-100 nm particles with reduced specific energy consumption and bead
wear. The use of small beads (100 m) has enabled the intensification of the process,
increase the breakage rate, and reduce the energy consumption without causing gross
contamination of the drug product with worn-out beads. The intensified process
methodology developed in Chapter 5 presents an opportunity for formulators/engineers to
design an intensified wet- milling process for production of sub-100 nm drug particles
with reduced cycle time and acceptable media contamination and/or to optimize existing
wet- milling processes.
In Chapters 3–5, nanoparticles of BCS Class II drugs were produced during
WSMM operating in recirculation mode. Scant information is available in the
pharmaceutical literature regarding the continuous production of drug nanoparticles via
wet media milling. GF and NAP were milled in both recirculation mode and multi-pass
continuous mode to study the breakage dynamics a nd to determine the effects of
suspension flow rate (Chapter 6). The evolution of the median particle size was measured
and described by an empirical breakage model. The results in Chapter 6 indicate that the
two operation modes could produce drug nanosusp ensions with similar particle size
distributions (PSDs). A reduced suspension flow rate slowed the breakage rate and led to
a wider PSD and more differentiation between the two operation modes. The latter part of
Chapter 6 focused on the roles of stabilizers (HPC and SDS) and elucidation of the socalled Rehbinder effect (reduction in particle strength due to adsorbed stabilizers such as
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polymers and surfactants). Milling the drugs in the absence of the stabilizers produced
primary nanoparticles and their aggregates, while milling with the stabilizers produced
smaller primary nanoparticles with minimal aggregation. Using laser diffraction, BET
nitrogen adsorption, SEM imaging, and a microhydrodynamic analysis of milling, this
study, for the first time, provides sufficient evidence for the existence of the Rehbinder
effect during the milling of drugs. Not only do the polymers and surfactants allow proper
stabilization of the nanoparticles in the suspensions, but they also do facilitate drug
particle breakage.
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CHAPTER 8
FUTURE WORK

8.1 Develop a Multi-Scale Modeling Approach for WSMM
To gain a fundamental insight into the kinetics of particle breakage and aggregation as
well as the stabilization behavior, a multi-scale modeling approach can be employed. In
this approach, the combined use of the population balance model (PBM) (process or
macro-scale) along with the microhydrodynamic model (micro-scale) will be
investigated. The multi-scale modeling approach will be adopted for a recirculation mill
so as to model the temporal evolution of the particle size distribution during milling. In
Chapters 3 and 4, the impacts of processing/formulation parameters on the
microhydrodynamics have been investigated. However, fitting and prediction of the
particle size distribution at the macro-scale via the population balance model has not been
investigated (see e.g. Bilgili and Scarlett 2005; Bilgili et al. 2006a, 2006b; Sommer et al.
2006 for population balance equation). Birth and death terms for particle aggregation will
be introduced. As a major novelty, the specific breakage rate k will be correlated to
granular temperature , thus enabling a first connection between the micro–macro scales.
PBM should also be used to elucidate diferrent breakage and aggregation mechanism.

8.2 Process Intensification for Formation of Sub-100 Nm Particles
with Multiple Drugs: Surfactant-Free Suspensions for Sterile
Filtration (Along with Process Intensification)
In Chapter 5, an intensified wet media milling process for faster p roduction of dense,
stable drug suspensions with sub-100 nm particles was investigated. The synergistic
combination of a polymer anda surfactant was employed, and small milling beads were
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used along with intensified process conditions: a high flow rate, high mill tip speed, and a
high bead concentration. The short-term physical stability of the drug suspensions was
also investigated and the suspensions were stable. The use of surfactants have been
identified to be the most effective class of dispersants improving the wettability and
redispersibility as compared with soluble polymers and sugars ( Bhakay et al., 2012).
However, the use of surfactants can affect the long term stability of the suspension upon
storage due to Ostwald ripening (Verma 2011; Ghosh, 2011). Other issues such as
toxicity of the surfactants due to excess use are a concern in most formulations
(Liversidge and Cundy 1995). For inhalation applications, the use of surfactant is either
prohibited or utilized at extremely low concentrations due to the toxicity (Suzuki et al.
2000). Future work will focus on the use of multiple drugs along with acceptable
polymers/surfactants. Future work should also explore the long term stability of such
drug suspensions.

8.3 Formulation Doe for Multiple Drugs and Relate Milling
Performance to Physicochemical, Mechanical,
and Surface Properties of the Drugs
The task aims at producing stable nanosuspensions of five BCS Class II drugs namely
griseofulvin, naproxen, fenofibrate, azodicarbonamide, and phenylbutazone using a
combination of HPC and SDS and superdisintegrants. Impact of wet- milled
superdisintegrants, as novel dispersants, on the physical stability of the drug suspensions
will also be investigated. Few systematic studies related the milling performance to the
physicochemical and surface properties of the drugs. Lee et al. (2005; 2008) studied the
effect of hydrophobicity of copolymers; Choi et al. (2005) studied the surface energy of
polymers on drug stabilization; Choi et al. (2008) and Sepassi et al. (2007) studied the
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effect of polymer molecular weight; George and Ghosh (2013) investigated the material
property variables (drug and stabilizer) that control the critical quality attributes (CQA)
defining a nanosuspension formulation; Cerdeira et al. (2011) investigated the role of
milling parameters and particle stabilization of drug materials with similar mechanical
properties. The Young’s modulus of the drug crystal was measured using in house
software and the Hertzian calculation model. Their result suggests that similar
mechanical properties of drugs exhibited similar milling behavior. Future work will
investigate how milling performance of multiple drugs relate to their physicochemical,
mechanical, and surface properties. The physical stability of the suspension should be
assessed. Elucidate the structure and the state of the polymer (mono- layer vs. multi- layer
coverage) on the surface of drug by experiments and models.

8.4 Is the Adsorbed Polymer or Surfactant Responsible for the Rehbinder Effect?
Chapter 6 sheds light on the role of the combination of polymer and surfactant on the
particle strength (Rehbinder effect) and suggests that either stabilizer could have affected
the strength of the drug particles. A systematic study with each type of stabilizer (i.e.
polymer or surfactant) alone can elucidate whether the observed Rehbinder effect
originated from either one of the stabilizers or both.

8.5 Effect of Temperature during WSMM
The effect of temperature during WSMM should be investigated along with different
degrees of cooling should be considered.
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8.6 Influence of Different Bead Materials along with Bead Mixtures of Various Sizes
on the Millng Pe rformance of Multiple Drugs
The task aims at investigating the influence of various bead materials (i.e. density of
grinding beads) along with the mixtures of the beads for the milling of multiple drugs.
Crosslinked polystyrene beads and yttrium stabilized zirconia bead is currently used for
the production of nanosuspension in the literature. Scant information exists on the impact
of bead mixtures on the milling performance of multiple drugs. Future work will involve
a systematic design of experiment to investigate the impact of bead mixtures on the
milling performance of multiple drugs. The impact of the ratio of drug particle size to the
bead size should be further examined using the microhydrodynamic model.
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APPENDIX A
SUPPLEMENTARY MATERIAL

Figures A.1 to A.6 shows supplementary material used in the text.

Figure A.1 Electrical double layer.

Figure A.2 Zeta potential.
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Figure A.3 Schematic representation of two coated nanoparticles of diameters d1 and d2
separated by surface to surface distance (s) and center to center distance (r).

Figure A.4 Possibilities for stabilization.
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Vrepulsive

Vtotal

Vattractive

Figure A.5 Typical energy versus distance profiles of DLVO theory.

Figure A.6 Bead–bead interaction.
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APPENDIX B
TYPICAL FLOW BEHAVIOR OF SUSPENSIONS

Figure B.1 Various types of common flow behavior (Edited from source: Schramm, G.,
2000. “A practical approach to rheology and rheometry”. Gebrueder HAAKE GmbH,
Karlsruhe, Dieselstrasse, Germany, pp. 20–25)
Newtonian behavior (curve 1) is observed in dilute stable dispersion of spherical
particles. For Newtonian fluids, the apparent viscosity stays relatively constant with shear
rate. The flow curve (1) is known to be ideal. All other liquids not exhibiting this “ideal”
flow behavior are called “Non-Newtonian liquids”. Liquids which show pseudoplastic
flow behavior under certain conditions of stress and shear rates – often just called
“pseudoplastic liquids” or shear thinning liquids. The structures formed by the drug
particles either due to aggregation are destroyed or deaggregated with increasing shear
rates thereby leading to a lower viscosities. For most liquid materials the shear-thinning
effect is reversible – often with some time lag – i.e. the liquids regain their original high
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viscosity when the shearing is slowed down or is even terminated: the chain-type
molecules return to their natural state of non-orientation, deformed droplets return to ball
shape and the aggregates reform due to Brownian motion (Schramm, 2000). Dilatant
liquid or shear thickening occurs when an increase in the shear rate increases the
viscosity. Shear thickening mostly occurs at high solid loadings and high shear rates due
to densely packed particles. Pseudoplastic liquids or shear thinning liquids with a yield
point is known to exhibit plasticity (Schramm, 2000). Schramm (2000) describes the
plastic fluid as dispersions which at rest can build up an intermolecular /interparticle
network of binding forces (polar forces, van der Waals forces, etc.). These forces restrict
positional change of volume elements and give the substance a solid character wit h an
infinitely high viscosity. The shear thickening behavior and the plastic fluid behavior was
not investigated in this work.
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